<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">69058</article-id><article-id pub-id-type="doi">10.7554/eLife.69058</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>REST/NRSF drives homeostatic plasticity of inhibitory synapses in a target-dependent fashion</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-234458"><name><surname>Prestigio</surname><given-names>Cosimo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-234457"><name><surname>Ferrante</surname><given-names>Daniele</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234459"><name><surname>Marte</surname><given-names>Antonella</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234679"><name><surname>Romei</surname><given-names>Alessandra</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234681"><name><surname>Lignani</surname><given-names>Gabriele</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3963-9296</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234461"><name><surname>Onofri</surname><given-names>Franco</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234460"><name><surname>Valente</surname><given-names>Pierluigi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-162351"><name><surname>Benfenati</surname><given-names>Fabio</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0653-8368</contrib-id><email>benfenati.fabio@iit.it</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-43106"><name><surname>Baldelli</surname><given-names>Pietro</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9599-3436</contrib-id><email>pietro.baldelli@unige.it</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution>Department of Experimental Medicine, University of Genova</institution><addr-line><named-content content-type="city">Genova</named-content></addr-line><country>Italy</country></aff><aff id="aff2"><label>2</label><institution>Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia</institution><addr-line><named-content content-type="city">Genova</named-content></addr-line><country>Italy</country></aff><aff id="aff3"><label>3</label><institution>Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, Queen Square House</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff4"><label>4</label><institution>IRCCS, Ospedale Policlinico San Martino</institution><addr-line><named-content content-type="city">Genova</named-content></addr-line><country>Italy</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Slutsky</surname><given-names>Inna</given-names></name><role>Reviewing Editor</role><aff><institution>Tel Aviv University</institution><country>Israel</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Chen</surname><given-names>Lu</given-names></name><role>Senior Editor</role><aff><institution>Stanford University</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>02</day><month>12</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e69058</elocation-id><history><date date-type="received" iso-8601-date="2021-04-01"><day>01</day><month>04</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-11-22"><day>22</day><month>11</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-04-21"><day>21</day><month>04</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.04.21.440758"/></event></pub-history><permissions><copyright-statement>© 2021, Prestigio et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Prestigio et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-69058-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-69058-figures-v1.pdf"/><abstract><p>The repressor-element 1-silencing transcription/neuron-restrictive silencer factor (REST/NRSF) controls hundreds of neuron-specific genes. We showed that REST/NRSF downregulates glutamatergic transmission in response to hyperactivity, thus contributing to neuronal homeostasis. However, whether GABAergic transmission is also implicated in the homeostatic action of REST/NRSF is unknown. Here, we show that hyperactivity-induced REST/NRSF activation, triggers a homeostatic rearrangement of GABAergic inhibition, with increased frequency of miniature inhibitory postsynaptic currents (IPSCs) and amplitude of evoked IPSCs in mouse cultured hippocampal neurons. Notably, this effect is limited to inhibitory-onto-excitatory neuron synapses, whose density increases at somatic level and decreases in dendritic regions, demonstrating a complex target- and area-selectivity. The upscaling of perisomatic inhibition was occluded by TrkB receptor inhibition and resulted from a coordinated and sequential activation of the <italic>Npas4</italic> and <italic>Bdnf</italic> gene programs. On the opposite, the downscaling of dendritic inhibition was REST-dependent, but BDNF-independent. The findings highlight the central role of REST/NRSF in the complex transcriptional responses aimed at rescuing physiological levels of network activity in front of the ever-changing environment.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>REST/NRSF</kwd><kwd>GABAergic synapses</kwd><kwd>BDNF</kwd><kwd>synaptic homeostasis</kwd><kwd>neural hyperactivity</kwd><kwd>homeostatic plasticity</kwd><kwd>NPAS4</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007388</institution-id><institution>Compagnia di San Paolo</institution></institution-wrap></funding-source><award-id>2017.20612</award-id><principal-award-recipient><name><surname>Baldelli</surname><given-names>Pietro</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007388</institution-id><institution>Compagnia di San Paolo</institution></institution-wrap></funding-source><award-id>2019.34760</award-id><principal-award-recipient><name><surname>Benfenati</surname><given-names>Fabio</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>H2020 Health</institution></institution-wrap></funding-source><award-id>SNAREopathies</award-id><principal-award-recipient><name><surname>Benfenati</surname><given-names>Fabio</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>IRCCS Ospedale Policlinico San Martino Genova</institution></institution-wrap></funding-source><award-id>Ricerca Corrente and &quot;5x1000</award-id><principal-award-recipient><name><surname>Baldelli</surname><given-names>Pietro</given-names></name><name><surname>Benfenati</surname><given-names>Fabio</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Ministero dell'Istruzione, dell'Università e della Ricerca</institution></institution-wrap></funding-source><award-id>PRIN2017-A9MK4R</award-id><principal-award-recipient><name><surname>Benfenati</surname><given-names>Fabio</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002426</institution-id><institution>Fondazione Telethon</institution></institution-wrap></funding-source><award-id>Grant GGP19120</award-id><principal-award-recipient><name><surname>Benfenati</surname><given-names>Fabio</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>Italian Ministry of Foreign Affairs and International Cooperation</institution></institution-wrap></funding-source><award-id>MAECI EPNZ008201</award-id><principal-award-recipient><name><surname>Benfenati</surname><given-names>Fabio</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A combination of electrophysiological, immunocytochemical, and biochemical approaches elucidate the mechanisms by which the transcriptional regulator REST/NRSF rescues neuronal homeostasis by upregulating GABAergic transmission selectively onto excitatory neurons in response to hyperactivity.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The brain is characterized by a constant and fine homeostatic regulation of neuronal intrinsic excitability and synaptic strength aimed at keeping neuronal networks’ activity within a physiological range. The dysregulation of such homeostatic mechanisms is implicated in the early phase progression of several neurological disorders, including epilepsy and Alzheimer’s disease (<xref ref-type="bibr" rid="bib27">Frere and Slutsky, 2018</xref>; <xref ref-type="bibr" rid="bib45">Lignani et al., 2020</xref>; <xref ref-type="bibr" rid="bib84">Styr and Slutsky, 2018</xref>). An increasing amount of experimental evidence shows that the repressor element 1-silencing transcription factor (REST; also known as neuron-restrictive silencer factor, NRSF) is the molecular hub of a complex neuronal transcriptomic remodeling aimed at maintaining brain homeostasis (<xref ref-type="bibr" rid="bib95">Zullo et al., 2019</xref>; <xref ref-type="bibr" rid="bib47">Lu et al., 2014</xref>; <xref ref-type="bibr" rid="bib35">Hu et al., 2011</xref>; <xref ref-type="bibr" rid="bib65">Pozzi et al., 2013</xref>; <xref ref-type="bibr" rid="bib63">Pecoraro-Bisogni et al., 2018</xref>).</p><p>REST, initially described as a nuclear negative regulator, is a zinc-finger transcription factor with several unique properties. Highly expressed in embryonic stem-cells, it is rapidly downregulated in neural progenitors and maintained at low levels after differentiation, thus enabling neurons to express the critical genes necessary for the acquisition and preservation of the neuronal phenotype (<xref ref-type="bibr" rid="bib8">Ballas et al., 2001</xref>; <xref ref-type="bibr" rid="bib9">Ballas et al., 2005</xref>; <xref ref-type="bibr" rid="bib17">Chong et al., 1995</xref>; <xref ref-type="bibr" rid="bib55">Ooi and Wood, 2007</xref>; <xref ref-type="bibr" rid="bib73">Schoenherr and Anderson, 1995</xref>). REST recruits multiple corepressors, including histone deacetylases and methyltransferases, to conserved 21 bp REST binding sites, known as RE-1 sites, on target gene promoters and represses their expression in non-neuronal cells (<xref ref-type="bibr" rid="bib9">Ballas et al., 2005</xref>; <xref ref-type="bibr" rid="bib8">Ballas et al., 2001</xref>; <xref ref-type="bibr" rid="bib30">Griffith et al., 2001</xref>). REST targets hundreds of neuron-specific genes, including those encoding for postsynaptic receptors, ion channels and transporters, cytoskeletal and synaptic proteins (<xref ref-type="bibr" rid="bib14">Bruce et al., 2004</xref>). However, some evidences showed that it may occasionally act as a transcriptional activator (<xref ref-type="bibr" rid="bib41">Kallunki et al., 1998</xref>; <xref ref-type="bibr" rid="bib64">Perera et al., 2015</xref>).</p><p>Although downregulated in differentiated neurons, REST levels are dynamically tuned in neurons and can be upregulated in response to kainate-induced seizures in vivo (<xref ref-type="bibr" rid="bib35">Hu et al., 2011</xref>; <xref ref-type="bibr" rid="bib52">McClelland et al., 2014</xref>; <xref ref-type="bibr" rid="bib51">McClelland et al., 2011</xref>; <xref ref-type="bibr" rid="bib59">Palm et al., 1998</xref>; <xref ref-type="bibr" rid="bib82">Spencer et al., 2006</xref>) and chronic hyperactivity in cultured neurons (<xref ref-type="bibr" rid="bib63">Pecoraro-Bisogni et al., 2018</xref>; <xref ref-type="bibr" rid="bib65">Pozzi et al., 2013</xref>). Moreover, REST levels progressively increase in cortical neurons of healthy humans over aging because of the increased Wnt/β-catenin signaling (<xref ref-type="bibr" rid="bib47">Lu et al., 2014</xref>). While the role of REST in epileptogenesis is still debated (<xref ref-type="bibr" rid="bib7">Baldelli and Meldolesi, 2015</xref>; <xref ref-type="bibr" rid="bib29">Garriga-Canut et al., 2006</xref>; <xref ref-type="bibr" rid="bib35">Hu et al., 2011</xref>; <xref ref-type="bibr" rid="bib45">Lignani et al., 2020</xref>; <xref ref-type="bibr" rid="bib52">McClelland et al., 2014</xref>; <xref ref-type="bibr" rid="bib51">McClelland et al., 2011</xref>), its function in aging was demonstrated to be protective from oxidative stress and amyloid β toxicity. Conditional deletion of REST in the mouse brain leads to age-related neurodegeneration and nuclear REST is decreased in mild cognitive impairment and Alzheimer’s brains, while elevated REST levels are associated with the preservation of cognitive functions in aged humans (<xref ref-type="bibr" rid="bib47">Lu et al., 2014</xref>). More recently, REST was found to be upregulated in the brain of humans with extended longevity (<xref ref-type="bibr" rid="bib95">Zullo et al., 2019</xref>).</p><p>Since neural excitation is believed to increase with age, the capability of REST to repress excitation-related genes (<xref ref-type="bibr" rid="bib65">Pozzi et al., 2013</xref>) suggests that the activation of REST and reduction of excitatory neural activity could be responsible for slowing aging in humans (<xref ref-type="bibr" rid="bib95">Zullo et al., 2019</xref>). These results are consistent with our previous studies, where we demonstrated that the hyperactivity-dependent activation of REST furthers neuronal-network homeostasis by downregulating intrinsic excitability and presynaptic function of excitatory neurons in response to chronic hyperactivity (<xref ref-type="bibr" rid="bib63">Pecoraro-Bisogni et al., 2018</xref>; <xref ref-type="bibr" rid="bib65">Pozzi et al., 2013</xref>). However, whether REST governs homeostatic plasticity by acting also on inhibitory GABAergic interneurons is still unknown.</p><p>Here, we demonstrate that REST translocates to the nucleus in excitatory and inhibitory neurons in response to hyperactivity. On inhibitory transmission, this is followed by upscaling of strength and density of perisomatic synapses and downscaling of dendritic synapses only when the postsynaptic target is an excitatory neuron. The increase of the perisomatic inhibitory inputs involves the activation of the P1 promoter-regulated <italic>Bdnf</italic> transcript through a REST-dependent activation of the immediate-early gene (IEG) <italic>Npas4</italic>, suggesting a retrograde action of BDNF released by excitatory neurons on perisomatic inhibitory terminals. The impairment of dendritic inhibition is instead exclusively REST-dependent, suggesting a direct activation of REST in inhibitory neurons.</p><p>These findings emphasize the role of REST as a master transcriptional regulator of neuronal homeostasis. By specifically acting at excitatory and inhibitory connections, REST activates a coordinated program that maintains brain circuits activity within physiological levels.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Neuronal hyperactivity induces nuclear translocation of REST/NRSF in inhibitory neurons</title><p>To study the transcriptional activity of REST in excitatory and inhibitory neurons, primary hippocampal neurons from <italic>Gad1</italic>-GFP mice (<xref ref-type="bibr" rid="bib87">Tamamaki et al., 2003</xref>; <xref ref-type="bibr" rid="bib91">Valente et al., 2016</xref>) were treated with a Cy3-tagged decoy oligodeoxynucleotide, complementary to the RE1-binding domain of REST (Cy3-ODN), that was chemically modified to improve its stability (<xref ref-type="bibr" rid="bib81">Soldati et al., 2011</xref>) and used to trace endogenous REST. A random decoy oligodeoxynucleotide sequence (Cy3-NEG) served as a negative control. Both Cy3-ODN and Cy3-NEG, added extracellularly, were able to efficiently cross the plasma membrane and diffuse in the cytosol (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A, B</xref>). Interestingly, upon hyperactivity induced by 1 hr treatment with the convulsant 4-aminopyrodine (4AP; 100 µM), Cy3-ODN doubled its partitioning ratio into the nucleus in both GFP-negative excitatory neurons and GFP-positive inhibitory neurons (<xref ref-type="fig" rid="fig1">Figure 1C–E</xref>). Conversely, Cy3-NEG treated neurons showed a homogeneous diffusion in both nucleus and cytosol that was unaffected by the 4AP treatment (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). These results confirm that REST exerts its transcriptional activity through its translocation from the cytoplasm to the nucleus also in GABAergic neurons (<xref ref-type="bibr" rid="bib79">Shimojo, 2008</xref>; <xref ref-type="bibr" rid="bib77">Shimojo et al., 2001</xref>; <xref ref-type="bibr" rid="bib78">Shimojo and Hersh, 2003</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Hyperactivity induces REST translocation to the nucleus in both inhibitory and excitatory neurons.</title><p>(<bold>A</bold>) Schematic representation of the ODN action. Having a complementary sequence to RE1, ODN binds REST, thus abrogating its capability to modulate its transcriptional activity. (<bold>B</bold>) <italic>Left:</italic> Primary hippocampal neurons (16–18 div) were incubated for 12 and 24 hr with Cy3-tagged ODN (Cy3-ODN, 200 nM). <italic>Right:</italic> Cy3-ODN efficiently permeated into primary hippocampal neurons. The bar plot shows the mean (± SEM) percentage of neurons that internalized Cy3-ODN after 12 and 24 hr of incubation (n=17 fields from two independent preparations; **p&lt;0.01; unpaired Student’s t-test). (<bold>C–E</bold>) Tracking of Cy3-ODN reveals both cytoplasmic and nuclear localizations of REST and its nuclear translocation upon hyperactivity in both excitatory and inhibitory neurons. (<bold>C, D</bold>) Representative fluorescence images of hippocampal GFP-positive inhibitory (l<italic>eft</italic>) and GFP-negative excitatory (<italic>right</italic>) neurons (17 div) treated with either vehicle or 4AP for 1 hr and subsequently labeled with Cy3-ODN for 24 hr. (<bold>E</bold>) Bar plots represent the mean± SEM of the REST partition ratio between cytosol and nucleus (Cy3-area<sub>nucleus</sub>/Cy3-area<sub>cytosol</sub>) in inhibitory (<italic>upper panel</italic>; ODN/veh n=33; ODN/4AP n=34) and excitatory (<italic>lower panel</italic>; ODN/veh n=25; ODN/4AP=32) neurons. ***p&lt;0.001; Mann–Whitney U-test. Scale bars: 20 µm (<bold>B</bold>), 10 µm (<bold>C, D</bold>). Data for (<bold>B</bold>) and (<bold>E</bold>) can be found in <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig1-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>A scrambled version of ODN (Cy3-NEG) does not translocate to the nucleus on hyperactivity.</title><p>Staining for Cy3-NEG revealed similar cytoplasmic and nuclear localization independently of the 4AP treatment. (<bold>A, B</bold>) Representative fluorescence images of hippocampal GFP-positive inhibitory (<bold>A</bold>) and GFP-negative excitatory (<bold>B</bold>) neurons treated at 17 div with either vehicle or 4AP for 1 hr and subsequently labeled with Cy3-NEG for 24 hr. Scale bar, 20 µm. (<bold>C</bold>) Bar plots (means± SEM) represent Cy3-NEG partition between cytosol and nucleus (Cy3-area<sub>nucleus</sub>/Cy3-area<sub>cyto</sub>) in inhibitory (<italic>upper panel</italic>; NEG/veh n=38; NEG/4AP n=34) and excitatory (<italic>lower panel</italic>; NEG/veh n=54; NEG/4AP n=41) neurons. p=0.82 and p=0.47, respectively; Mann–Whitney U-test. Data for (<bold>C</bold>) can be found in .</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Treatment with ODN blocks the repression of REST target genes upon hyperactivity.</title><p>(<bold>A</bold>) Schematics of the experimental protocol. Primary hippocampal neurons (16–18 div) were treated with ODN (200 nM) in the presence or absence of 4AP (100 µM) for 24 hr before qRT-PCR analysis. (<bold>B</bold>) 4AP treatment downregulates the mRNA levels of the REST target genes: <italic>Hcn1, Scn2a,</italic> and <italic>Syn1</italic>. The effect was suppressed by ODN, demonstrating its ability to inhibit REST transcriptional silencing triggered by neuronal hyperactivity. Bar plots show the fold changes (means± SEM) in <italic>Hcn1</italic>, <italic>Syn1,</italic> and <italic>Scn2a</italic> mRNAs in cortical neurons treated with NEG/vehicle, NEG/4AP, ODN/vehicle, or ODN/4AP for 24 hr (6&lt;n&lt;7 from three independent neuronal preparations). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001; two-way ANOVA/Tukey’s tests. Data for (<bold>B</bold>) can be found in <xref ref-type="supplementary-material" rid="fig1s2sdata1">Figure 1—figure supplement 2—source data 1</xref>.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig1-figsupp2-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig1-figsupp2-v1.tif"/></fig></fig-group><p>The nuclear translocation of REST induced by hyperactivity was associated with downregulation of the mRNAs of <italic>Hcn1, Syn1,</italic> and <italic>Scn2a (Nav1.2</italic>), three well-known REST target genes (<xref ref-type="bibr" rid="bib51">McClelland et al., 2011</xref>; <xref ref-type="bibr" rid="bib60">Paonessa et al., 2013</xref>; <xref ref-type="bibr" rid="bib65">Pozzi et al., 2013</xref>) in control neurons, while it was fully blocked in neurons treated with ODN (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Altogether, these data demonstrate that: (i) ODN is an excellent intracellular tracer of REST; (ii) it inhibits REST activity on its target genes; and (iii) the nuclear translocation of REST upon hyperactivity occurs in both inhibitory and excitatory neurons.</p></sec><sec id="s2-2"><title>GABAergic inhibition contributes to the REST-dependent homeostatic recovery from network hyperactivity</title><p>To investigate the role played by inhibitory transmission in REST-dependent homeostatic processes, primary cortical networks were treated at 17 days in vitro (div) with either NEG or ODN in the presence or absence of 4AP and their spontaneous firing activity was monitored over time (1–48 hr) by microelectrode array (MEA) recordings (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Untreated networks (NEG/veh and ODN/veh) behaved in a similar way, showing a progressive ~20% increase of mean firing rate (MFR), mostly due to an increased burst duration (BD), as previously observed under similar culture conditions (<xref ref-type="bibr" rid="bib65">Pozzi et al., 2013</xref>). Soon after 4AP stimulation (1 hr), NEG-treated neurons displayed greatly enhanced MFR and burst frequency (BF), accompanied by a moderate decrease of BD (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Both firing and bursting rates started to decrease after 24 hr of 4AP exposure and were significantly downscaled at the levels of control neurons at 48 hr, while the decrement of BD, acutely induced by 4AP, persisted after 48 hr. Blockade of REST activity by ODN in neurons treated for 48 hr with 4AP did not alter the acute effect of 4AP, but significantly reduced the homeostatic downscaling of both MFR and BF and fully removed the 4AP-induced decrease in BD (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>GABAergic transmission contributes to the REST-dependent homeostatic response to hyperactivity.</title><p>(<bold>A</bold>) <italic>Left panel:</italic> Representative MEA plate-map showing treatment group assignment (NEG/vehicle; NEG/4AP; ODN/vehicle; ODN/4AP). <italic>Right panels:</italic> Firing rate heat maps (<italic>left</italic>), raw voltage recordings from individual electrodes (<italic>middle</italic>) and corresponding spike detection results (<italic>right</italic>), for representative wells of the four experimental groups maintained for 48 hr in 4AP. (<bold>B</bold>) Mean firing rate (MFR) (<italic>left</italic>), bursting rate (<italic>middle</italic>) and burst duration (BD) (<italic>right</italic>) are expressed in percent of the NEG/veh baseline as a function of time after the onset of the treatments (1, 24, and 48 hr). **p&lt;0.01, ***p&lt;0.001 NEG/veh versus NEG/4AP; °°p&lt;0.01, °°°p&lt;0.001 NEG/4AP versus ODN/4AP; two-way ANOVA/Tukey’s tests. (<bold>C</bold>) Percent increases in MFR (<italic>left</italic>), burst frequency (<italic>middle</italic>), and BD (<italic>right</italic>) induced by BIC (30 μM) after 48 hr of the indicated treatments. *p&lt;0.05, **p&lt;0.01; two-way ANOVA/Tukey’s tests. Data are means± SEM (panel (<bold>B</bold>), 78&lt;n&lt;59; panel (<bold>C</bold>), 65&lt;n&lt;45 MEA wells for NEG/veh, NEG/4AP; ODN/veh and ODN/4AP, from n=7 independent neuronal preparations). Data for (<bold>B</bold>) and (<bold>C</bold>) can be found in <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig2-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig2-v1.tif"/></fig><p>To evaluate the contribution of GABAergic inhibition to the REST-dependent homeostatic response to 4AP, we blocked GABA<sub>A</sub> receptors (GABA<sub>A</sub> Rs) with bicuculline (BIC, 30 μM) at the end of the 48 hr treatment with 4AP. While BD was similarly increased by BIC in all experimental groups, the GABA<sub>A</sub>R blockade induced a significantly larger increase in MFR and BF in NEG-treated neurons stimulated with 4AP than in NEG-treated neurons stimulated with vehicle (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), suggesting the removal of a synaptic inhibition whose strength was increased by hyperactivity. Interestingly, such effect was abolished in ODN-treated neurons, demonstrating an involvement of REST in the upscaling of GABAergic transmission.</p></sec><sec id="s2-3"><title>Hyperactivity induces a REST-mediated increase of mIPSC frequency in excitatory, but not inhibitory, neurons</title><p>Miniature postsynaptic currents (mPSCs) are widely used to get information about changes in synaptic properties during homeostatic plasticity (<xref ref-type="bibr" rid="bib88">Turrigiano et al., 1998</xref>; <xref ref-type="bibr" rid="bib89">Turrigiano, 2008</xref>; <xref ref-type="bibr" rid="bib63">Pecoraro-Bisogni et al., 2018</xref>). While changes in amplitude mostly depend on the density or conductance of postsynaptic receptors (<xref ref-type="bibr" rid="bib58">O’Brien et al., 1998</xref>), changes in frequency reflect the number of active synapses and/or the quantal release probability (<xref ref-type="bibr" rid="bib75">Shao and Dudek, 2005</xref>). To evaluate whether GABAergic transmission is effectively enhanced in 4AP-treated neurons, we measured miniature inhibitory postsynaptic currents (mIPSCs) in excitatory (GFP-negative) and inhibitory (GFP-positive) neurons treated with NEG/vehicle, NEG/4AP, ODN/vehicle, and ODN/4AP for 48 hr (<xref ref-type="fig" rid="fig3">Figure 3A and E</xref>). Chronic treatment with 4AP significantly increased the frequency of mIPSCs recorded from excitatory neurons, an effect that was fully blocked by ODN (<xref ref-type="fig" rid="fig3">Figure 3B and C</xref>). Conversely, 4AP or ODN treatment did not affect the mIPSC amplitude (<xref ref-type="fig" rid="fig3">Figure 3B and D</xref>). Strikingly, 4AP-mediated chronic hyperactivity had no effects on both mIPSC frequency and amplitude recorded from inhibitory neurons (<xref ref-type="fig" rid="fig3">Figure 3F–H</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Neuronal hyperactivity selectively increases the frequency of mIPSCs in excitatory neurons in a REST-dependent fashion.</title><p>(<bold>A</bold>) Schematic representation and representative microphotographs of a patched GFP-negative excitatory neuron. (<bold>B–D</bold>) Representative mIPSC traces (<bold>B</bold>) recorded at 19 div in the four experimental groups after 48 hr of treatment. Means± SEM of mIPSC frequency (<bold>C</bold>) and amplitude (<bold>D</bold>) of NEG/vehicle (n=21), NEG/4AP (n=21), ODN/vehicle (n=21), and ODN/4AP (n=21) treated neurons. (<bold>E</bold>) Schematic representation and representative microphotograph of a patched GFP-positive inhibitory neuron. (<bold>F–H</bold>) Representative mIPSC traces (<bold>F</bold>) recorded at 19 div in the four experimental groups after 48 hr of treatment. Mean (± SEM) IPSC frequency (<bold>G</bold>) and amplitude (<bold>H</bold>) of NEG/vehicle (n=13), NEG/4AP (n=13), ODN/vehicle (n=13), and ODN/4AP (n=13) treated neurons. ***p&lt;0.001, two-way ANOVA/Tukey’s tests. Scale bars, 30 µm. Data for (<bold>C</bold>), (<bold>D</bold>), (<bold>G</bold>), and (<bold>H</bold>) can be found in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>. mIPSC, miniature inhibitory postsynaptic current.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig3-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig3-v1.tif"/></fig><p>These results indicate the presynaptic origin of the REST-dependent homeostatic changes in inhibitory transmission in response to hyperactivity and demonstrate that these effects are fully target-specific, only occurring in inhibitory-to-excitatory neuron synapses.</p></sec><sec id="s2-4"><title>Neuronal hyperactivity induces a REST-mediated increase of evoked IPSCs onto excitatory neurons</title><p>To investigate whether the increased mIPSC frequency recorded in excitatory neurons is attributable to a change in the number of active inhibitory synapses or in the quantal release probability at existing sites, we investigated evoked postsynaptic inhibitory currents (eIPSCs) in 18–21 div hippocampal neurons. Extracellular minimal stimulation in loose-patch configuration was used to evoke action potentials (APs) in GFP-positive presynaptic inhibitory interneurons and patch-clamp recordings were obtained from postsynaptic GFP-negative excitatory neurons (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Evoked IPSCs in excitatory neurons treated for 48 h with 4AP displayed an increased amplitude that was suppressed upon treatment with ODN. The 4AP-induced eIPSC enhancement was accompanied by a decrease in the paired-pulse ratio (PPR), which was also abolished by treatment with ODN (<xref ref-type="fig" rid="fig4">Figure 4B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>The hyperactivity-induced upscaling of eIPSCs is specific for excitatory neurons and mediated by a REST-dependent increase in RRP<sub>syn</sub> and P<sub>r</sub>.</title><p>(<bold>A</bold>) <italic>Left:</italic> Experimental setup showing the stimulation electrode located on a GFP-positive GABAergic neuron and the recording electrode patching a GFP-negative excitatory neuron. Scale bar, 20 µm. <italic>Right:</italic> Representative eIPSCs evoked by a paired-pulse stimulation protocol (interpulse interval, 50 ms). (<bold>B</bold>) The amplitude of the first eIPSC in the pair (<italic>top</italic>) and the paired-pulse ratio (PPR=I<sub>2</sub>/I<sub>1</sub>; <italic>bottom</italic>) of NEG/vehicle (n=32), NEG/4AP (n=31), ODN/vehicle (n=29), or ODN/4AP (n=24) treated neurons are shown as means± SEM. (<bold>C–G</bold>) Quantal analysis of RRP<sub>syn</sub> and P<sub>r</sub> in GABAergic synapses onto excitatory neurons. (<bold>C</bold>) Representative eIPSC traces evoked by a 2-s tetanic stimulation at 20 Hz in NEG-treated neurons in the absence (blue) or presence (red) of 4AP. (<bold>D</bold>) Averaged plot of normalized eIPSC amplitude versus time during the tetanic stimulation. The inset shows the boxed area in an expanded time scale. (<bold>E</bold>) Averaged cumulative profiles of eIPSCs. To calculate RRP<sub>syn</sub>, data points in the 1–2 s range were fitted by linear regression and back extrapolated to time 0. (<bold>F, G</bold>) Means (± SEM) of the individual values of RRP<sub>syn</sub> (<bold>F</bold>) and P<sub>r</sub> (<bold>G</bold>) of NEG/vehicle (n=22), NEG/4AP (n=19), ODN/vehicle (n=21), or ODN/4AP (n=21) treated neurons. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001; two-way ANOVA/Tukey’s tests. Data for (<bold>B</bold>), (<bold>D</bold>), (<bold>E</bold>), (<bold>F</bold>), and (<bold>G</bold>) can be found in <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>. eIPSC, evoked postsynaptic inhibitory current.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig4-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>eIPSCs recorded in inhibitory interneurons are not homeostatically modulated by neuronal hyperactivity.</title><p>(<bold>A</bold>) <italic>Left:</italic> Experimental setup showing the stimulation electrode located on a GFP-positive GABAergic neuron and the recording electrode patching a mono-synaptically connected GFP-positive inhibitory neuron. Scale bar, 20 µm. <italic>Right:</italic> Representative eIPSCs evoked by a paired-pulse stimulation protocol (interpulse interval=50 ms). (<bold>B</bold>) Lack of effect of 4AP on the amplitude of the first eIPSC in the pair (<italic>top</italic>) and the PPR (<italic>bottom</italic>) of NEG/vehicle (n=15), NEG/4AP (n=15), ODN/vehicle (n=15), and ODN/4AP (n=15) treated inhibitory neurons. Data are means± SEM. (<bold>C–G</bold>) Quantal analysis of RRP<sub>syn</sub> and P<sub>r</sub> in GABAergic synapses onto inhibitory neurons. (<bold>C</bold>) Representative eIPSC traces evoked by a 2-s tetanic stimulation at 20 Hz in NEG/veh- (blue) and NEG/4AP-treated neurons (red). (<bold>D</bold>) Averaged plot of normalized eIPSC amplitude versus time during the tetanic stimulation. (<bold>E</bold>) Averaged cumulative profiles of the eIPSCs. To calculate the RRP<sub>syn</sub>, data points in the 1–2 s range were fitted by linear regression and back extrapolated to time 0. (<bold>F, G</bold>) Means (± SEM) of the individual values of RRP<sub>syn</sub> (<bold>F</bold>) and P<sub>r</sub> (<bold>G</bold>) of NEG/vehicle (n=15), NEG/4AP (n=15), ODN/vehicle (n=15), and ODN/4AP (n=15) treated inhibitory neurons. No significant differences were found by two-way ANOVA/Tukey’s tests. Data for (<bold>B</bold>), (<bold>F</bold>), and (<bold>G</bold>) can be found in <xref ref-type="supplementary-material" rid="fig4s1sdata1">Figure 4—figure supplement 1—source data 1</xref>. eIPSC, evoked postsynaptic inhibitory current.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig4-figsupp1-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig4-figsupp1-v1.tif"/></fig></fig-group><p>To better define the mechanism by which neuronal hyperactivity modulates GABA release, we estimated the readily releasable pool for synchronous release (RRP<sub>syn</sub>) and the probability of release (P<sub>r</sub>) of any given synaptic vesicle in the RRP, using the cumulative amplitude analysis (<xref ref-type="bibr" rid="bib6">Baldelli et al., 2005</xref>; <xref ref-type="bibr" rid="bib72">Schneggenburger et al., 1999</xref>). When inhibitory synapses onto excitatory neurons were challenged with a 2 s train at 20 Hz (40 APs), a significant depression of eIPSCs became apparent during the stimulation period, irrespective of the amplitude of the first current of the train. In NEG-treated neurons, 4AP increased synaptic depression, an effect that was virtually absent in ODN-treated cells (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>). We next analyzed the cumulative profiles of eIPSC amplitude that display a rapid rise followed by a slower linear increase reflecting the equilibrium between depletion and constant replenishment of the RRP<sub>syn</sub> (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). The graphical extraction of the RRP<sub>syn</sub> and P<sub>r</sub> from the cumulative curves of individual neurons showed that the 4AP-induced eIPSC increase was due to an increase in both RRP<sub>syn</sub> and P<sub>r</sub>, while both quantal parameters were not affected by 4AP in ODN-treated neurons (<xref ref-type="fig" rid="fig4">Figure 4F and G</xref>).</p><p>Interestingly, the eIPSC amplitude and PPR recorded from inhibitory interneurons revealed that the synaptic strength of inhibitory synapses onto excitatory neurons was not modulated by 4AP. Accordingly, the cumulative amplitude analysis confirmed that the quantal parameters RRP<sub>syn</sub> and P<sub>r</sub> were unaffected by chronic neuronal hyperactivity and/or ODN treatment (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). The quantal analysis of synaptic strength and short-term plasticity of inhibitory transmission in neurons exposed to chronic hyperactivity confirmed the striking postsynaptic target-specificity of the homeostatic adaptations, as already highlighted by the mIPSC analysis, demonstrating that the REST-dependent upscaling of inhibitory transmission only occurs when the postsynaptic target is an excitatory neuron.</p></sec><sec id="s2-5"><title>REST-dependent increase of perisomatic GABAergic synapses onto excitatory neurons</title><p>Although the increased mIPSC frequency and eIPSC amplitude directly correlated with parallel changes in P<sub>r</sub> and RRP<sub>syn</sub> size, a concomitant increase in the number of functional synaptic contacts cannot be excluded. Moreover, being patch-clamp mostly sensitive to synaptic currents of somatic origin, the functional changes observed in GABAergic synapses onto excitatory neurons predominantly regard perisomatic synapses. To evaluate whether the REST-mediated homeostatic response to hyperactivity also affects the density of GABAergic synapses at somatic level and in more peripheral dendritic districts, we triple immunostained hippocampal neurons for VGAT, gephyrin, and β3-tubulin to label inhibitory presynaptic terminals, inhibitory postsynaptic scaffolds, and somato-dendritic structures, respectively (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). We then analyzed inhibitory synapses along the soma and dendrites of GFP-negative excitatory neurons and GFP-positive inhibitory neurons. When the postsynaptic target neuron was excitatory, the sustained hyperactivity doubled the density of inhibitory perisomatic synapses and slightly, but significantly, decreased dendritic contacts. The changes of both perisomatic and dendritic inhibitory synapses required an intact REST transcriptional activity, as they were fully blocked by treatment with ODN (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). The strict target specificity of these effects was further underlined by the absence of any change on both somatic and dendritic inhibitory synapses when the postsynaptic target was an inhibitory neuron (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Hyperactivity induces a REST-dependent specific increase of perisomatic inhibitory synapses onto excitatory neurons.</title><p>(<bold>A</bold>) Representative microphotographs showing GFP-negative excitatory neurons (20 div), treated with NEG/ctrl, NEG/4AP, ODN/veh, and ODN/4AP, labeled with β3-tubulin (light blue) and decorated with gephyrin (red) and VGAT (yellow) antibodies to identify GABAergic synapses. White lines highlight somatic areas. Scale bars, 10 µm. (<bold>B</bold>) Quantification of the density of somatic inhibitory synapses onto excitatory neurons. Data are means± SEM of 48&lt;n&lt;25, respectively, from three independent neuronal preparations. ***p&lt;0.001; two-way ANOVA/Tukey’s tests. Data for (<bold>B</bold>) can be found in <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig5-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Hyperactivity induces a REST-dependent decrease of dendritic inhibitory synapses onto excitatory neurons.</title><p>(<bold>A</bold>) Representative microphotographs showing GFP-negative excitatory dendritic processes (20 div), treated with NEG/ctrl, NEG/4AP, ODN/veh, and ODN/4 A, labeled with β3-tubulin (light blue) and decorated with gephyrin (red) and VGAT (yellow) antibodies to identify GABAergic synapses. Scale bars, 2 µm. (<bold>B</bold>) Quantification of the density inhibitory synapses onto excitatory dendrites. Data are means± SEM of 87&lt;n&lt;71, from three independent neuronal preparations. ***p&lt;0.001; two-way ANOVA/Tukey’s tests. Data for (<bold>B</bold>) can be found in <xref ref-type="supplementary-material" rid="fig5s1sdata1">Figure 5—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig5-figsupp1-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Hyperactivity does not affect the density of inhibitory synapses onto inhibitory neurons.</title><p>(<bold>A</bold>) Representative microphotographs showing a 20 div GFP-positive inhibitory neuron, treated with NEG/ctrl, labeled with β3-tubulin (light blue) and decorated with gephyrin (red) and VGAT (yellow) antibodies to identify GABAergic synapses. White lines highlight somatic and dendritic areas. Scale bar, 10 µm. (<bold>B, C</bold>) Quantification of the density of perisomatic (<bold>B</bold>) and dendritic (<bold>C</bold>) inhibitory synapses onto inhibitory neurons. Data are means± SEM of 27&lt;n&lt;20 and 87&lt;n&lt;67 for perisomatic and axodendritic synapses, respectively, from three independent neuronal preparations. No significant differences were found by two-way ANOVA/Tukey’s tests. Data for (<bold>B</bold>) and (<bold>C</bold>) can be found in <xref ref-type="supplementary-material" rid="fig5s2sdata1">Figure 5—figure supplement 2—source data 1</xref>.</p><p><supplementary-material id="fig5s2sdata1"><label>Figure 5—figure supplement 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig5-figsupp2-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig5-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-6"><title>Inhibition of BDNF-TrkB binding mimics the effect of REST blockade on the upscaling of inhibitory inputs onto excitatory neurons</title><p>It is widely accepted that BDNF is expressed and released in an activity-dependent fashion primarily by excitatory neurons (<xref ref-type="bibr" rid="bib15">Canals et al., 2001</xref>; <xref ref-type="bibr" rid="bib22">Dieni et al., 2012</xref>; <xref ref-type="bibr" rid="bib23">Ernfors et al., 1990</xref>; <xref ref-type="bibr" rid="bib50">Matsumoto et al., 2008</xref>; <xref ref-type="bibr" rid="bib34">Hofer et al., 1990</xref>; <xref ref-type="bibr" rid="bib37">Isackson et al., 1991</xref>) while it is absent from cortical inhibitory interneurons (<xref ref-type="bibr" rid="bib18">Cohen-Cory et al., 2010</xref>; <xref ref-type="bibr" rid="bib2">Andreska et al., 2014</xref>; <xref ref-type="bibr" rid="bib83">Spiegel et al., 2014</xref>). In addition, BDNF has a well-known action on the development of GABAergic synapses (<xref ref-type="bibr" rid="bib36">Huang et al., 1999</xref>; <xref ref-type="bibr" rid="bib49">Marty et al., 2000</xref>; <xref ref-type="bibr" rid="bib74">Seil and Drake-Baumann, 2000</xref>; <xref ref-type="bibr" rid="bib94">Yamada et al., 2002</xref>; <xref ref-type="bibr" rid="bib54">Ohba et al., 2005</xref>; <xref ref-type="bibr" rid="bib46">Lin et al., 2008</xref>) that mostly occurs presynaptically (<xref ref-type="bibr" rid="bib6">Baldelli et al., 2005</xref>; <xref ref-type="bibr" rid="bib5">Baldelli et al., 2002</xref>) at perisomatic synapses (<xref ref-type="bibr" rid="bib26">Fiorentino et al., 2009</xref>; <xref ref-type="bibr" rid="bib38">Jiao et al., 2011</xref>).</p><p>Based on this evidence, we focused on a possible crosstalk between REST and BDNF to elucidate molecular mechanisms of the target-specific REST action on inhibitory transmission. We first analyzed the time-course of the changes in <italic>Rest</italic> and <italic>coding sequence-Bdnf</italic> (<italic>cds-Bdnf</italic>), mRNA levels in neurons treated with 4AP for 6, 24, 48, and 96 hr (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). We also included the mRNA of the membrane trafficking protein Synaptotagmin-4 (SYT4), known to localize in BDNF-containing vesicles and modulate their release (<xref ref-type="bibr" rid="bib20">Dean et al., 2009</xref>). A significant increase in <italic>Rest</italic>, <italic>cds-Bdnf,</italic> and <italic>Syt4</italic> mRNA levels was already apparent after 6 hr of treatment with 4AP. While the <italic>Rest</italic> elevation persisted for 48 hr and recovered to basal level only after 96 hr, the fast increments in <italic>cds-Bdnf</italic> and <italic>Syt4</italic> mRNAs were short-lasting and fully recovered their basal values after 48 hr (<xref ref-type="fig" rid="fig6">Figure 6A</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>BDNF specifically potentiates GABAergic synapses onto excitatory neurons in response to hyperactivity.</title><p>(<bold>A</bold>) Time-course of <italic>Rest</italic>, <italic>cds-Bdnf,</italic> and <italic>Syt4</italic> mRNA fold changes in control (blue symbols) and 4AP-treated (red symbols) cortical neurons treated for various times with 4AP. All 4AP-treated samples were collected at 20 div after 6, 24,48, and 96 hr of 4AP treatment, respectively. The control sample was also collected at 20 div without any prior treatment. For each time point, data are means± SEM of 9&lt;n&lt;10 from three independent neuronal preparations. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 versus control; one-way ANOVA/Dunnett’s tests. (<bold>B</bold>) RT-qPCR analysis of changes (means± SEM) of <italic>Rest</italic> and <italic>cds-Bdnf</italic> mRNA transcript levels in control (blue symbols) and 4AP-treated (red symbols; 24 and 48 hr) neurons that had been infected with either scrRNA (<italic>open symbols</italic>) or shRNA (<italic>closed symbols</italic>) viruses. Treatments were performed as described in (<bold>A</bold>), with neurons collected at 20 div. For each time point, data are means± SEM of 9&lt;n&lt;10 from three independent neuronal preparations. *p&lt;0.05, ***p&lt;0.001 shRNA versus scrRNA; <sup>o</sup>p&lt;0.05, <sup>ooo</sup>p&lt;0.001 4AP-treated versus control; two-way ANOVA/Tukey’s tests. (<bold>C</bold>) Representative eIPSCs onto GFP-negative excitatory neurons in response to paired-pulse stimulation recorded in ctrl/veh, ctrl/4AP, TrkB-fc/veh and TrkB-fc/4AP treated neurons. (<bold>D</bold>) Mean (± SEM) amplitude of the first eIPSC (I<sub>1</sub>; left) and paired-pulse ratio (PPR=I<sub>2</sub>/I<sub>1</sub>; right) of ctrl/veh (n=43), ctrl/4AP (n=39), TrkB-fc/veh (n=44), and TrkB-fc/4AP (n=43) treated neurons. *p&lt;0.05, ***p&lt;0.001, two-way ANOVA/Tukey’s tests. Data for (<bold>A</bold>) and (<bold>B</bold>) can be found in <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig6-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig6-v1.tif"/></fig><p>To investigate the molecular relationship between REST and BDNF transcription, we compared the hyperactivity-dependent increase of <italic>Rest</italic> and <italic>Bdnf</italic> mRNAs in control and <italic>Rest</italic> knockdown (KD) hippocampal neurons (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). While the hyperactivity-dependent increase of <italic>Rest</italic> mRNA was fully suppressed by R<italic>Rest</italic> KD (<xref ref-type="bibr" rid="bib63">Pecoraro-Bisogni et al., 2018</xref>; <xref ref-type="bibr" rid="bib65">Pozzi et al., 2013</xref>), the temporal profile of <italic>cds-Bdnf</italic> mRNA induced by hyperactivity was markedly altered by <italic>Rest</italic> silencing. REST deficiency significantly reduced the transient increase of <italic>Bdnf</italic> at 24 hr, while it completely suppressed the recovery of <italic>Bdnf</italic> mRNA to basal levels at 48 hr, transforming the bell-shaped <italic>Bdnf</italic> expression curve into a monotonic increment.</p><p>To evaluate whether BDNF could contribute to the REST-dependent upscaling of inhibitory synapses, the effect of 4AP on evoked inhibitory transmission was studied in hippocampal excitatory neurons (18 div) treated for 48 hr with either vehicle (ctrl) or the BDNF-scavenger TrkB-fc (TrkB-fc), a recombinant chimeric protein that suppresses BDNF binding to TrkB receptors (<xref ref-type="bibr" rid="bib71">Sakuragi et al., 2013</xref>; <xref ref-type="fig" rid="fig6">Figure 6C</xref>). Interestingly, the previously observed increase of eIPSC amplitude and decrease of PPR evoked by 4AP were fully suppressed by BDNF sequestration (<xref ref-type="fig" rid="fig6">Figure 6D</xref>).</p><p>In line with this result, the 4AP-induced enhancement of perisomatic GABAergic contacts onto excitatory neurons was also fully suppressed in neurons treated with TrkB-fc (<xref ref-type="fig" rid="fig7">Figure 7</xref>). On the contrary, the 4AP-induced decrease of dendritic GABAergic contacts to excitatory neurons was insensitive to BDNF sequestration (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). Finally, as previously shown in neurons treated with ODN, either 4AP-induced hyperactivity or BDNF scavenging did not affect the density of both perisomatic and dendritic inhibitory boutons when the postsynaptic target was an inhibitory neuron (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>BDNF scavenging suppresses the 4AP-induced enhancement of perisomatic inhibitory synapses to excitatory neurons.</title><p>(<bold>A</bold>) Representative microphotographs showing GFP-negative excitatory neurons (20 div), treated with ctrl/veh, ctrl/4AP, TrkB-fc/veh, and TrkB-fc/4AP, labeled with β3-tubulin (light blue) and decorated with gephyrin (<italic>red</italic>) and VGAT (<italic>yellow</italic>) antibodies to identify GABAergic synapses. White lines highlight somatic areas. Scale bars, 10 µm. (<bold>B</bold>) Quantification (means± SEM) of the densities of somatic inhibitory synapses onto excitatory neurons (33&lt;n&lt;44), from two independent neuronal preparations. ***p&lt;0.001; two-way ANOVA/Tukey’s tests. Data for (<bold>B</bold>) can be found in <xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref>.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7">Figure 7</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig7-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>BDNF scavenging does not affect the 4AP-induced reduction of dendritic inhibitory synapses to excitatory neurons.</title><p>(<bold>A</bold>) Representative microphotographs showing a GFP-negative excitatory dendritic processes (20 div), treated with ctrl/veh, ctrl/4AP, TrkB-fc/veh, and TrkB-fc/4AP, labeled with β3-tubulin (light blue) and decorated with gephyrin (<italic>red</italic>) and VGAT (<italic>yellow</italic>) antibodies to identify GABAergic synapses. Scale bars, 2 µm. (<bold>B</bold>) Quantification (means± SEM) of the densities of somatic inhibitory synapses onto excitatory neurons (63&lt;n&lt;64), from two independent neuronal preparations. ***p&lt;0.001; two-way ANOVA/Tukey’s tests. Data for (<bold>B</bold>) can be found in <xref ref-type="supplementary-material" rid="fig7s1sdata1">Figure 7—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig7s1sdata1"><label>Figure 7—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig7-figsupp1-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig7-figsupp1-v1.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>The lack of effect of 4AP on the density of inhibitory synapses onto inhibitory neurons is not affected by BDNF.</title><p>(<bold>A</bold>) Representative microphotographs showing a 20 div GFP-positive inhibitory neuron, treated with ctr/veh, labeled with β3-tubulin (light blue), and decorated with gephyrin (<italic>red</italic>) and VGAT (<italic>yellow</italic>) antibodies to identify GABAergic synapses. White lines highlight somatic and dendritic areas. Scale bar, 15 µm. Quantification of the density of perisomatic (<bold>B</bold>) and dendritic (<bold>C</bold>) inhibitory synapses onto inhibitory neurons, in ctrl/veh, ctrl/4AP, TrkB-fc/veh, and TrkB-fc/4AP treated neurons. Data are means± SEM of 33&lt;n&lt;36 and 53&lt;n&lt;85 for perisomatic and axodendritic synapses, respectively, from two independent neuronal preparations. No significant differences were found by two-way ANOVA/Tukey’s tests. Data for (<bold>B</bold>) and (<bold>C</bold>) can be found in <xref ref-type="supplementary-material" rid="fig7s2sdata1">Figure 7—figure supplement 2—source data 1</xref>.</p><p><supplementary-material id="fig7s2sdata1"><label>Figure 7—figure supplement 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig7-figsupp2-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig7-figsupp2-v1.tif"/></fig><fig id="fig7s3" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 3.</label><caption><title>BDNF is a downstream effector of REST for the increase in perisomatic inhibitory synapses onto excitatory neurons induced by chronic hyperactivity.</title><p>(<bold>A</bold>) Representative microphotographs showing 20 div GFP-negative excitatory neurons in the absence of 4AP or treated with chronic 4AP in the presence or absence of various combinations of ODN, TrkBfc, exogenous BDNF, or their respective vehicles. Neurons labeled with β3-tubulin (light blue) and decorated with gephyrin (<italic>red</italic>) and VGAT (<italic>yellow</italic>) antibodies to identify GABAergic synapses. White lines highlight somatic and dendritic areas. Scale bars, 10 µm. (<bold>B</bold>) Quantification of the density of perisomatic inhibitory synapses onto excitatory neurons in the various experimental conditions. Inhibition of REST and inhibition of BDNF actions occlude each other when treatments are combined indicating the existence of an interaction between the two pathways (interaction F<sub>1,123</sub>=27.66; p&lt;0.0001; two-way ANOVA). Exogenous BDNF fully recapitulates the homeostatic response to hyperactivity, irrespective of whether REST is functional or blocked, demonstrating that BDNF lies downstream the REST initiated cascade. Data are means± SEM of 30&lt;n&lt;35 from three independent neuronal preparations. ***p&lt;0.001; two-way ANOVA/Tukey’s tests. Data for (<bold>B</bold>) can be found in <xref ref-type="supplementary-material" rid="fig7s3sdata1">Figure 7—figure supplement 3—source data 1</xref>.</p><p><supplementary-material id="fig7s3sdata1"><label>Figure 7—figure supplement 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig7-figsupp3-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig7-figsupp3-v1.tif"/></fig></fig-group></sec><sec id="s2-7"><title>The increase of perisomatic synapses depends on the sequential activation of REST and BDNF</title><p>Altogether, the results reveal a REST/BDNF-dependent enhancement of strength and density of perisomatic inhibitory synapses onto excitatory neurons, accompanied by a REST-dependent, but BDNF-independent, downscaling of dendritic synapses. To obtain evidence showing that the effects of REST on perisomatic inhibitory transmission depend on BDNF, we further studied the change in perisomatic synapses by combining REST inhibition with either TrkB inhibition or TrkB stimulation. This experiment was aimed at understanding whether the effects of REST on perisomatic inhibition were mediated by a sequential activation of BDNF or if, instead, REST and BDNF worked in parallel through two distinct pathways converging on the regulation of perisomatic synapses. The results (<xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3</xref>) confirmed that the 4AP-induced increase of perisomatic synapses was fully blocked by either REST inhibition or TrkB inhibition or both, indicating a full occlusion of the homeostatic effect. Importantly, the increase of perisomatic contacts was fully recovered by TrkB activation with exogenous BDNF, irrespective of whether REST was inhibited or not. Interestingly, under conditions of 4AP-induced hyperactivity, treatment with BDNF alone did not further increase the magnitude of the homeostatic change in perisomatic synapses, indicating the lack of additive effects between REST and BDNF.</p><p>Altogether, these results demonstrate that the signaling pathway underlying the hyperactivity-induced increase in perisomatic synapses depends on a serial activation of REST and BDNF, excluding the possibility of two independent pathways stimulated by hyperactivity and converging on the same target.</p></sec><sec id="s2-8"><title>REST triggers the activation of the “<italic>Npas4-Bdnf”</italic> gene program</title><p>We have shown that REST exerts a temporal constraint on the increase of <italic>Bdnf</italic> mRNA, allowing its full recovery to basal levels after 48 hr (see <xref ref-type="fig" rid="fig6">Figure 6B</xref>). This effect was expected and widely supported by experimental evidence showing that <italic>Bdnf</italic> is a REST-target gene (<xref ref-type="bibr" rid="bib29">Garriga-Canut et al., 2006</xref>; <xref ref-type="bibr" rid="bib61">Paonessa et al., 2016</xref>; <xref ref-type="bibr" rid="bib31">Hara et al., 2009</xref>; <xref ref-type="bibr" rid="bib57">Otto et al., 2007</xref>; <xref ref-type="bibr" rid="bib14">Bruce et al., 2004</xref>). On the contrary, the increase of <italic>Bdnf</italic> mRNA observed in neurons treated for 24 hr with 4AP was significantly reduced in REST KD neurons, demonstrating that REST plays an unexpected role in the early increase of <italic>Bdnf</italic> mRNA induced by hyperactivity (see <xref ref-type="fig" rid="fig6">Figure 6B</xref>). Searching for a possible causal link between REST and BDNF, we focused our attention on NPAS4, a transcriptional activator recently demonstrated to induce a hyperactivity-induced increase in the number and strength of perisomatic inhibitory synapses onto excitatory neurons by inducing BDNF release from excitatory neurons (<xref ref-type="bibr" rid="bib12">Bloodgood et al., 2013</xref>; <xref ref-type="bibr" rid="bib46">Lin et al., 2008</xref>; <xref ref-type="bibr" rid="bib83">Spiegel et al., 2014</xref>).</p><p>The existence of a crosstalk between REST, NPAS4, BDNF, and SYT4 was investigated by analyzing the changes in their transcripts in cultured neurons treated with NEG/vehicle, NEG/4AP, ODN/vehicle, and ODN/4AP at a higher temporal resolution (0, 1, 3, 6, 12, and 24 hr). Interestingly, the 4AP-induced increase of <italic>Rest</italic> mRNA was very fast, peaking at 1 hr and persisting for 24 hr (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). ODN treatment per se, rapidly increased <italic>Rest</italic> mRNA levels under basal conditions (<xref ref-type="bibr" rid="bib40">Johnson et al., 2007</xref>), indicating that the basal levels of REST protein exert a tonic transcriptional repression on the <italic>Rest</italic> gene.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>The REST-dependent potentiation of GABAergic synapses involves <italic>Npas4</italic> and <italic>P1-Bdnf</italic> activation.</title><p>(<bold>A–H</bold>) Time course of the REST-dependent transcriptomic profile induced by hyperactivity. Mean (± SEM) fold changes of <italic>Rest</italic> (<bold>A</bold>), <italic>Npas4</italic> (<bold>B</bold>), <italic>cds-Bdnf</italic> (<bold>C</bold>), <italic>Syt4</italic> (<bold>D</bold>), <italic>P1-Bdnf</italic> (<bold>E</bold>), <italic>P2-Bdnf</italic> (<bold>F</bold>), <italic>P3-Bdnf</italic> (<bold>G</bold>), and <italic>P4-Bdnf</italic> (<bold>H</bold>) mRNAs in cortical neurons treated with NEG/vehicle, NEG/4AP, ODN/vehicle, or ODN/4AP before and at various times after the respective treatments. All values are normalized to the NEG/vehicle mRNA levels. For each time point, 11&lt;n&lt;5 from three independent neuronal preparations. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, NEG/veh versus NEG/4AP; <sup>o</sup>p&lt;0.05, <sup>oo</sup>p&lt;0.01, <sup>ooo</sup>p&lt;0.001, NEG/4AP versus ODN/4AP; two-way ANOVA/Tukey’s tests. (<bold>I, J</bold>) Representative immunoblots (<bold>I</bold>) and quantitative analysis (<bold>J</bold>) of REST, NPAS4 and SYT4 protein expression in cortical neurons treated for 24 hr with NEG/vehicle, NEG/4AP, ODN/vehicle or ODN/4AP. All values (means ± sem) are normalized to the NEG/vehicle level. GAPDH was included as control of equal loading. For each protein, 6&lt;n&lt;5 from three independent neuronal preparations. *p&lt;0.05, **p&lt;0.01; ***p&lt;0.001, two-way ANOVA/Tukey’s test. Data for (<bold>A–J</bold>) can be found in <xref ref-type="supplementary-material" rid="fig8sdata1">Figure 8—source data 1</xref>.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8">Figure 8</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig8-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig8-v1.tif"/></fig><p>As previously reported (<xref ref-type="bibr" rid="bib46">Lin et al., 2008</xref>), <italic>Npas4</italic> mRNA raised already 1 hr after 4AP, but the increase was transient, and the levels started to decrease at 12 hr to return to basal values after 24 hr. Inhibition of REST activity by ODN delayed the <italic>Npas4</italic> rise and suppressed the return of <italic>Npas4</italic> to basal levels (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). These results demonstrate that REST affects <italic>Npas4</italic> transcription kinetics in a fashion similar to that of BDNF (see <xref ref-type="fig" rid="fig6">Figure 6B</xref>) but developing on a shorter time scale. Moreover, the data underline a dual role of REST in (i) the early induction of <italic>Npas4</italic> mRNA and (ii) the late return of <italic>Npas4</italic> mRNA to basal levels. Indeed, when REST is blocked by ODN, the increase of <italic>Npas4</italic> mRNA is delayed and its recovery to control value after 24 hr is inhibited.</p><p>4AP-induced hyperactivity also promoted increases in <italic>cds-Bdnf</italic> and <italic>Syt4</italic> mRNAs that were delayed (6 hr) with respect to the raise of <italic>Rest</italic> and <italic>Npas4</italic> transcripts (1 hr); this delayed rise in <italic>cds-Bdnf</italic> and <italic>Syt4</italic> mRNAs was also attenuated by REST inhibition with ODN treatment (<xref ref-type="fig" rid="fig8">Figure 8C and D</xref>).</p><p>Since BDNF is one of the main actors in the development of GABAergic inputs, the fine spatial and temporal regulation of the expression of distinct BDNF-transcripts could contribute to the REST-dependent potentiation of perisomatic GABAergic inhibition. This hypothesis brought us to investigate the mRNAs changes of <italic>P1-, P2-, P3-,</italic> and <italic>P4-Bdnf</italic> splice variants, known for their high expression in the postnatal hippocampus and cortex and for their activity-dependent regulation (<xref ref-type="bibr" rid="bib1">Aid et al., 2007</xref>) in cultured neurons treated with NEG/vehicle, NEG/4AP, ODN/vehicle, and ODN/4AP for different times. While all <italic>Bdnf</italic> transcripts were increased by hyperactivity (<xref ref-type="fig" rid="fig8">Figure 8E–H</xref>), only the <italic>P1-Bdnf</italic> mRNA was significantly inhibited by ODN (<xref ref-type="fig" rid="fig8">Figure 8E</xref>). This specific effect is highly suggestive, in view of the previously demonstrated crucial role that NPAS4 selectively exerts on the activity-dependent transcription of <italic>P1-Bdnf</italic> (<xref ref-type="bibr" rid="bib46">Lin et al., 2008</xref>; <xref ref-type="bibr" rid="bib68">Pruunsild et al., 2011</xref>).</p><p>To investigate at the protein level the outcome of the REST-dependent transcriptional changes, cultured neurons (17 div) treated with NEG/vehicle, NEG/4AP, ODN/vehicle, and ODN/4AP for 24 hr were processed by western blotting (<xref ref-type="fig" rid="fig8">Figure 8I</xref>). The data confirm the previously observed increase of REST expression in 4AP treated neurons (<xref ref-type="bibr" rid="bib63">Pecoraro-Bisogni et al., 2018</xref>; <xref ref-type="bibr" rid="bib65">Pozzi et al., 2013</xref>). Moreover, the increase in REST expression in neurons treated with ODN in the absence of 4AP reveals a negative feedback regulation exerted by REST on its own expression. Twenty-four hours of hyperactivity induced a parallel increase in both NPAS4 and SYT4 protein levels. When 4AP was applied in the presence of ODN, however, the increase of NPAS4 protein was fully suppressed, while SYT4 overexpression was unaffected (<xref ref-type="fig" rid="fig8">Figure 8J</xref>).</p><p>The data confirm the existence of a sequential mechanism for the target-specific enhancement of inhibitory transmission induced by hyperactivity in which REST induces an early activation of the fast immediate early gene NPAS4 that is followed by transcription of BDNF controlled by the P1 promoter (<xref ref-type="bibr" rid="bib1">Aid et al., 2007</xref>).</p></sec><sec id="s2-9"><title>Translational correlates of the REST-dependent homeostatic response to hyperactivity</title><p>To complete the picture, we analyzed the changes in the transcripts encoding for presynaptic and postsynaptic molecular actors, crucial for structural and functional plasticity of GABAergic synapses, in the same timescale adopted for the transcriptional profiles of <italic>Rest, Npas4, and Bdnf</italic>.</p><p>While <italic>Gad2</italic>(GAD65) mRNA was not modulated by hyperactivity, both <italic>Gad1</italic>(GAD67) and <italic>Slc32a1</italic>(VGAT) mRNAs showed significant increases under 4AP stimulation that were fully blocked by ODN treatment (<xref ref-type="fig" rid="fig9">Figure 9A–C</xref>). Notably, the mRNA peaks of these presynaptic target genes were temporally shifted to 12 hr with respect to <italic>Rest</italic>, <italic>Npas4,</italic> and <italic>Bdnf</italic> mRNA that peaked within 6 hr from the onset of hyperactivity (see <xref ref-type="fig" rid="fig8">Figure 8A–H</xref>). These results were confirmed by immunoblot analysis (<xref ref-type="fig" rid="fig9">Figure 9D</xref>), which revealed a further delayed increase of GAD67 and VGAT protein levels 48 hr after the onset of hyperactivity, that was also suppressed by ODN treatment (<xref ref-type="fig" rid="fig9">Figure 9E</xref>). The selective increase in GAD67, but not in GAD65 preferentially localized to synaptic terminals, confirms a key role of GAD67, also found at synapses (<xref ref-type="bibr" rid="bib24">Esclapez et al., 1994</xref>; <xref ref-type="bibr" rid="bib28">Fukuda et al., 1998</xref>), in GABA synthesis (<xref ref-type="bibr" rid="bib3">Asada et al., 1997</xref>) and its modulation by neuronal activity and BDNF (<xref ref-type="bibr" rid="bib25">Esclapez and Houser, 1999</xref>; <xref ref-type="bibr" rid="bib33">Hartman et al., 2006</xref>; <xref ref-type="bibr" rid="bib42">Lau and Murthy, 2012</xref>; <xref ref-type="bibr" rid="bib69">Ramírez and Gutiérrez, 2001</xref>; <xref ref-type="bibr" rid="bib70">Rutherford et al., 1997</xref>; <xref ref-type="bibr" rid="bib86">Swanwick et al., 2006</xref>).</p><fig-group><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>REST-dependent activation of GABAergic synaptic genes.</title><p>(<bold>A–C</bold>) Time course of the fold changes in mRNA levels of <italic>Gad2</italic> (<bold>A</bold>), <italic>Gad1</italic> (<bold>B</bold>), and <italic>Slc32a1</italic> (<bold>C</bold>) in cortical neurons treated with NEG/vehicle, NEG/4AP, ODN/vehicle, or ODN/4AP before and various times after the respective treatments. All values (means± SEM) are normalized to the NEG/veh levels. For each time point, 9&lt;n&lt;6 from three independent neuronal preparations. **p&lt;0.01, ***p&lt;0.001 NEG/veh versus NEG/4AP; °°p&lt;0.01, °°°p&lt;0.001 NEG/4AP versus ODN/4AP; two-way ANOVA/ Tukey’s tests. (<bold>D, E</bold>) Representative immunoblots (<bold>D</bold>) and quantitative analysis (<bold>E</bold>) of GAD67 and VGAT protein expression in cortical neurons treated for 48 hr with NEG/vehicle, NEG/4AP, ODN/vehicle, or ODN/4AP. All values (means± SEM) are normalized to the NEG/vehicle level. GAPDH was included as control of equal loading. For each protein, 6&lt;n&lt;5 from three independent neuronal preparations. *p&lt;0.05, **p&lt;0.01; two-way ANOVA/Tukey’s tests. Data for (<bold>A–E</bold>) can be found in <xref ref-type="supplementary-material" rid="fig9sdata1">Figure 9—source data 1</xref>.</p><p><supplementary-material id="fig9sdata1"><label>Figure 9—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig9">Figure 9</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig9-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig9-v1.tif"/></fig><fig id="fig9s1" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 1.</label><caption><title>The levels of α2/γ2, GABA<sub>A</sub> receptor subunits were not affected by hyperactivity.</title><p>(<bold>A</bold>) Time course of the fold changes in mRNA levels of <italic>Gabra2</italic> and <italic>Gabrg2</italic> (<bold>α</bold>2 (left) and <bold>γ</bold>2 (right) GABA<sub>A</sub> receptor subunits, respectively) in cortical neurons treated with NEG/vehicle, NEG/4AP, ODN/vehicle, or ODN/4AP before and various times after the respective treatments. All values (means± SEM) are normalized to the NEG/veh levels. For each time point, n=6 from three independent neuronal preparations. p&gt;0.05; two-way ANOVA/Tukey’s tests. (<bold>B, C</bold>) Representative immunoblots (<bold>B</bold>) and quantitative analysis (<bold>C</bold>) of the protein expression of <bold>α</bold>2 (left) and <bold>γ</bold>2 (right) GABA<sub>A</sub> receptor subunits in cortical neurons treated for 48 hr with NEG/vehicle, NEG/4AP, ODN/vehicle, or ODN/4AP. All values (means± SEM) are normalized to the NEG/vehicle level. GAPDH was included as control of equal loading. For each protein, 9&lt;n&lt;6 from three independent neuronal preparations. p&gt;0.05; two-way ANOVA/Tukey’s tests. Data for (<bold>A–C</bold>) can be found in <xref ref-type="supplementary-material" rid="fig9s1sdata1">Figure 9—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig9s1sdata1"><label>Figure 9—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-fig9-figsupp1-data1-v1.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig9-figsupp1-v1.tif"/></fig></fig-group><p>The mRNA levels of <italic>Gabra2 and Gabrg2,</italic> and the corresponding protein levels of the postsynaptic GABA<sub>A</sub> receptor subunits α<sub>2</sub> and γ<sub>2</sub>, were not affected by hyperactivity (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1</xref>). This lack of effect can be explained by the opposite actions of hyperactivity on the density of perisomatic and dendritic synapses. On the contrary, the increase in the expression of presynaptic markers could be due to the fact that perisomatic terminals are more active and larger than dendritic ones (<xref ref-type="bibr" rid="bib32">Harney and Jones, 2002</xref>; <xref ref-type="bibr" rid="bib53">Miles et al., 1996</xref>) and that the functional upscaling of perisomatic contacts occurs at the presynaptic level. This can explain why the increase of perisomatic terminals could strongly boost the expression of presynaptic proteins in a way that is not fully compensated by the observed decrease in dendritic synapses.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The dissection of the complex and articulated epigenetic mechanisms that orchestrate synaptic plasticity and excitability of individual excitatory and inhibitory neurons to maintain stability in neural circuits is an intriguing challenge in neuroscience. We previously showed that sustained neuronal hyperactivity causes REST upregulation that is crucial for maintaining neural network homeostasis via downscaling of intrinsic excitability of excitatory neurons and excitatory synaptic transmission (<xref ref-type="bibr" rid="bib63">Pecoraro-Bisogni et al., 2018</xref>; <xref ref-type="bibr" rid="bib65">Pozzi et al., 2013</xref>).</p><p>In this paper, we investigated the homeostatic role of REST in the hyperactivity-induced changes of GABAergic transmission by using the experimental paradigm of long-term treatment with the convulsive agent 4AP and applying sequestration of endogenously expressed REST with ODN. In contrast to the previously used RNA interference, that inhibits REST activity by slowly reducing its expression, ODN operates a competitive inhibition of both constitutively and newly expressed REST, allowing a better temporal dissection of the effects of REST activation by hyperactivity (<xref ref-type="bibr" rid="bib52">McClelland et al., 2014</xref>; <xref ref-type="bibr" rid="bib51">McClelland et al., 2011</xref>). A fluorescently tagged variant of ODN demonstrated that REST translocation to the nucleus occurs in both excitatory and inhibitory neurons in response to sustained hyperactivity. However, the resulting responses at inhibitory synapses were opposite to those elicited at excitatory synapses and strikingly target specific: inhibitory synapses on inhibitory neurons were not affected, while inhibitory synapses on excitatory neurons displayed an upscaling of perisomatic inhibition with increased (i) frequency of mIPSCs, (ii) density of perisomatic inhibitory synapses, (iii) amplitude of eIPSCs, and (iv) RRP size, release probability, and transcription of the presynaptic markers GAD67 and VGAT. This potentiation of perisomatic synapses was accompanied by an opposite, milder decrease of the density of dendritic synapses.</p><p>The clear-cut target selectivity of these effects suggests that the REST-dependent transcriptional cascades activated by hyperactivity involve a retrograde crosstalk between excitatory neurons and inhibitory terminals, restricting the synaptic changes only to inhibitory→excitatory synapses. This possibility prompted us to investigate the interplay between REST and BDNF. In fact, BDNF is well known for its capability to strengthen GABAergic inputs (<xref ref-type="bibr" rid="bib36">Huang et al., 1999</xref>; <xref ref-type="bibr" rid="bib49">Marty et al., 2000</xref>; <xref ref-type="bibr" rid="bib74">Seil and Drake-Baumann, 2000</xref>) by acting at the presynaptic level (<xref ref-type="bibr" rid="bib6">Baldelli et al., 2005</xref>; <xref ref-type="bibr" rid="bib5">Baldelli et al., 2002</xref>; <xref ref-type="bibr" rid="bib90">Valente et al., 2012</xref>). Moreover, neuronal hyperactivity is known to enhance BDNF transcription and release by excitatory, but not inhibitory, neurons (<xref ref-type="bibr" rid="bib83">Spiegel et al., 2014</xref>; <xref ref-type="bibr" rid="bib34">Hofer et al., 1990</xref>; <xref ref-type="bibr" rid="bib37">Isackson et al., 1991</xref>; <xref ref-type="bibr" rid="bib18">Cohen-Cory et al., 2010</xref>; <xref ref-type="bibr" rid="bib2">Andreska et al., 2014</xref>). Using BDNF scavenging, we demonstrate that BDNF is necessary for the hyperactivity-induced, REST-dependent enhancement of perisomatic inhibitory synapses, while it is not involved in the decrease of dendritic synapses. These results are reminiscent of previous reports showing a BDNF-dependent increase of perisomatic synapses and a BDNF-independent decrease of dendritic synapses onto hippocampal CA1 pyramidal neurons of mice exposed to enriched environment or treated with kainic acid (<xref ref-type="bibr" rid="bib12">Bloodgood et al., 2013</xref>). Moreover, in vivo studies showed that mutant mice lacking activity-dependent P4-BDNF expression exhibit reduced GABA release from parvalbumin-positive fast-spiking interneurons mediating perisomatic inhibition, but not from other interneuronal subtypes (<xref ref-type="bibr" rid="bib38">Jiao et al., 2011</xref>).</p><p>From these considerations, BDNF appears as the best candidate downstream effector of the homeostatic effects of REST on perisomatic inhibitory synapses. Indeed: (i) BDNF-TrkB binding inhibition fully recapitulates the effects of REST inhibition on strength/density of perisomatic inhibitory synapses onto excitatory neurons; (ii) REST inhibition dampens the hyperactivity-induced increase in <italic>cds-Bdnf</italic> transcript and, more specifically, of the <italic>P1-Bdnf</italic> transcript; (iii) a sequential temporal profile of transcriptional changes exists with a prompt (1 hr) elevation of <italic>Rest</italic> expression, followed by activation of <italic>cds-Bdnf/P1-Bdnf</italic> transcription (6 hr) and by the late increase in transcription of the presynaptic GABAergic markers <italic>Gad1</italic> and <italic>Slc32a1</italic> (12 hr). In addition, using a 2×2 factorial paradigm combining REST inhibition with the inhibition or stimulation of the TrkB pathway, we demonstrate that REST and BDNF act <italic>‘in series’</italic> and do not simply converge as independent cascades to elicit the changes in perisomatic inhibitory synapses. In fact, the combined blockade of REST and BDNF activities exerts the same extent of inhibition of the homeostatic response of the respective single treatments (occlusion). On the other hand, exogenous BDNF fully rescues the homeostatic response in the presence of REST inhibition, indicating that it lies downstream of REST activation.</p><p>Interestingly, REST had a biphasic effect on BDNF expression in response to hyperactivity, with an early enhancement followed by a late inhibition that confined the BDNF response within a time window of 48 hr. While the latter action is coherent with the transcriptional repressive action of REST on BDNF expression (<xref ref-type="bibr" rid="bib14">Bruce et al., 2004</xref>; <xref ref-type="bibr" rid="bib29">Garriga-Canut et al., 2006</xref>; <xref ref-type="bibr" rid="bib31">Hara et al., 2009</xref>; <xref ref-type="bibr" rid="bib57">Otto et al., 2007</xref>; <xref ref-type="bibr" rid="bib61">Paonessa et al., 2016</xref>), the early enhancement of the BDNF response is somewhat unexpected and may involve an indirect effect. In this respect, it has been shown that the occupancy of RE-1 sites on the promoters of <italic>Rest</italic> target genes can occasionally induce transcriptional activation (<xref ref-type="bibr" rid="bib41">Kallunki et al., 1998</xref>; <xref ref-type="bibr" rid="bib64">Perera et al., 2015</xref>) by favoring the expression of other transcription factors. Relevant to this study, it has been reported that the deletion of the RE-1 element in the <italic>Npas4</italic> promoter exerted a negative effect on <italic>Npas4</italic> transcription (<xref ref-type="bibr" rid="bib11">Bersten et al., 2014</xref>). NPAS4 is one of the most recently identified IEGs with peculiar characteristics (<xref ref-type="bibr" rid="bib46">Lin et al., 2008</xref>; <xref ref-type="bibr" rid="bib85">Sun and Lin, 2016</xref>). It is among the most rapidly induced IEGs, it is neuron-specific and selectively activated by neuronal activity (<xref ref-type="bibr" rid="bib85">Sun and Lin, 2016</xref>). Moreover, NPAS4 is known to upregulate perisomatic inhibitory synapses to excitatory neurons, an effect mediated by the activity-dependent transcription of BDNF (<xref ref-type="bibr" rid="bib12">Bloodgood et al., 2013</xref>; <xref ref-type="bibr" rid="bib83">Spiegel et al., 2014</xref>; <xref ref-type="bibr" rid="bib46">Lin et al., 2008</xref>) that mimics the homeostatic effects of REST described here. This may involve NPAS4 in the transcriptional program initiated by REST and actuated by BDNF.</p><p>The analysis of the temporal profiles of <italic>Rest, Npas4, Bdnf,</italic> and <italic>Syt4</italic> transcriptional responses to hyperactivity suggests the existence of a sequential activation of interrelated transcriptional regulators. In fact, both <italic>Rest</italic> and <italic>Npas4</italic> mRNAs increase after 1 hr of heightened activity, while <italic>cds-Bdnf</italic> and <italic>Syt4</italic> mRNAs display a later increase (6 hr) that was partially REST-dependent. It is known that the various <italic>Bdnf</italic> promoters are differentially responsive to neuronal activity (<xref ref-type="bibr" rid="bib1">Aid et al., 2007</xref>). While the <italic>P4</italic> transcript responded more quickly, the <italic>P1</italic> transcript, which showed the highest upregulation, was the only REST-dependent one. This result further supports a REST-NPAS4 link, since NPAS4 is known to specifically control the activity-dependent activation of <italic>P1-Bdnf</italic> transcription (<xref ref-type="bibr" rid="bib68">Pruunsild et al., 2011</xref>). In addition, REST has also a crucial role in the temporal confinement of the transcriptional response to hyperactivity, limiting the <italic>Npas4</italic> and <italic>Bdnf</italic> activation window in time.</p><p>It is tempting to speculate that REST by translocating from the cytoplasm to the nucleus, triggers the activation <italic>‘Npas4/P1-Bdnf’</italic> gene transcription cascade for the homeostatic rearrangement of perisomatic inhibitory inputs to excitatory neurons (<xref ref-type="fig" rid="fig10">Figure 10</xref>). An initial transcriptional wave is characterized by the activation of fast IEGs such as <italic>Rest</italic> and <italic>Npas4</italic>, in which the nuclear translocation of REST has an early facilitating role on <italic>Npas4</italic>. A second transcriptional wave involves the expression of the <italic>P1-Bdnf</italic> transcript by NPAS4, which potentially restricts BDNF action to the soma of excitatory neurons (<xref ref-type="bibr" rid="bib13">Brigadski et al., 2005</xref>; <xref ref-type="bibr" rid="bib21">Dean et al., 2012</xref>; <xref ref-type="bibr" rid="bib62">Pattabiraman et al., 2005</xref>). In turn BDNF, secreted by the soma of excitatory neurons, retrogradely reaches the inhibitory presynaptic terminals where it activates, through the TrkB signaling pathway, the final transcriptional wave of effector genes that actuates the homeostatic synaptic changes. The downscaling of dendritic inhibitory synapses to excitatory neurons, occurring in parallel with the homeostatic potentiation of perisomatic synapses, is exclusively dependent on REST, consistent with its well-known transcriptional repressor activity (<xref ref-type="fig" rid="fig10">Figure 10</xref>). Interestingly, similar opposite changes in the perisomatic and dendritic inhibitory synapses on hippocampal pyramidal neurons were found in experimental models of temporal lobe epilepsy (<xref ref-type="bibr" rid="bib19">Cossart et al., 2001</xref>).</p><fig id="fig10" position="float"><label>Figure 10.</label><caption><title>Mechanistic model of REST-dependent homeostatic rearrangement of inhibitory inputs in response to hyperactivity.</title><p>The homeostatic response to hyperactivity at inhibitory synapses onto excitatory principal neurons (in red at the onset of hyperactivity; in yellow after the homeostatic response) consists of the upscaling of perisomatic synapses and a parallel downscaling of dendritic inhibitory synapses. The decrease in dendritic inhibitory synapses is exclusively dependent on REST and independent on BDNF and consists in the canonical effect of transcriptional repression of REST rapidly activated by hyperactivity. The upscaling of perisomatic inhibitory synapses is based on the activation of three sequential transcriptional waves. The first one consists the initial nuclear translocation of REST that exerts an early facilitating role on the fast onset of <italic>Npas4</italic> transcription. The second wave involves the expression of the <italic>P1-Bdnf</italic> transcript by <italic>Npas4</italic> that potentially restricts the functional changes to the soma of excitatory neurons. Finally, in the third wave, BDNF secreted by the excitatory neurons retrogradely reaches the inhibitory terminals and activates, via the TrkB signaling pathway, the transcription of effectors genes (<italic>Slc32a1</italic> and <italic>Gad1</italic>) whose products (VGAT and GAD67) eventually increase the strength of perisomatic inhibitory inputs to excitatory target neurons through a presynaptic mechanism. Notably, REST is also involved in the late transcriptional inhibition of <italic>Npas4</italic> and <italic>Bdnf</italic>, crucial to ensuring a temporal constrain to their expressional increase (created in <ext-link ext-link-type="uri" xlink:href="https://biorender.com/">BioRender.com</ext-link>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-fig10-v1.tif"/></fig><p>Network electrophysiology with MEAs testified that the complex REST-dependent rearrangement of GABAergic inhibition onto principal neurons is a fundamental component of the homeostatic recovery of the network from hyperactivity. In fact, blockade of GABA<sub>A</sub> receptors uncovered an increased synaptic inhibition in response to hyperactivity that was blocked by REST inhibition. A key point is how the REST-mediated changes in response to hyperexcitability mechanistically result in the observed network-wide behavior. Chronic exposure to 4AP activates a complex of REST-dependent changes at the cellular level: (i) reduced expression of voltage-gated Na<sub>V</sub>1.2 channels, downregulating intrinsic excitability in principal neurons (<xref ref-type="bibr" rid="bib65">Pozzi et al., 2013</xref>); (ii) reduced strength of excitatory synapses to excitatory neurons, acting at the presynaptic level (<xref ref-type="bibr" rid="bib63">Pecoraro-Bisogni et al., 2018</xref>); (iii) increased strength and density of perisomatic GABAergic synaptic contacts to excitatory neurons; and (iv) decreased density of dendritic inhibitory synapses onto excitatory neurons (this paper). Collectively, the first three effects highlight a dramatic alteration of the E/I balance that can explain the robust homeostatic control of network dynamics characterized by compensation of the BF and moderate overcompensation of MFR. While the enhancement of perisomatic inhibitory inputs represents the main limitation to the repetitive firing of excitatory neurons, the decrease of dendritic inhibition, that normally controls the efficacy of afferent inputs by suppressing dendritic Ca<sup>2+</sup> spikes and limiting EPSC-induced depolarization (<xref ref-type="bibr" rid="bib53">Miles et al., 1996</xref>), could favor postsynaptic integration and plasticity at the dendritic level.</p><p>In conclusion, the results strengthen the idea that the complex epigenetic pathways mediated by REST and downstream transcriptional cascades activate a multiplicity of homeostatic processes acting at different levels. It was previously shown that network stability and compensatory network responses are greater at the population level compared to the single-unit level (<xref ref-type="bibr" rid="bib80">Slomowitz et al., 2015</xref>), indicating that similar network properties may arise from multiple configurations of individual components (<xref ref-type="bibr" rid="bib48">Marder and Goaillard, 2006</xref>; <xref ref-type="bibr" rid="bib67">Prinz et al., 2004</xref>). Consistent with this concept, our results suggest that firing macro-stability can emerge from the distinct combination of changes in synaptic strength and intrinsic neuronal properties of excitatory and inhibitory neurons operated by the homeostatic cascades initiated by REST.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type(species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus)</italic></td><td align="left" valign="bottom">C57BL6/J</td><td align="left" valign="bottom">Charles River</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent(<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Gad1</italic>-GFP</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib87">Tamamaki et al., 2003</xref></td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">beta3-Tubulin <break/>(Chicken Polyclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">Cat. #302306; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2620048">AB_2620048</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">VGAT cytoplasmic <break/>domain (Mouse <break/>Monoclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">Cat. #131011; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_887872">AB_887872</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Gephyrin (Mouse <break/>Monoclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">Cat. #147011; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_887717">AB_887717</ext-link></td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa405 goat <break/>anti-chicken</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat. #ab175674; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2890171">AB_2890171</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa546 goat <break/>anti-rabbit</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat. #A11010; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534077">AB_2534077</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa647 goat <break/>anti-mouse</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat. #A32728; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2633277">AB_2633277</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-REST <break/>(Rabbit Polyclonal)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">Cat. #07-579; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11211936">AB_11211936</ext-link></td><td align="left" valign="bottom">WB (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">NPAS4 <break/>(Mouse Monoclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat. #S408-79; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2735296">AB_2735296</ext-link></td><td align="left" valign="bottom">WB (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Synaptotagmin <break/>4 (Rabbit <break/>Polyclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">Cat. #105043; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_887837">AB_887837</ext-link></td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GAD67 <break/>(Mouse <break/>Monoclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #MAB5406; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2278725">AB_2278725</ext-link></td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GAPDH <break/>(Rabbit Polyclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">Cat. #Sc-25778; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10167668">AB_10167668</ext-link></td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse <break/>Peroxidase <break/>conjugated</td><td align="left" valign="bottom">Bio-Rad</td><td align="left" valign="bottom">Cat. #1706516; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11125547">AB_11125547</ext-link></td><td align="left" valign="bottom">WB (1:3000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit <break/>Peroxidase <break/>conjugated</td><td align="left" valign="bottom">Bio-Rad</td><td align="left" valign="bottom">Cat. #1706515; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11125142">AB_11125142</ext-link></td><td align="left" valign="bottom">WB (1:3000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">GABA-A receptor <break/>alpha2 (Rabbit <break/>Polyclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">Cat. #224 103; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2108839">AB_2108839</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">GABA-A <break/>receptor gamma2 <break/>(Rabbit Polyclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">Cat. #224 003; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2263066">AB_2263066</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent vectors</td><td align="left" valign="bottom">pcDNA6.2-<break/>GW/EmGFP-miR</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat. #K493600</td><td align="left" valign="bottom">BLOCK-iT <break/>Pol II miR <break/>RNAi Expression <break/>Vector Kit</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pCCL.sin.cPPT.<break/>PGK.GFP.WPRE</td><td align="left" valign="bottom">TIGET, SanRaffaeleSci.Institute</td><td align="left" valign="bottom">Gift from M. Amendola and <break/>L. Naldini</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">ODN (Positive <break/>decoy, top)</td><td align="left" valign="bottom">Sigma Genosys (<xref ref-type="bibr" rid="bib81">Soldati et al., 2011</xref>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5′-GpPpCpPTPTT<break/>CAGCACCACGG<break/>ACAGCGCCAGC-3′</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">ODN (Positive <break/>decoy, bot)</td><td align="left" valign="bottom">Sigma Genosys (<xref ref-type="bibr" rid="bib81">Soldati et al., 2011</xref>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">3′-GpPpCpPTPGGC<break/>GCTGTCCGTGG<break/>TGCTGAAAGC-5′</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">NEG (Negative <break/>decoy, top)</td><td align="left" valign="bottom">Sigma Genosys (<xref ref-type="bibr" rid="bib81">Soldati et al., 2011</xref>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">5′-GpPpCpPTPTCC<break/>AGCACAGTGG<break/>TCAGACCC-3′</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">NEG (Negative <break/>decoy, bot)</td><td align="left" valign="bottom">Sigma Genosys (<xref ref-type="bibr" rid="bib81">Soldati et al., 2011</xref>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">3′-GpPpCpPTPTC<break/>TGACCACTGTG<break/>CTGGAAGC-5′</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gapdh_F</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GAACATCATC<break/>CCTGCATCCA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gapdh_R</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCAGTGAGC<break/>TTCCCGTTCA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Ppia_F</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CACTGTCGC<break/>TTTTCGC<break/>CGCTTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Ppia_R</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TTTCTGCTGTC<break/>TTTGGAACT<break/>TTGTCTGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Rest_F</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GAACCACCT<break/>CCCAGTATG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Rest_R</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CTTCTGACA<break/>ATCCTCCATAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Bdnf cds_F</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GATGCCGCAA<break/>ACATGTCTATGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Bdnf cds_R</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TAATACTGTCAC<break/>ACACGCT<break/>CAGCTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Bdnf (P1)_F</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGGTAACCT<break/>CGCTCATT<break/>CATTAGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Bdnf (P1)_R</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCCTTCGCAAT<break/>ATCCGCAAAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Bdnf (P4)_F</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CAAATGGAGC<break/>TTCTCGC<break/>TGAAGGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Bdnf (P4)_R</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GTGGAAATTG<break/>CATGGCG<break/>GAGGTAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Npas4_F</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGGGTTTGCT<break/>GATGAGTTGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Npas4_R</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCCCTCCAC<break/>TTCCATCTTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gabrg2_F</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCATGCCCA<break/>ATCCGTGGTTAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gabrg2_R</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCTCAAAGG<break/>TATCTTGC<break/>TCAGTGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gabra2_F</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCTGCTCTC<break/>CATTGTGAAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gabra2_R</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGTGCTGGG<break/>AACTTGAAAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gad1_F</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CTAGGGACC<break/>CAGGGAAAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gad1_R</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GTACATCTGTC<break/>ATCCATCATCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gad2_F</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ACCAATTATGG<break/>AGCGTCACAGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gad2_R</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CTGAGGAGCA<break/>GCACCTTCTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Slc32a1_F</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TTCAGTGCTT<break/>GGAATCTAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Slc32a1_R</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TTCTCCAGAG<break/>TGAAGTCG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Syt4_F</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCTCACTCAT<break/>CGCCATCCA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Syt4_R</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GACCGCAGC<break/>TCACTCCAT</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Trypsin</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat. #1505014</td><td align="char" char="." valign="bottom">(0.25%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">HBSS</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat. #14170-088</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">HEPES</td><td align="left" valign="bottom">AppliChem</td><td align="left" valign="bottom">Cat. #A37240500</td><td align="char" char="." valign="bottom">(10 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">D-Glucose</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #G7021</td><td align="char" char="." valign="bottom">(30 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Gentamicin <break/>solution</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #G1272</td><td align="left" valign="bottom">(5 µg/ml)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">KOH</td><td align="left" valign="bottom">AppliChem</td><td align="left" valign="bottom">Cat. #131515</td><td align="char" char="." valign="bottom">(1 M)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Bovine Serum <break/>Albumin (BSA)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #A4503</td><td align="char" char="." valign="bottom">(10%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">MgSO<sub>4</sub> + H<sub>2</sub>O</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #63138</td><td align="char" char="." valign="bottom">(6 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Poly-L-lysine hydrobromide</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #P2636</td><td align="char" char="." valign="bottom">(0.1 mg/ml)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Boric Acid</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #B-7901</td><td align="char" char="." valign="bottom">(0.1 M)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">di-Sodium <break/>tetraborate <break/>decahydrate</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #A267508</td><td align="char" char="." valign="bottom">(0.1 M)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Neurobasal-A <break/>Medium</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat. #10888-022</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Neurobasal <break/>Medium</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat. #21103049</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">B-27 Supplement</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat. #17504044</td><td align="char" char="." valign="bottom">(2%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">GlutaMAX -I <break/>(100×)</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat. #35050-061</td><td align="char" char="." valign="bottom">(1 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Penicillin-<break/>Streptomycin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #P4333</td><td align="char" char="." valign="bottom">(1%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">4-Aminopyridine</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #A78403</td><td align="left" valign="bottom">(100 μM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">CaCl<sub>2</sub></td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #C8106</td><td align="char" char="." valign="bottom">(2 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">MgCl<sub>2</sub></td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #A4425</td><td align="char" char="." valign="bottom">(1 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">KCl</td><td align="left" valign="bottom">Merk</td><td align="left" valign="bottom">Cat. #TA638736</td><td align="char" char="." valign="bottom">(4 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">ATP</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #A6419</td><td align="char" char="." valign="bottom">(3 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">GTP</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #G8877</td><td align="char" char="." valign="bottom">(0.1 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">EGTA</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #E4378</td><td align="char" char="." valign="bottom">(0.1 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">TrkB-Fc</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #T8694</td><td align="left" valign="bottom">(1 µg/ml)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Triton X-100</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #T9284</td><td align="char" char="." valign="bottom">(0,2%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Sucrose</td><td align="left" valign="bottom">AppliChem</td><td align="left" valign="bottom">Cat. #A2211</td><td align="char" char="." valign="bottom">(4%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Phosphate<break/>-buffered saline</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #P4417</td><td align="char" char="." valign="bottom">(1 ×)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Paraformaldehyde</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #P6148</td><td align="char" char="." valign="bottom">(4%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Fetal Bovine <break/>Serum, qualified, <break/>heat</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat. #10500064</td><td align="char" char="." valign="bottom">(5%)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Tetrodotoxin (TTX)</td><td align="left" valign="bottom">Tocris</td><td align="left" valign="bottom">Cat. #1078</td><td align="left" valign="bottom">(1 µM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">D-AP5</td><td align="left" valign="bottom">Tocris</td><td align="left" valign="bottom">Cat. #0106</td><td align="left" valign="bottom">(50 µM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">CNQX</td><td align="left" valign="bottom">Tocris</td><td align="left" valign="bottom">Cat. #0190</td><td align="left" valign="bottom">(10 µM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">QX314</td><td align="left" valign="bottom">Tocris</td><td align="left" valign="bottom">Cat. #1014</td><td align="char" char="." valign="bottom">(10 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">EDTA</td><td align="left" valign="bottom">AppliChem</td><td align="left" valign="bottom">Cat. #A5097</td><td align="char" char="." valign="bottom">(10 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">NaCl</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #793566</td><td align="char" char="." valign="bottom">(1 M)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Tris-HCl</td><td align="left" valign="bottom">Merk</td><td align="left" valign="bottom">Cat. #10812846001</td><td align="char" char="." valign="bottom">(100 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Tris(2-carboxyethyl)<break/>phosphine (TCEP)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #C4706</td><td align="char" char="." valign="bottom">(50 mM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Protease <break/>inhibitor cocktail</td><td align="left" valign="bottom">Cell Signaling</td><td align="left" valign="bottom">Cat. #5871</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">BCA Assay</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat. #23225</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Hoechst 33342</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat. #H1399</td><td align="left" valign="bottom">(3.33 µl/ml)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">TRIzol Reagent</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat. #15596018</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Brain-derived neurotrophic factor (BDNF)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat. #B3795</td><td align="char" char="." valign="bottom">(100 ng/ml)</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad <break/>Prism</td><td align="left" valign="bottom">GraphPad Software, Inc</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">PatchMaster</td><td align="left" valign="bottom">HEKA Inst</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_000034">SCR_000034</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Fitmaster</td><td align="left" valign="bottom">HEKA Inst</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016233">SCR_016233</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ, Fiji</td><td align="left" valign="bottom">(ImageJ; <ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij">http://rsb.info.nih.gov/ij</ext-link>)</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002285">SCR_002285</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">LASX</td><td align="left" valign="bottom">Leica Microsystems</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_013673">SCR_013673</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">AxIS 2.4</td><td align="left" valign="bottom">Axion BioSystems</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016308">SCR_016308</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Experimental animals</title><p><italic>Gad1</italic>-GFP knock-in mice were generated by inserting the cDNA encoding enhanced GFP into the Gad1 locus in TT2 embryonic stem cells, as described (<xref ref-type="bibr" rid="bib87">Tamamaki et al., 2003</xref>). Heterozygous <italic>Gad1</italic>-GFP males were mated with wild-type C57BL6/J females, and GFP-positive pups were identified at birth through a Dual Fluorescent Protein Flashlight (DFP-1, NIGHTSEA, Lexington, MA) and confirmed by genotyping, performed by PCR with the following primers: TR-1b: <named-content content-type="sequence">GGCACAGCTCTCCCTTCTGTTTGC</named-content>; TR-3: <named-content content-type="sequence">GCTCTCCTTTCGCGTTCCGACAG</named-content>; TRGFP-8: <named-content content-type="sequence">CTGCTTGTCGGCCATGATATAGACG</named-content>. All animals were provided by our institutional animal breeding facility in accordance with the guidelines approved by the local Animal Care Committee of the University of Genova. All experiments were carried out in accordance with the guidelines established by the European Communities Council (Directive 2010/63/EU of March 4, 2014) and were approved by the Italian Ministry of Health (authorization 73/2014-PR and 1276/2015-PR).</p></sec><sec id="s4-2"><title>Cell cultures</title><p>Primary hippocampal and cortical neurons were prepared from postnatal <italic>Gad1</italic>-GFP knock-in mice (P0–P1), as previously described (<xref ref-type="bibr" rid="bib10">Beaudoin et al., 2012</xref>; <xref ref-type="bibr" rid="bib66">Prestigio et al., 2019</xref>). Experiments used 0/2-day-old pups. Some control experiments were done using wild-type C57BL6/J mice. Briefly, hippocampi and cortex were dissociated by enzymatic digestion in 0.25% trypsin for 6 min at 37°C and then triturated with a fire-polished Pasteur pipette. No antimitotic drugs were added to prevent glia proliferation. The following solutions were used for cell culture preparations: HANKS solution, prepared from HBSS (GIBCO 14170-088; red) supplemented with 10 mM HEPES, 30 mM D-glucose, 5 μg/ml Gentamycin, pH 7.4 with KOH; dissection solution, prepared from HANKS solution supplemented with 10% bovine serum albumin (BSA) and 6 mM MgSO<sub>4</sub>. Primary hippocampal neurons were plated at density of 120 cells/mm<sup>2</sup> on 3.5 cm diameter Petri dishes (Falcon 35 mm, 353001) treated for 24 hr with poly-L-lysine (0.1 mg/ml; Sigma-Aldrich) in borate buffer (0.1 M). Cells were grown in a culture medium consisting of Neurobasal A (Gibco) supplemented with 2% B-27 (Invitrogen, Italy), 1 mM Glutamax, and 5 μg/ml Gentamycin and maintained at 37°C in a humidified incubator with 5% CO<sub>2</sub>. To induce neuronal hyperactivity, 4AP, a non-selective K<sup>+</sup> channel blocker, was applied on mature neurons, at 17–18 days in vitro (div). 4AP-treatment represents a widely adopted model of drug-induced epileptiform activity in cultured neurons and brain slices (<xref ref-type="bibr" rid="bib4">Avoli and Jefferys, 2016</xref>) that we have previously used in cultured neurons to induce network hyperactivity (<xref ref-type="bibr" rid="bib63">Pecoraro-Bisogni et al., 2018</xref>; <xref ref-type="bibr" rid="bib65">Pozzi et al., 2013</xref>). 4AP (100 μM) was dissolved in complete Neurobasal medium, applied to neuronal cultures, and maintained for the entire indicated times. At this concentration, we have previously demonstrated (<xref ref-type="bibr" rid="bib65">Pozzi et al., 2013</xref>) that the treatment with 4AP for 24, 48 but also 96 hr did not affect viability of cultured neurons.</p></sec><sec id="s4-3"><title>Oligodeoxynucleotides decoy</title><p>REST activity was blocked by using oligodeoxynuclotides (ODNs) that act as surrogate binding sites for REST and sequester the native transcription factor from its genomic binding sites (<xref ref-type="bibr" rid="bib39">Johnson et al., 2006</xref>; <xref ref-type="bibr" rid="bib51">McClelland et al., 2011</xref>; <xref ref-type="bibr" rid="bib81">Soldati et al., 2011</xref>). The ODN decoy (ODN) was designed corresponding to the canonical REST-binding site, RE1, while a negative decoy control (NEG) was generated using a sequence corresponding to a non-canonical RE1 that does not bind REST (<xref ref-type="bibr" rid="bib14">Bruce et al., 2004</xref>). The decoy ODN sequences were:</p><list list-type="bullet"><list-item><p>ODN (Positive decoy): (Top) 5′-<named-content content-type="sequence">GpPpCpPTPTTCAGCACCACGGACAGCGCCAGC</named-content>-3′</p></list-item><list-item><p>(Bot) 3′-<named-content content-type="sequence">GpPpCpPTPGGCGCTGTCCGTGGTGCTGAAAGC</named-content>-5′;</p></list-item><list-item><p>NEG (Negative decoy) (Top) 5′-<named-content content-type="sequence">GpPpCpPTPTCCAGCACAGTGGTCAGACCC</named-content>-3′</p></list-item><list-item><p>(Bot) 3′-<named-content content-type="sequence">GpPpCpPTPTCTGACCACTGTGCTGGAAGC</named-content>-5′.</p></list-item></list><p>ODNs were designed with phosphorothioate modification on the first three nucleotides to avoid degradation (<xref ref-type="bibr" rid="bib43">Lee et al., 2003</xref>; <xref ref-type="bibr" rid="bib56">Osako et al., 2007</xref>). Single-stranded oligodeoxynucleotides were synthesized by Sigma Genosys (St. Louis, MO). Annealing was performed in 10× buffer (100 mM Tris-HCl, pH 8.0, 10 mM EDTA, and 1 M NaCl) by heating to at least 5–10°C above their melting temperature and cooling slowly using a heat block. Cultured neurons were treated with 200 nM decoys ODNs. For the live-cell imaging of activity-dependent REST translocation from the cytoplasm to the nucleus, we used the following fluorescent ODNs:</p><list list-type="bullet"><list-item><p>ODN-Top-Cy3: 5′-<named-content content-type="sequence">GpPpCpPTP</named-content> <named-content content-type="sequence">TTCAGCACCACGGACAGCGCCAGC</named-content>-Cy-3;</p></list-item><list-item><p>NEG-Top-Cy3: 5′-<named-content content-type="sequence">GpPpCpPTPTCCAGCACAGTGGTCAGACCC</named-content>-Cy3-3′.</p></list-item></list></sec><sec id="s4-4"><title>RNA interference, lentivirus production, and infection procedures</title><p>The REST target sequence used to design the shRNA that we employed in <xref ref-type="fig" rid="fig5">Figure 5B</xref> was: 5′-<named-content content-type="sequence">ACATGCAAGACAGGTTCACAA</named-content>-3′. This shRNA together with an alternative one were previously validated for their capability of decreasing <italic>Rest</italic> mRNA levels in neuroblastoma and cultured cortical neurons (<xref ref-type="bibr" rid="bib63">Pecoraro-Bisogni et al., 2018</xref>; <xref ref-type="bibr" rid="bib65">Pozzi et al., 2013</xref>). Briefly, the shRNA construct was obtained by cloning the sequence into pcDNA6.2-GW/EmGFP-miR plasmid using a microRNA (miR)-based expression vector kit (BLOCK-iT Pol II miR; Invitrogen), thereby creating an expression cassette consisting of the 5′ miR flanking region, the REST target sequence, and the 3′ miR flanking region. As a negative control, the pcDNA6.2-GW/EmGFP-miR-neg plasmid (Invitrogen), containing a sequence not targeting any known vertebrate gene, was used. The shRNA was then sub-cloned into the lentiviral vector pCCL.sin.cPPT.PGK.GFP.WPRE (a kind gift from M. Amendola and L. Naldini, TIGET, San Raffaele Sci. Institute, Milan, Italy). Cultured neurons were infected at 14 div by using 10 multiplicity of infection, and neurons were used at 18–20 div.</p></sec><sec id="s4-5"><title>Multielectrode array recordings</title><p>Neuronal network activity was recorded using a multi-well MEA system (Maestro, Axion BioSystems, Atlanta, GA). The MEA plates (M768-tMEA-48W) were composed of 48 wells, each containing a square grid of 16 PEDOT electrodes (50 μm electrode diameter; 350 μm center-to-center spacing) that creates a 1.1×1.1 mm<sup>2</sup> recording area. Spiking activity from networks grown onto MEAs was recorded and monitored using Axion BioSystems hardware (Maestro1 amplifier and Middle-man data acquisition interface) and the Axion’s Integrated Studio software in Spontaneous Neural Configuration (AxIS 2.4). After 1200× amplification, raw data were digitized at 12.5 kHz/channel and stored on a hard disk for subsequent offline analysis. The day before culture preparation, MEAs were coated by depositing a 20 μl drop of poly-L-lysine (0.1 mg/ml, Sigma-Aldrich) over each recording area and subsequently incubated overnight. After thorough washing, dissociated cortical neurons were plated at a density of 50,000 per well in a 25 μl drop that covered a surface of 20 mm<sup>2</sup>, yielding a final cell density of 2500 cells/mm<sup>2</sup>. Cells were incubated in Neurobasal medium supplemented with 1% Glutamax, 2% B27, and 1% penicillin/streptomycin. Half-volume replacement of the culture medium was performed every 3 days.</p><p>Experiments were performed in culture medium maintained at 37°C. Under these culture conditions, we previously observed (<xref ref-type="bibr" rid="bib65">Pozzi et al., 2013</xref>), a time-dependent increase of the activity of the neuronal network, corresponding to the functional maturation of the network with elongation of neural processes and increase of the functional synaptic connectivity.</p><p>At div 17, MEA plates were set on the Maestro apparatus and their spontaneous activity recorded for 10 min in standard culture medium (basal condition). Cultured neurons were then treated with either ODN or NEG (200 nM) in the presence of 4AP (100 μM) or vehicle. To remove the effects of mechanical perturbations and to allow neuronal activity to reach a steady state under 4AP, MEA plates were returned to the incubator and recordings were collected 1, 24, and 48 hr after the treatment. On the last day of recording, networks were acutely exposed to the GABA<sub>A</sub>R blocker bicuculline (BIC, 30 μM, Tocris Bioscience). After 5 min re-equilibration, recordings continued for 10 min (<xref ref-type="bibr" rid="bib92">Valente et al., 2019</xref>). Spike and burst detection were both computed using the Axion BioSystems software NeuralMetricTool. To study firing and bursting properties, only the wells that contained ≥4 active electrodes (≥5 spikes/min) were retained for further analysis. Moreover, we excluded from the analysis the 4AP-untreated wells showing a time-dependent increase of the spontaneous activity higher than 60% during the 48 hr of observation and the 4AP-treated wells that were unresponsive to 4AP. Extracellular APs were detected by adaptive threshold crossing (7× the standard deviation of the rms-noise on each channel) on 200 Hz high‐pass‐filtered traces. Bursts within single channels were identified by applying an inter-spike interval (ISI) threshold algorithm (<xref ref-type="bibr" rid="bib16">Chiappalone et al., 2006</xref>) that defines bursts as collections of a minimum number of spikes (N<sub>min</sub>=5) separated by a maximum ISI (ISI<sub>max</sub>) of 100 ms. Electrodes that recorded less than five spikes/min were deemed inactive and were not included in the burst analysis.</p></sec><sec id="s4-6"><title>Patch-clamp recordings</title><p>Whole-cell patch-clamp recordings were performed in the voltage-clamp configuration on hippocampal neurons plated at density of 120 cells/mm<sup>2</sup>. Electrophysiological experiments were performed at 17–19 div after treatment with either ODN or NEG (200 nM) in the presence of 4AP (100 μM) or vehicle for 48 hr. Patch pipettes, prepared from thin borosilicate glass (Kimble, Kimax, Mexico), were pulled and fire-polished to a final resistance of 3–4 MΩ when filled with the intracellular solution. IPSCs were recorded in Tyrode extracellular solution containing (in mM): 140 NaCl, 2 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 4 KCl, 10 glucose, and 10 HEPES (pH 7.3 with NaOH), to which D-2-amino-5-phosphonopentanoic acid (D-AP5; 50 µM), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 10 µM), and N-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium chloride (QX314; 10 mM) were added to block NMDA receptors, non-NMDA receptors, and voltage-activated Na<sup>+</sup> channels, respectively. The internal solution composition was (in mM): 140 KCl, 4 NaCl, 1 MgSO<sub>4</sub>, 0.1 EGTA, 15 glucose, 5 HEPES, 3 ATP, and 0.1 GTP (pH 7.2 with KOH). All recordings were performed at 22–24 °C. Under this condition, internal and external chloride concentrations were equimolar, shifting the chloride reversal potential from a negative value to 0 mV. This experimental configuration, that transforms IPSCs in inward currents, is typically used for increasing the amplitude of the IPSCs, evoked at negative holding potentials. IPSCs were acquired at 20 kHz sample frequency and filtered at half the acquisition rate with an 8-pole low-pass Bessel filter. Patch-clamp recordings with leak currents &gt;200 pA or series resistance &gt;15 MΩ were discarded. Series resistance was compensated 80% (2 μs response time) and the compensation was readjusted before each stimulation. The shown potentials were not corrected for the measured liquid junction potential (9 mV). Data acquisition was performed using PatchMaster and analyzed with Fit master programs (HEKA Elektronik).</p><p>For recording eIPSCs, the postsynaptic <italic>Gad1</italic>-GFP negative excitatory cell was clamped at –70 mV and the soma of the presynaptic <italic>Gad1</italic>-GFP positive interneuron was stimulated through a glass electrode (1 µm tip diameter) filled with Tyrode solution in a <italic>‘loose patch configuration.’</italic> The stimulating extracellular pipette delivered biphasic current pulses lasting 0.5 ms of variable amplitude (50–150 mA) by an isolated pulse stimulator (model 2100; A-M Systems, Carlsburg, WA). Monosynaptically connected neurons were identified by the short latency (2–4 ms) necessary to induce eIPSCs. To ensure that only the synaptic contacts of the selected presynaptic neuron were stimulated by the extracellular stimulating pipette, we recorded only those eIPSCs that were completely lost after a few µm displacements from the soma of the presynaptic neuron. Considering that the evoked currents remained stable for stimulation intensities twofold the threshold, the stimulation intensity was set at 1.5-fold the threshold for all experiments. The current artifact produced by the presynaptic extracellular stimulation was subtracted in all the eIPSC traces. Only cells with resting membrane potentials between –57 and –64 mV were considered for analysis. eIPSCs were evoked by two consecutive stimuli separated by a time interval of 50 ms for calculating the paired-pulse ratio (PPR; I<sub>2</sub>/I<sub>1</sub>), where I<sub>1</sub> and I<sub>2</sub> are the amplitudes of the eIPSCs evoked by the conditioning and test stimuli, respectively. The amplitude of I<sub>2</sub> was determined as the difference between the I<sub>2</sub> peak and the corresponding value of I<sub>1</sub> calculated by mono-exponential fitting of the eIPSC decay. A similar experimental protocol was used to evaluate whether BDNF played a functional role in the 4AP-induced strengthening of inhibitory synapses. To block BDNF activity, 17 div cultured neurons were incubated with TrkB-Fc (1 µg/mL, T8694-Sigma), a BDNF scavenger suppressing BDNF binding to TrkB (<xref ref-type="bibr" rid="bib71">Sakuragi et al., 2013</xref>; <xref ref-type="bibr" rid="bib76">Shelton et al., 1995</xref>).</p><p>The size of the RRP of synchronous release (RRP<sub>syn</sub>) and the probability for any given synaptic vesicle in the RRP to be released (P<sub>r</sub>) were calculated using the cumulative amplitude analysis (<xref ref-type="bibr" rid="bib72">Schneggenburger et al., 1999</xref>). High-frequency stimulation (2 s at 20 Hz) was applied to presynaptic fibers with the extracellular electrode and the RRP<sub>syn</sub> was determined by summing up peak IPSC amplitudes during the 40 stimuli. The analysis assumes that the depression induced by the train is limited by a constant recycling of synaptic vesicles and that equilibrium is present between released and recycled vesicles. The number of data points to include in the fit of the steady-state phase was evaluated by calculating, for each cell, the best linear fit which included the maximal number of data points starting from the last one. According to this procedure, the intercept with the y-axis gives an estimation of the size of the RRP<sub>syn</sub> and the ratio between the amplitude of the first eIPSC evoked by the stimulation train (I<sub>1</sub>) and RRP<sub>syn</sub> yields an estimation of P<sub>r</sub>.</p><p>mIPSCs were recorded from hippocampal <italic>Gad1</italic>-GFP negative excitatory and <italic>Gad1</italic>-GFP positive inhibitory neurons incubated in the presence of tetrodotoxin (TTX, 1 μM; Tocris) to block spontaneous APs. mIPSC analysis was performed by using the Minianalysis program (Synaptosoft, Leonia, NJ) and the Prism software (GraphPad Software, Inc). The amplitude and frequency of mIPSCs were calculated using a peak detector function with a threshold amplitude set at 4 pA and a threshold area at 50 ms*pA.</p></sec><sec id="s4-7"><title>Immunocytochemistry</title><p>Immunocytochemistry of primary hippocampal neurons obtained from postnatal <italic>Gad1</italic>-GFP knock-in mice was performed after treatment with either ODN or NEG (200 nM) in the presence of 4AP (100 μM) or vehicle for 48 hr. Neurons were fixed at 19 div with 4% paraformaldehyde/4% sucrose for 12 min at room temperature and then washed with phosphate-buffered saline (PBS). Cells were then permeabilized with methanol (–20°C; 10 min on ice) followed by 0.2% Triton X-100 for 10 min (<xref ref-type="bibr" rid="bib44">Liao et al., 2010</xref>) and washed for 30 min with PBS supplemented with 5% fetal bovine serum (FBS)/0.1% BSA. Incubation with primary antibodies in PBS/5% FBS/0.1% BSA was performed for 2 hr, followed by washing with PBS and final incubation with secondary antibodies for 2 hr. Neurons were immunostained with antibodies to chicken β3-Tubulin (1:500, Synaptic Systems 302306), rabbit VGAT (1:500, Synaptic Systems 131011) and mouse Gephyrin (1:200, Synaptic Systems 147011). Secondary antibodies were Alexa405 goat anti-chicken (Abcam, ab175674), Alexa546 goat anti-rabbit, and Alexa647 goat anti-mouse (1:500 in all cases, Thermo Fisher Scientific, Cat. A11010, A32728).</p><p>Confocal images were acquired by using a 63× oil objective (N.A. 1.4) in a Leica TCS SP8 Confocal Laser Scanning Microscope equipped with Hybrid Detectors (Leica Microsystem). Images were processed and analyzed using the ImageJ software (<ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link>). For capturing in-focus images of objects at high magnification, multiple (25) images were taken at increasing focal distances (0.3 µm increments) and Z-stacking image processing was used to obtain a composite image with a greater depth of field than individual source images. Analysis of fluorescence intensity was performed on dendritic linear regions of interest (ROIs; 3–5 per image) of 60–160 μm in length and somatic surface ROIs (2–3 per image) of 1000–2000 μm<sup>2</sup> under blind conditions. The fluorescence intensity profiles were analyzed in each ROI and putative inhibitory synaptic contacts were identified as the ROIs in which both VGAT and gephyrin average intensity profiles exceeded a threshold level (set at three times the background intensity). The synaptic density on dendrites was obtained by counting the total number of positive puncta divided by the length of the tubulin-positive segment (in μm). The synaptic density on the soma was obtained by counting the total number of positive puncta divided by the tubulin-positive soma area (in μm<sup>2</sup>). The indicated sample number (n) represents the number of coverslips collected from at least three independent neuronal preparations. From each coverslip, at least 10–15 images were acquired.</p></sec><sec id="s4-8"><title>Live imaging of the REST translocation</title><p>Cultured hippocampal neurons (17 div) from <italic>Gad1</italic>-GFP knock-in mice were treated with either vehicle or 4AP for 1 hr and then incubated for 24 hr with either ODN or NEG decoy tagged with Cyanine-3, (Cy3-ODN; Cy3-NEG). Five minutes before images acquisition, neurons were washed with Tyrode solution, stained with Hoechst-333342 (3.33 µl/ml) and further washed two times with Tyrode solution. Differential interference contrast and fluorescence images were acquired using an Olympus IX71 microscope with a 40× objective (Olympus LCPlanFI 40×) equipped with a Hamamatsu (ORCA-ER) camera and a Leica EL6000 fluorescence lamp. Somatic and nuclear Cy3-positive ROIs were drawn for each neuron to calculate the REST partition between the cytosol and the nucleus (Cy3-area<sub>nucleus</sub>/Cy3-area<sub>cyto</sub> ratio) in stimulated and control excitatory and inhibitory neurons. Images were analyzed using the ImageJ software.</p></sec><sec id="s4-9"><title>Real-time qPCR</title><p>RNA was extracted with TRIzol reagent and purified on RNeasy spin columns (Qiagen). RNA samples were quantified at 260 nm with an ND1000 Nanodrop spectrophotometer (Thermo Fisher Scientific). RNA purity was also determined by absorbance at 280 and 230 nm. All samples showed A260/280 and A260/230 ratios greater than 1.9. Reverse transcription was performed according to the manufacturer’s recommendations on 1 μg of RNA with the QuantiTect Reverse Transcription Kit (Qiagen), which includes a genomic DNA-removal step. SYBR green RT-qPCR was performed in triplicate with 10 ng of template cDNA using QuantiTect Master Mix (Qiagen) on a 7900-HT Fast Real-Time System (Applied Biosystems) as previously described (<xref ref-type="bibr" rid="bib65">Pozzi et al., 2013</xref>), using the following conditions: 5 min at 95°C, 40 cycles of denaturation at 95°C for 15 s, and annealing/extension at 60°C for 30 s. Product specificity and occurrence of primer dimers were verified by melting-curve analysis. Primers were designed with Beacon Designer software (Premier Biosoft) to avoid template secondary structure and significant cross homology with other genes by BLAST search. The PCR reaction efficiency for each primer pair was calculated by the standard curve method with four serial-dilution points of cDNA. The PCR efficiency calculated for each primer set was used for subsequent analysis. All experimental samples were detected within the linear range of the assay. Gene-expression data were normalized via the multiple-internal-control-gene method (<xref ref-type="bibr" rid="bib93">Vandesompele et al., 2002</xref>) with the GeNorm algorithm available in qBasePlus software (Biogazelle).</p><p>The control genes used were GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and PPIA (peptidylprolyl isomerase), the expression of these genes was found not to be affected by the 4AP treatment. Primers sequences (5′–3′) were indicated in the Key Resources Table.</p></sec><sec id="s4-10"><title>Protein extraction and western blotting</title><p>Total cell lysates were obtained from 18/19 div cortical neurons treated as previously described. Neurons were lysed in lysis buffer (150 mM NaCl, 50 mM Tris, 1 mM EDTA, and 1% Triton X-100) supplemented with protease inhibitor cocktail (Cell Signaling, Danvers, MA). After 10 min of incubation, lysates were collected and clarified by centrifugation (10 min at 10,000×<italic>g</italic>). Protein concentrations were determined by the BCA protein assay (Thermo Fisher Scientific, Waltham, MA). Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was performed according to Laemmli (1970); equivalent amounts of protein were separated on 8% polyacrylamide gels and transferred onto nitrocellulose membranes (Whatman, St. Louis, MO). Membranes were blocked for 1 hr in 5% non-fat dry milk in Tris-buffered saline (10 mM Tris, 150 mM NaCl, and pH 8.0) plus 0.1% Triton X-100 and incubated overnight at 4°C or for 2 hr at room temperature with the following primary antibodies: anti-REST (1:500; 07-579 Millipore, MA), anti-NPAS4 (1:500; S408-79 Thermo Fisher Scientific, Waltham, MA), anti-SYT4 (1:2000; 105043 Synaptic Systems, Gottingen, Germany), anti-GAD67 (1:2000; MAB5406, Sigma-Aldrich, St. Louis, MO), anti VGAT (1:1000; 131002 Synaptic Systems, Gottingen, Germany), and anti-GAPDH (1:2000; sc-25778 Santa Cruz Biotechnology, Dallas, TX). After several washes, membranes were incubated for 1 hr at room temperature with peroxidase-conjugated anti-mouse (1:3000; Bio-Rad, Hercules, CA) or anti-rabbit (1:3000; Bio-Rad, Hercules, CA) antibodies. Bands were revealed with the ECL chemiluminescence detection system (Thermo Fisher Scientific, Waltham, MA). Immunoblots were quantified by densitometric analysis of the fluorograms (ChemiDoc XRS+; Bio-Rad, Hercules, CA).</p></sec><sec id="s4-11"><title>Statistical analysis</title><p>Data are given as means± SEM for n=sample size. The normal distribution of experimental data was assessed using Kolmogorov-Smirnov normality test. To compare two normally distributed sample groups, the unpaired two-tailed Student’s t-test was used. To compare two sample groups that were not normally distributed, the Mann–Whitney U-test was used. To compare more than two normally distributed sample groups, we used one- or two-way ANOVA, followed by the Tukey’s or Dunnett’s multiple comparison tests. Alpha levels for all tests were 0.5% (95% confidence intervals). Statistical analysis was carried out by using the SPSS (version 21, IBM Software) and the Prism software (GraphPad Software, Inc).</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Formal analysis, Investigation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Visualization</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Funding acquisition, Project administration, Resources, Validation, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Supervision, Validation, Writing – original draft, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All experiments were carried out in accordance with the guidelines established by the European Communities Council (Directive 2010/63/EU of 4 March 2014) and were approved by the Italian Ministry of Health (authorization 73/2014-PR and 1276/2015-PR).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69058-transrepform1-v1.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript. Source data files are provided for all the figures presented in the manuscript.</p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors thank Dr Yuchio Yanagawa (Gunma University, Maebashi, Japan) for kindly providing <italic>Gad1</italic>-GFP knock-in mice; Drs Anna Rocchi and Andrea Contestabile (Istituto Italiano di Tecnologia, Genova, Italy) for help and advice for RT-qPCR experiments; Drs M Amendola and L Naldini (TIGET, San Raffaele Sci. Institute, Milan, Italy) for kindly providing the lentiviral vectors; Drs Silvia Casagrande (Department Experimental Medicine, University of Genova) and Arta Mehilli (Istituto Italiano di Tecnologia, Genova, Italy) for help in the preparation of primary cultures; Drs Riccardo Navone and Diego Moruzzo (Istituto Italiano di Tecnologia, Genova, Italy) for help in the maintenance and genotyping of mouse strains.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aid</surname><given-names>T</given-names></name><name><surname>Kazantseva</surname><given-names>A</given-names></name><name><surname>Piirsoo</surname><given-names>M</given-names></name><name><surname>Palm</surname><given-names>K</given-names></name><name><surname>Timmusk</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Mouse and rat BDNF gene structure and expression revisited</article-title><source>Journal of Neuroscience Research</source><volume>85</volume><fpage>525</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1002/jnr.21139</pub-id><pub-id pub-id-type="pmid">17149751</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreska</surname><given-names>T</given-names></name><name><surname>Aufmkolk</surname><given-names>S</given-names></name><name><surname>Sauer</surname><given-names>M</given-names></name><name><surname>Blum</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>High abundance of BDNF within glutamatergic presynapses of cultured hippocampal neurons</article-title><source>Frontiers in Cellular Neuroscience</source><volume>8</volume><elocation-id>00107</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2014.00107</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asada</surname><given-names>H</given-names></name><name><surname>Kawamura</surname><given-names>Y</given-names></name><name><surname>Maruyama</surname><given-names>K</given-names></name><name><surname>Kume</surname><given-names>H</given-names></name><name><surname>Ding</surname><given-names>RG</given-names></name><name><surname>Kanbara</surname><given-names>N</given-names></name><name><surname>Kuzume</surname><given-names>H</given-names></name><name><surname>Sanbo</surname><given-names>M</given-names></name><name><surname>Yagi</surname><given-names>T</given-names></name><name><surname>Obata</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase</article-title><source>PNAS</source><volume>94</volume><fpage>6496</fpage><lpage>6499</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.12.6496</pub-id><pub-id pub-id-type="pmid">9177246</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avoli</surname><given-names>M</given-names></name><name><surname>Jefferys</surname><given-names>JGR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Models of drug-induced epileptiform synchronization in vitro</article-title><source>Journal of Neuroscience Methods</source><volume>260</volume><fpage>26</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.jneumeth.2015.10.006</pub-id><pub-id pub-id-type="pmid">26484784</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldelli</surname><given-names>P</given-names></name><name><surname>Novara</surname><given-names>M</given-names></name><name><surname>Carabelli</surname><given-names>V</given-names></name><name><surname>Hernández-Guijo</surname><given-names>JM</given-names></name><name><surname>Carbone</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>BDNF up-regulates evoked GABAergic transmission in developing hippocampus by potentiating presynaptic N- and P/Q-type Ca2+ channels signalling</article-title><source>The European Journal of Neuroscience</source><volume>16</volume><fpage>2297</fpage><lpage>2310</lpage><pub-id pub-id-type="doi">10.1046/j.1460-9568.2002.02313.x</pub-id><pub-id pub-id-type="pmid">12492424</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldelli</surname><given-names>P</given-names></name><name><surname>Hernandez-Guijo</surname><given-names>JM</given-names></name><name><surname>Carabelli</surname><given-names>V</given-names></name><name><surname>Carbone</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Brain-derived neurotrophic factor enhances GABA release probability and nonuniform distribution of N- and P/Q-type channels on release sites of hippocampal inhibitory synapses</article-title><source>The Journal of Neuroscience</source><volume>25</volume><fpage>3358</fpage><lpage>3368</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4227-04.2005</pub-id><pub-id pub-id-type="pmid">15800191</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldelli</surname><given-names>P</given-names></name><name><surname>Meldolesi</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The Transcription Repressor REST in Adult Neurons: Physiology, Pathology, and Diseases</article-title><source>ENeuro</source><volume>2</volume><elocation-id>ENEURO.0010-15.2015</elocation-id><pub-id pub-id-type="doi">10.1523/ENEURO.0010-15.2015</pub-id><pub-id pub-id-type="pmid">26465007</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballas</surname><given-names>N</given-names></name><name><surname>Battaglioli</surname><given-names>E</given-names></name><name><surname>Atouf</surname><given-names>F</given-names></name><name><surname>Andres</surname><given-names>ME</given-names></name><name><surname>Chenoweth</surname><given-names>J</given-names></name><name><surname>Anderson</surname><given-names>ME</given-names></name><name><surname>Burger</surname><given-names>C</given-names></name><name><surname>Moniwa</surname><given-names>M</given-names></name><name><surname>Davie</surname><given-names>JR</given-names></name><name><surname>Bowers</surname><given-names>WJ</given-names></name><name><surname>Federoff</surname><given-names>HJ</given-names></name><name><surname>Rose</surname><given-names>DW</given-names></name><name><surname>Rosenfeld</surname><given-names>MG</given-names></name><name><surname>Brehm</surname><given-names>P</given-names></name><name><surname>Mandel</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Regulation of neuronal traits by a novel transcriptional complex</article-title><source>Neuron</source><volume>31</volume><fpage>353</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(01)00371-3</pub-id><pub-id pub-id-type="pmid">11516394</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballas</surname><given-names>N</given-names></name><name><surname>Grunseich</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>DD</given-names></name><name><surname>Speh</surname><given-names>JC</given-names></name><name><surname>Mandel</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>REST and Its Corepressors Mediate Plasticity of Neuronal Gene Chromatin throughout Neurogenesis</article-title><source>Cell</source><volume>121</volume><fpage>645</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.03.013</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaudoin</surname><given-names>GMJ</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Ng</surname><given-names>YG</given-names></name><name><surname>Reichardt</surname><given-names>LF</given-names></name><name><surname>Arikkath</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex</article-title><source>Nature Protocols</source><volume>7</volume><fpage>1741</fpage><lpage>1754</lpage><pub-id pub-id-type="doi">10.1038/nprot.2012.099</pub-id><pub-id pub-id-type="pmid">22936216</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bersten</surname><given-names>DC</given-names></name><name><surname>Wright</surname><given-names>JA</given-names></name><name><surname>McCarthy</surname><given-names>PJ</given-names></name><name><surname>Whitelaw</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Regulation of the neuronal transcription factor NPAS4 by REST and microRNAs</article-title><source>Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms</source><volume>1839</volume><fpage>13</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.bbagrm.2013.11.004</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloodgood</surname><given-names>BL</given-names></name><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Browne</surname><given-names>HA</given-names></name><name><surname>Trepman</surname><given-names>AZ</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The activity-dependent transcription factor NPAS4 regulates domain-specific inhibition</article-title><source>Nature</source><volume>503</volume><fpage>121</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1038/nature12743</pub-id><pub-id pub-id-type="pmid">24201284</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brigadski</surname><given-names>T</given-names></name><name><surname>Hartmann</surname><given-names>M</given-names></name><name><surname>Lessmann</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Differential vesicular targeting and time course of synaptic secretion of the mammalian neurotrophins</article-title><source>The Journal of Neuroscience</source><volume>25</volume><fpage>7601</fpage><lpage>7614</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1776-05.2005</pub-id><pub-id pub-id-type="pmid">16107647</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruce</surname><given-names>AW</given-names></name><name><surname>Donaldson</surname><given-names>IJ</given-names></name><name><surname>Wood</surname><given-names>IC</given-names></name><name><surname>Yerbury</surname><given-names>SA</given-names></name><name><surname>Sadowski</surname><given-names>MI</given-names></name><name><surname>Chapman</surname><given-names>M</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Buckley</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes</article-title><source>PNAS</source><volume>101</volume><fpage>10458</fpage><lpage>10463</lpage><pub-id pub-id-type="doi">10.1073/pnas.0401827101</pub-id><pub-id pub-id-type="pmid">15240883</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canals</surname><given-names>JM</given-names></name><name><surname>Checa</surname><given-names>N</given-names></name><name><surname>Marco</surname><given-names>S</given-names></name><name><surname>Akerud</surname><given-names>P</given-names></name><name><surname>Michels</surname><given-names>A</given-names></name><name><surname>Pérez-Navarro</surname><given-names>E</given-names></name><name><surname>Tolosa</surname><given-names>E</given-names></name><name><surname>Arenas</surname><given-names>E</given-names></name><name><surname>Alberch</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area</article-title><source>The Journal of Neuroscience</source><volume>21</volume><fpage>117</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-01-00117.2001</pub-id><pub-id pub-id-type="pmid">11150327</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiappalone</surname><given-names>M</given-names></name><name><surname>Bove</surname><given-names>M</given-names></name><name><surname>Vato</surname><given-names>A</given-names></name><name><surname>Tedesco</surname><given-names>M</given-names></name><name><surname>Martinoia</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Dissociated cortical networks show spontaneously correlated activity patterns during in vitro development</article-title><source>Brain Research</source><volume>1093</volume><fpage>41</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2006.03.049</pub-id><pub-id pub-id-type="pmid">16712817</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>JA</given-names></name><name><surname>Tapia-Ramírez</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Toledo-Aral</surname><given-names>JJ</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Boutros</surname><given-names>MC</given-names></name><name><surname>Altshuller</surname><given-names>YM</given-names></name><name><surname>Frohman</surname><given-names>MA</given-names></name><name><surname>Kraner</surname><given-names>SD</given-names></name><name><surname>Mandel</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons</article-title><source>Cell</source><volume>80</volume><fpage>949</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90298-8</pub-id><pub-id pub-id-type="pmid">7697725</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen-Cory</surname><given-names>S</given-names></name><name><surname>Kidane</surname><given-names>AH</given-names></name><name><surname>Shirkey</surname><given-names>NJ</given-names></name><name><surname>Marshak</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Brain-derived neurotrophic factor and the development of structural neuronal connectivity</article-title><source>Developmental Neurobiology</source><volume>70</volume><fpage>271</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1002/dneu.20774</pub-id><pub-id pub-id-type="pmid">20186709</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cossart</surname><given-names>R</given-names></name><name><surname>Dinocourt</surname><given-names>C</given-names></name><name><surname>Hirsch</surname><given-names>JC</given-names></name><name><surname>Merchan-Perez</surname><given-names>A</given-names></name><name><surname>De Felipe</surname><given-names>J</given-names></name><name><surname>Ben-Ari</surname><given-names>Y</given-names></name><name><surname>Esclapez</surname><given-names>M</given-names></name><name><surname>Bernard</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Dendritic but not somatic GABAergic inhibition is decreased in experimental epilepsy</article-title><source>Nature Neuroscience</source><volume>4</volume><fpage>52</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1038/82900</pub-id><pub-id pub-id-type="pmid">11135645</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Dunning</surname><given-names>FM</given-names></name><name><surname>Chang</surname><given-names>PY</given-names></name><name><surname>Jackson</surname><given-names>MB</given-names></name><name><surname>Chapman</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Synaptotagmin-IV modulates synaptic function and long-term potentiation by regulating BDNF release</article-title><source>Nature Neuroscience</source><volume>12</volume><fpage>767</fpage><lpage>776</lpage><pub-id pub-id-type="doi">10.1038/nn.2315</pub-id><pub-id pub-id-type="pmid">19448629</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Staudt</surname><given-names>T</given-names></name><name><surname>Stahlberg</surname><given-names>MA</given-names></name><name><surname>Vingill</surname><given-names>S</given-names></name><name><surname>Bückers</surname><given-names>J</given-names></name><name><surname>Kamin</surname><given-names>D</given-names></name><name><surname>Engelhardt</surname><given-names>J</given-names></name><name><surname>Jackson</surname><given-names>MB</given-names></name><name><surname>Hell</surname><given-names>SW</given-names></name><name><surname>Chapman</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Distinct subsets of Syt-IV/BDNF vesicles are sorted to axons versus dendrites and recruited to synapses by activity</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>5398</fpage><lpage>5413</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4515-11.2012</pub-id><pub-id pub-id-type="pmid">22514304</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dieni</surname><given-names>S</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name><name><surname>Dekkers</surname><given-names>M</given-names></name><name><surname>Rauskolb</surname><given-names>S</given-names></name><name><surname>Ionescu</surname><given-names>MS</given-names></name><name><surname>Deogracias</surname><given-names>R</given-names></name><name><surname>Gundelfinger</surname><given-names>ED</given-names></name><name><surname>Kojima</surname><given-names>M</given-names></name><name><surname>Nestel</surname><given-names>S</given-names></name><name><surname>Frotscher</surname><given-names>M</given-names></name><name><surname>Barde</surname><given-names>YA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>BDNF and its pro-peptide are stored in presynaptic dense core vesicles in brain neurons</article-title><source>The Journal of Cell Biology</source><volume>196</volume><fpage>775</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1083/jcb.201201038</pub-id><pub-id pub-id-type="pmid">22412021</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernfors</surname><given-names>P</given-names></name><name><surname>Wetmore</surname><given-names>C</given-names></name><name><surname>Olson</surname><given-names>L</given-names></name><name><surname>Persson</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family</article-title><source>Neuron</source><volume>5</volume><fpage>511</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(90)90090-3</pub-id><pub-id pub-id-type="pmid">2206535</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esclapez</surname><given-names>M</given-names></name><name><surname>Tillakaratne</surname><given-names>NJ</given-names></name><name><surname>Kaufman</surname><given-names>DL</given-names></name><name><surname>Tobin</surname><given-names>AJ</given-names></name><name><surname>Houser</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms</article-title><source>The Journal of Neuroscience</source><volume>14</volume><fpage>1834</fpage><lpage>1855</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.14-03-01834.1994</pub-id><pub-id pub-id-type="pmid">8126575</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esclapez</surname><given-names>M</given-names></name><name><surname>Houser</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Up-regulation of GAD65 and GAD67 in remaining hippocampal GABA neurons in a model of temporal lobe epilepsy</article-title><source>The Journal of Comparative Neurology</source><volume>412</volume><fpage>488</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19990927)412:3&lt;488::AID-CNE8&gt;3.0.CO;2-6</pub-id><pub-id pub-id-type="pmid">10441235</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiorentino</surname><given-names>H</given-names></name><name><surname>Kuczewski</surname><given-names>N</given-names></name><name><surname>Diabira</surname><given-names>D</given-names></name><name><surname>Ferrand</surname><given-names>N</given-names></name><name><surname>Pangalos</surname><given-names>MN</given-names></name><name><surname>Porcher</surname><given-names>C</given-names></name><name><surname>Gaiarsa</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>GABA(B) receptor activation triggers BDNF release and promotes the maturation of GABAergic synapses</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>11650</fpage><lpage>11661</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3587-09.2009</pub-id><pub-id pub-id-type="pmid">19759312</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frere</surname><given-names>S</given-names></name><name><surname>Slutsky</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Alzheimer’s Disease: From Firing Instability to Homeostasis Network Collapse</article-title><source>Neuron</source><volume>97</volume><fpage>32</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.11.028</pub-id><pub-id pub-id-type="pmid">29301104</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>T</given-names></name><name><surname>Aika</surname><given-names>Y</given-names></name><name><surname>Heizmann</surname><given-names>CW</given-names></name><name><surname>Kosaka</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>GABAergic axon terminals at perisomatic and dendritic inhibitory sites show different immunoreactivities against two GAD isoforms, GAD67 and GAD65, in the mouse hippocampus: a digitized quantitative analysis</article-title><source>The Journal of Comparative Neurology</source><volume>395</volume><fpage>177</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1002/(sici)1096-9861(19980601)395:2&lt;177::aid-cne3&gt;3.0.co;2-#</pub-id><pub-id pub-id-type="pmid">9603371</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garriga-Canut</surname><given-names>M</given-names></name><name><surname>Schoenike</surname><given-names>B</given-names></name><name><surname>Qazi</surname><given-names>R</given-names></name><name><surname>Bergendahl</surname><given-names>K</given-names></name><name><surname>Daley</surname><given-names>TJ</given-names></name><name><surname>Pfender</surname><given-names>RM</given-names></name><name><surname>Morrison</surname><given-names>JF</given-names></name><name><surname>Ockuly</surname><given-names>J</given-names></name><name><surname>Stafstrom</surname><given-names>C</given-names></name><name><surname>Sutula</surname><given-names>T</given-names></name><name><surname>Roopra</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure</article-title><source>Nature Neuroscience</source><volume>9</volume><fpage>1382</fpage><lpage>1387</lpage><pub-id pub-id-type="doi">10.1038/nn1791</pub-id><pub-id pub-id-type="pmid">17041593</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>EC</given-names></name><name><surname>Cowan</surname><given-names>CW</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>REST acts through multiple deacetylase complexes</article-title><source>Neuron</source><volume>31</volume><fpage>339</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(01)00386-5</pub-id><pub-id pub-id-type="pmid">11516389</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>D</given-names></name><name><surname>Fukuchi</surname><given-names>M</given-names></name><name><surname>Miyashita</surname><given-names>T</given-names></name><name><surname>Tabuchi</surname><given-names>A</given-names></name><name><surname>Takasaki</surname><given-names>I</given-names></name><name><surname>Naruse</surname><given-names>Y</given-names></name><name><surname>Mori</surname><given-names>N</given-names></name><name><surname>Kondo</surname><given-names>T</given-names></name><name><surname>Tsuda</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Remote control of activity-dependent BDNF gene promoter-I transcription mediated by REST/NRSF</article-title><source>Biochemical and Biophysical Research Communications</source><volume>384</volume><fpage>506</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2009.05.007</pub-id><pub-id pub-id-type="pmid">19426709</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harney</surname><given-names>SC</given-names></name><name><surname>Jones</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Pre- and postsynaptic properties of somatic and dendritic inhibition in dentate gyrus</article-title><source>Neuropharmacology</source><volume>43</volume><fpage>584</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1016/s0028-3908(02)00169-7</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartman</surname><given-names>KN</given-names></name><name><surname>Pal</surname><given-names>SK</given-names></name><name><surname>Burrone</surname><given-names>J</given-names></name><name><surname>Murthy</surname><given-names>VN</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Activity-dependent regulation of inhibitory synaptic transmission in hippocampal neurons</article-title><source>Nature Neuroscience</source><volume>9</volume><fpage>642</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1038/nn1677</pub-id><pub-id pub-id-type="pmid">16582905</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofer</surname><given-names>M</given-names></name><name><surname>Pagliusi</surname><given-names>SR</given-names></name><name><surname>Hohn</surname><given-names>A</given-names></name><name><surname>Leibrock</surname><given-names>J</given-names></name><name><surname>Barde</surname><given-names>YA</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain</article-title><source>The EMBO Journal</source><volume>9</volume><fpage>2459</fpage><lpage>2464</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1990.tb07423.x</pub-id><pub-id pub-id-type="pmid">2369898</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X-L</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>G-H</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Feng</surname><given-names>X-Y</given-names></name><name><surname>Lu</surname><given-names>T-J</given-names></name><name><surname>Xiong</surname><given-names>H</given-names></name><name><surname>Fei</surname><given-names>J</given-names></name><name><surname>Xiong</surname><given-names>Z-Q</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Conditional deletion of NRSF in forebrain neurons accelerates epileptogenesis in the kindling model</article-title><source>Cerebral Cortex</source><volume>21</volume><fpage>2158</fpage><lpage>2165</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhq284</pub-id><pub-id pub-id-type="pmid">21339379</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>ZJ</given-names></name><name><surname>Kirkwood</surname><given-names>A</given-names></name><name><surname>Pizzorusso</surname><given-names>T</given-names></name><name><surname>Porciatti</surname><given-names>V</given-names></name><name><surname>Morales</surname><given-names>B</given-names></name><name><surname>Bear</surname><given-names>MF</given-names></name><name><surname>Maffei</surname><given-names>L</given-names></name><name><surname>Tonegawa</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex</article-title><source>Cell</source><volume>98</volume><fpage>739</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81509-3</pub-id><pub-id pub-id-type="pmid">10499792</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isackson</surname><given-names>PJ</given-names></name><name><surname>Huntsman</surname><given-names>MM</given-names></name><name><surname>Murray</surname><given-names>KD</given-names></name><name><surname>Gall</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF</article-title><source>Neuron</source><volume>6</volume><fpage>937</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(91)90234-q</pub-id><pub-id pub-id-type="pmid">2054188</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Sakata</surname><given-names>K</given-names></name><name><surname>Lu</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>QQ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A key mechanism underlying sensory experience-dependent maturation of neocortical GABAergic circuits in vivo</article-title><source>PNAS</source><volume>108</volume><fpage>12131</fpage><lpage>12136</lpage><pub-id pub-id-type="doi">10.1073/pnas.1105296108</pub-id><pub-id pub-id-type="pmid">21730187</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>Gamblin</surname><given-names>RJ</given-names></name><name><surname>Ooi</surname><given-names>L</given-names></name><name><surname>Bruce</surname><given-names>AW</given-names></name><name><surname>Donaldson</surname><given-names>IJ</given-names></name><name><surname>Westhead</surname><given-names>DR</given-names></name><name><surname>Wood</surname><given-names>IC</given-names></name><name><surname>Jackson</surname><given-names>RM</given-names></name><name><surname>Buckley</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Identification of the REST regulon reveals extensive transposable element-mediated binding site duplication</article-title><source>Nucleic Acids Research</source><volume>34</volume><fpage>3862</fpage><lpage>3877</lpage><pub-id pub-id-type="doi">10.1093/nar/gkl525</pub-id><pub-id pub-id-type="pmid">16899447</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>DS</given-names></name><name><surname>Mortazavi</surname><given-names>A</given-names></name><name><surname>Myers</surname><given-names>RM</given-names></name><name><surname>Wold</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Genome-wide mapping of in vivo protein-DNA interactions</article-title><source>Science</source><volume>316</volume><fpage>1497</fpage><lpage>1502</lpage><pub-id pub-id-type="doi">10.1126/science.1141319</pub-id><pub-id pub-id-type="pmid">17540862</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallunki</surname><given-names>P</given-names></name><name><surname>Edelman</surname><given-names>GM</given-names></name><name><surname>Jones</surname><given-names>FS</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The neural restrictive silencer element can act as both a repressor and enhancer of L1 cell adhesion molecule gene expression during postnatal development</article-title><source>PNAS</source><volume>95</volume><fpage>3233</fpage><lpage>3238</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.6.3233</pub-id><pub-id pub-id-type="pmid">9501246</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>CG</given-names></name><name><surname>Murthy</surname><given-names>VN</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Activity-dependent regulation of inhibition via GAD67</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>8521</fpage><lpage>8531</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1245-12.2012</pub-id><pub-id pub-id-type="pmid">22723692</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>IK</given-names></name><name><surname>Ahn</surname><given-names>JD</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Park</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>KU</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Advantages of the circular dumbbell decoy in gene therapy and studies of gene regulation</article-title><source>Current Drug Targets</source><volume>4</volume><fpage>619</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.2174/1389450033490821</pub-id><pub-id pub-id-type="pmid">14577652</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>IH</given-names></name><name><surname>Corbett</surname><given-names>BA</given-names></name><name><surname>Gilbert</surname><given-names>DL</given-names></name><name><surname>Bunge</surname><given-names>SA</given-names></name><name><surname>Sharp</surname><given-names>FR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Blood gene expression correlated with tic severity in medicated and unmedicated patients with Tourette Syndrome</article-title><source>Pharmacogenomics</source><volume>11</volume><fpage>1733</fpage><lpage>1741</lpage><pub-id pub-id-type="doi">10.2217/pgs.10.160</pub-id><pub-id pub-id-type="pmid">21142917</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lignani</surname><given-names>G</given-names></name><name><surname>Baldelli</surname><given-names>P</given-names></name><name><surname>Marra</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Homeostatic Plasticity in Epilepsy</article-title><source>Frontiers in Cellular Neuroscience</source><volume>14</volume><elocation-id>197</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2020.00197</pub-id><pub-id pub-id-type="pmid">32676011</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Bloodgood</surname><given-names>BL</given-names></name><name><surname>Hauser</surname><given-names>JL</given-names></name><name><surname>Lapan</surname><given-names>AD</given-names></name><name><surname>Koon</surname><given-names>AC</given-names></name><name><surname>Kim</surname><given-names>T-K</given-names></name><name><surname>Hu</surname><given-names>LS</given-names></name><name><surname>Malik</surname><given-names>AN</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Activity-dependent regulation of inhibitory synapse development by Npas4</article-title><source>Nature</source><volume>455</volume><fpage>1198</fpage><lpage>1204</lpage><pub-id pub-id-type="doi">10.1038/nature07319</pub-id><pub-id pub-id-type="pmid">18815592</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>T</given-names></name><name><surname>Aron</surname><given-names>L</given-names></name><name><surname>Zullo</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>TH</given-names></name><name><surname>Kim</surname><given-names>HM</given-names></name><name><surname>Drake</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Colaiácovo</surname><given-names>MP</given-names></name><name><surname>Yankner</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>REST and stress resistance in ageing and Alzheimer’s disease</article-title><source>Nature</source><volume>507</volume><fpage>448</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1038/nature13163</pub-id><pub-id pub-id-type="pmid">24670762</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marder</surname><given-names>E</given-names></name><name><surname>Goaillard</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Variability, compensation and homeostasis in neuron and network function</article-title><source>Nature Reviews. Neuroscience</source><volume>7</volume><fpage>563</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1038/nrn1949</pub-id><pub-id pub-id-type="pmid">16791145</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marty</surname><given-names>S</given-names></name><name><surname>Wehrlé</surname><given-names>R</given-names></name><name><surname>Sotelo</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Neuronal activity and brain-derived neurotrophic factor regulate the density of inhibitory synapses in organotypic slice cultures of postnatal hippocampus</article-title><source>The Journal of Neuroscience</source><volume>20</volume><fpage>8087</fpage><lpage>8095</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-21-08087.2000</pub-id><pub-id pub-id-type="pmid">11050130</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>T</given-names></name><name><surname>Rauskolb</surname><given-names>S</given-names></name><name><surname>Polack</surname><given-names>M</given-names></name><name><surname>Klose</surname><given-names>J</given-names></name><name><surname>Kolbeck</surname><given-names>R</given-names></name><name><surname>Korte</surname><given-names>M</given-names></name><name><surname>Barde</surname><given-names>YA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF</article-title><source>Nature Neuroscience</source><volume>11</volume><fpage>131</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1038/nn2038</pub-id><pub-id pub-id-type="pmid">18204444</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClelland</surname><given-names>S</given-names></name><name><surname>Flynn</surname><given-names>C</given-names></name><name><surname>Dubé</surname><given-names>C</given-names></name><name><surname>Richichi</surname><given-names>C</given-names></name><name><surname>Zha</surname><given-names>Q</given-names></name><name><surname>Ghestem</surname><given-names>A</given-names></name><name><surname>Esclapez</surname><given-names>M</given-names></name><name><surname>Bernard</surname><given-names>C</given-names></name><name><surname>Baram</surname><given-names>TZ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neuron-restrictive silencer factor-mediated hyperpolarization-activated cyclic nucleotide gated channelopathy in experimental temporal lobe epilepsy</article-title><source>Annals of Neurology</source><volume>70</volume><fpage>454</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1002/ana.22479</pub-id><pub-id pub-id-type="pmid">21905079</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClelland</surname><given-names>S</given-names></name><name><surname>Brennan</surname><given-names>GP</given-names></name><name><surname>Dubé</surname><given-names>C</given-names></name><name><surname>Rajpara</surname><given-names>S</given-names></name><name><surname>Iyer</surname><given-names>S</given-names></name><name><surname>Richichi</surname><given-names>C</given-names></name><name><surname>Bernard</surname><given-names>C</given-names></name><name><surname>Baram</surname><given-names>TZ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The transcription factor NRSF contributes to epileptogenesis by selective repression of a subset of target genes</article-title><source>eLife</source><volume>3</volume><elocation-id>e01267</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.01267</pub-id><pub-id pub-id-type="pmid">25117540</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miles</surname><given-names>R</given-names></name><name><surname>Tóth</surname><given-names>K</given-names></name><name><surname>Gulyás</surname><given-names>AI</given-names></name><name><surname>Hájos</surname><given-names>N</given-names></name><name><surname>Freund</surname><given-names>TF</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Differences between somatic and dendritic inhibition in the hippocampus</article-title><source>Neuron</source><volume>16</volume><fpage>815</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80101-4</pub-id><pub-id pub-id-type="pmid">8607999</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohba</surname><given-names>S</given-names></name><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Ikegaya</surname><given-names>Y</given-names></name><name><surname>Nishiyama</surname><given-names>N</given-names></name><name><surname>Matsuki</surname><given-names>N</given-names></name><name><surname>Yamada</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>BDNF locally potentiates GABAergic presynaptic machineries: target-selective circuit inhibition</article-title><source>Cerebral Cortex</source><volume>15</volume><fpage>291</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhh130</pub-id><pub-id pub-id-type="pmid">15238431</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ooi</surname><given-names>L</given-names></name><name><surname>Wood</surname><given-names>IC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Chromatin crosstalk in development and disease: lessons from REST</article-title><source>Nature Reviews. Genetics</source><volume>8</volume><fpage>544</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1038/nrg2100</pub-id><pub-id pub-id-type="pmid">17572692</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osako</surname><given-names>MK</given-names></name><name><surname>Tomita</surname><given-names>N</given-names></name><name><surname>Nakagami</surname><given-names>H</given-names></name><name><surname>Kunugiza</surname><given-names>Y</given-names></name><name><surname>Yoshino</surname><given-names>M</given-names></name><name><surname>Yuyama</surname><given-names>K</given-names></name><name><surname>Tomita</surname><given-names>T</given-names></name><name><surname>Yoshikawa</surname><given-names>H</given-names></name><name><surname>Ogihara</surname><given-names>T</given-names></name><name><surname>Morishita</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Increase in nuclease resistance and incorporation of NF-kappaB decoy oligodeoxynucleotides by modification of the 3’-terminus</article-title><source>The Journal of Gene Medicine</source><volume>9</volume><fpage>812</fpage><lpage>819</lpage><pub-id pub-id-type="doi">10.1002/jgm.1077</pub-id><pub-id pub-id-type="pmid">17640082</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otto</surname><given-names>SJ</given-names></name><name><surname>McCorkle</surname><given-names>SR</given-names></name><name><surname>Hover</surname><given-names>J</given-names></name><name><surname>Conaco</surname><given-names>C</given-names></name><name><surname>Han</surname><given-names>JJ</given-names></name><name><surname>Impey</surname><given-names>S</given-names></name><name><surname>Yochum</surname><given-names>GS</given-names></name><name><surname>Dunn</surname><given-names>JJ</given-names></name><name><surname>Goodman</surname><given-names>RH</given-names></name><name><surname>Mandel</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A new binding motif for the transcriptional repressor REST uncovers large gene networks devoted to neuronal functions</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>6729</fpage><lpage>6739</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0091-07.2007</pub-id><pub-id pub-id-type="pmid">17581960</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Brien</surname><given-names>RJ</given-names></name><name><surname>Kamboj</surname><given-names>S</given-names></name><name><surname>Ehlers</surname><given-names>MD</given-names></name><name><surname>Rosen</surname><given-names>KR</given-names></name><name><surname>Fischbach</surname><given-names>GD</given-names></name><name><surname>Huganir</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Activity-dependent modulation of synaptic AMPA receptor accumulation</article-title><source>Neuron</source><volume>21</volume><fpage>1067</fpage><lpage>1078</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80624-8</pub-id><pub-id pub-id-type="pmid">9856462</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palm</surname><given-names>K</given-names></name><name><surname>Belluardo</surname><given-names>N</given-names></name><name><surname>Metsis</surname><given-names>M</given-names></name><name><surname>Timmusk</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Neuronal expression of zinc finger transcription factor REST/NRSF/XBR gene</article-title><source>The Journal of Neuroscience</source><volume>18</volume><fpage>1280</fpage><lpage>1296</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-04-01280.1998</pub-id><pub-id pub-id-type="pmid">9454838</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paonessa</surname><given-names>F</given-names></name><name><surname>Latifi</surname><given-names>S</given-names></name><name><surname>Scarongella</surname><given-names>H</given-names></name><name><surname>Cesca</surname><given-names>F</given-names></name><name><surname>Benfenati</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Specificity protein 1 (Sp1)-dependent activation of the synapsin I gene (SYN1) is modulated by RE1-silencing transcription factor (REST) and 5’-cytosine-phosphoguanine (CpG) methylation</article-title><source>The Journal of Biological Chemistry</source><volume>288</volume><fpage>3227</fpage><lpage>3239</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.399782</pub-id><pub-id pub-id-type="pmid">23250796</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paonessa</surname><given-names>F</given-names></name><name><surname>Criscuolo</surname><given-names>S</given-names></name><name><surname>Sacchetti</surname><given-names>S</given-names></name><name><surname>Amoroso</surname><given-names>D</given-names></name><name><surname>Scarongella</surname><given-names>H</given-names></name><name><surname>Pecoraro Bisogni</surname><given-names>F</given-names></name><name><surname>Carminati</surname><given-names>E</given-names></name><name><surname>Pruzzo</surname><given-names>G</given-names></name><name><surname>Maragliano</surname><given-names>L</given-names></name><name><surname>Cesca</surname><given-names>F</given-names></name><name><surname>Benfenati</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Regulation of neural gene transcription by optogenetic inhibition of the RE1-silencing transcription factor</article-title><source>PNAS</source><volume>113</volume><fpage>E91</fpage><lpage>E100</lpage><pub-id pub-id-type="doi">10.1073/pnas.1507355112</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pattabiraman</surname><given-names>PP</given-names></name><name><surname>Tropea</surname><given-names>D</given-names></name><name><surname>Chiaruttini</surname><given-names>C</given-names></name><name><surname>Tongiorgi</surname><given-names>E</given-names></name><name><surname>Cattaneo</surname><given-names>A</given-names></name><name><surname>Domenici</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Neuronal activity regulates the developmental expression and subcellular localization of cortical BDNF mRNA isoforms in vivo</article-title><source>Molecular and Cellular Neurosciences</source><volume>28</volume><fpage>556</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2004.11.010</pub-id><pub-id pub-id-type="pmid">15737745</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pecoraro-Bisogni</surname><given-names>F</given-names></name><name><surname>Lignani</surname><given-names>G</given-names></name><name><surname>Contestabile</surname><given-names>A</given-names></name><name><surname>Castroflorio</surname><given-names>E</given-names></name><name><surname>Pozzi</surname><given-names>D</given-names></name><name><surname>Rocchi</surname><given-names>A</given-names></name><name><surname>Prestigio</surname><given-names>C</given-names></name><name><surname>Orlando</surname><given-names>M</given-names></name><name><surname>Valente</surname><given-names>P</given-names></name><name><surname>Massacesi</surname><given-names>M</given-names></name><name><surname>Benfenati</surname><given-names>F</given-names></name><name><surname>Baldelli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>REST-Dependent Presynaptic Homeostasis Induced by Chronic Neuronal Hyperactivity</article-title><source>Molecular Neurobiology</source><volume>55</volume><fpage>4959</fpage><lpage>4972</lpage><pub-id pub-id-type="doi">10.1007/s12035-017-0698-9</pub-id><pub-id pub-id-type="pmid">28786015</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perera</surname><given-names>A</given-names></name><name><surname>Eisen</surname><given-names>D</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Laube</surname><given-names>SK</given-names></name><name><surname>Künzel</surname><given-names>AF</given-names></name><name><surname>Koch</surname><given-names>S</given-names></name><name><surname>Steinbacher</surname><given-names>J</given-names></name><name><surname>Schulze</surname><given-names>E</given-names></name><name><surname>Splith</surname><given-names>V</given-names></name><name><surname>Mittermeier</surname><given-names>N</given-names></name><name><surname>Müller</surname><given-names>M</given-names></name><name><surname>Biel</surname><given-names>M</given-names></name><name><surname>Carell</surname><given-names>T</given-names></name><name><surname>Michalakis</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>TET3 is recruited by REST for context-specific hydroxymethylation and induction of gene expression</article-title><source>Cell Reports</source><volume>11</volume><fpage>283</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.03.020</pub-id><pub-id pub-id-type="pmid">25843715</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pozzi</surname><given-names>D</given-names></name><name><surname>Lignani</surname><given-names>G</given-names></name><name><surname>Ferrea</surname><given-names>E</given-names></name><name><surname>Contestabile</surname><given-names>A</given-names></name><name><surname>Paonessa</surname><given-names>F</given-names></name><name><surname>D’Alessandro</surname><given-names>R</given-names></name><name><surname>Lippiello</surname><given-names>P</given-names></name><name><surname>Boido</surname><given-names>D</given-names></name><name><surname>Fassio</surname><given-names>A</given-names></name><name><surname>Meldolesi</surname><given-names>J</given-names></name><name><surname>Valtorta</surname><given-names>F</given-names></name><name><surname>Benfenati</surname><given-names>F</given-names></name><name><surname>Baldelli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>REST/NRSF-mediated intrinsic homeostasis protects neuronal networks from hyperexcitability</article-title><source>The EMBO Journal</source><volume>32</volume><fpage>2994</fpage><lpage>3007</lpage><pub-id pub-id-type="doi">10.1038/emboj.2013.231</pub-id><pub-id pub-id-type="pmid">24149584</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prestigio</surname><given-names>C</given-names></name><name><surname>Ferrante</surname><given-names>D</given-names></name><name><surname>Valente</surname><given-names>P</given-names></name><name><surname>Casagrande</surname><given-names>S</given-names></name><name><surname>Albanesi</surname><given-names>E</given-names></name><name><surname>Yanagawa</surname><given-names>Y</given-names></name><name><surname>Benfenati</surname><given-names>F</given-names></name><name><surname>Baldelli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Spike-Related Electrophysiological Identification of Cultured Hippocampal Excitatory and Inhibitory Neurons</article-title><source>Molecular Neurobiology</source><volume>56</volume><fpage>6276</fpage><lpage>6292</lpage><pub-id pub-id-type="doi">10.1007/s12035-019-1506-5</pub-id><pub-id pub-id-type="pmid">30746640</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prinz</surname><given-names>AA</given-names></name><name><surname>Bucher</surname><given-names>D</given-names></name><name><surname>Marder</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Similar network activity from disparate circuit parameters</article-title><source>Nature Neuroscience</source><volume>7</volume><fpage>1345</fpage><lpage>1352</lpage><pub-id pub-id-type="doi">10.1038/nn1352</pub-id><pub-id pub-id-type="pmid">15558066</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pruunsild</surname><given-names>P</given-names></name><name><surname>Sepp</surname><given-names>M</given-names></name><name><surname>Orav</surname><given-names>E</given-names></name><name><surname>Koppel</surname><given-names>I</given-names></name><name><surname>Timmusk</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Identification of cis-elements and transcription factors regulating neuronal activity-dependent transcription of human BDNF gene</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>3295</fpage><lpage>3308</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4540-10.2011</pub-id><pub-id pub-id-type="pmid">21368041</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramírez</surname><given-names>M</given-names></name><name><surname>Gutiérrez</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Activity-dependent expression of GAD67 in the granule cells of the rat hippocampus</article-title><source>Brain Research</source><volume>917</volume><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/s0006-8993(01)02794-9</pub-id><pub-id pub-id-type="pmid">11640899</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutherford</surname><given-names>LC</given-names></name><name><surname>DeWan</surname><given-names>A</given-names></name><name><surname>Lauer</surname><given-names>HM</given-names></name><name><surname>Turrigiano</surname><given-names>GG</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Brain-derived neurotrophic factor mediates the activity-dependent regulation of inhibition in neocortical cultures</article-title><source>The Journal of Neuroscience</source><volume>17</volume><fpage>4527</fpage><lpage>4535</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-12-04527.1997</pub-id><pub-id pub-id-type="pmid">9169513</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakuragi</surname><given-names>S</given-names></name><name><surname>Tominaga-Yoshino</surname><given-names>K</given-names></name><name><surname>Ogura</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Involvement of TrkB- and p75(NTR)-signaling pathways in two contrasting forms of long-lasting synaptic plasticity</article-title><source>Scientific Reports</source><volume>3</volume><elocation-id>3185</elocation-id><pub-id pub-id-type="doi">10.1038/srep03185</pub-id><pub-id pub-id-type="pmid">24212565</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneggenburger</surname><given-names>R</given-names></name><name><surname>Meyer</surname><given-names>AC</given-names></name><name><surname>Neher</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Released fraction and total size of a pool of immediately available transmitter quanta at a calyx synapse</article-title><source>Neuron</source><volume>23</volume><fpage>399</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80789-8</pub-id><pub-id pub-id-type="pmid">10399944</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoenherr</surname><given-names>CJ</given-names></name><name><surname>Anderson</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Silencing is golden: negative regulation in the control of neuronal gene transcription</article-title><source>Current Opinion in Neurobiology</source><volume>5</volume><fpage>566</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1016/0959-4388(95)80060-3</pub-id><pub-id pub-id-type="pmid">8580707</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seil</surname><given-names>FJ</given-names></name><name><surname>Drake-Baumann</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>TrkB receptor ligands promote activity-dependent inhibitory synaptogenesis</article-title><source>The Journal of Neuroscience</source><volume>20</volume><fpage>5367</fpage><lpage>5373</lpage><pub-id pub-id-type="pmid">10884321</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>LR</given-names></name><name><surname>Dudek</surname><given-names>FE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Changes in mIPSCs and sIPSCs after kainate treatment: evidence for loss of inhibitory input to dentate granule cells and possible compensatory responses</article-title><source>Journal of Neurophysiology</source><volume>94</volume><fpage>952</fpage><lpage>960</lpage><pub-id pub-id-type="doi">10.1152/jn.01342.2004</pub-id><pub-id pub-id-type="pmid">15772233</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shelton</surname><given-names>DL</given-names></name><name><surname>Sutherland</surname><given-names>J</given-names></name><name><surname>Gripp</surname><given-names>J</given-names></name><name><surname>Camerato</surname><given-names>T</given-names></name><name><surname>Armanini</surname><given-names>MP</given-names></name><name><surname>Phillips</surname><given-names>HS</given-names></name><name><surname>Carroll</surname><given-names>K</given-names></name><name><surname>Spencer</surname><given-names>SD</given-names></name><name><surname>Levinson</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins</article-title><source>The Journal of Neuroscience</source><volume>15</volume><fpage>477</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.15-01-00477.1995</pub-id><pub-id pub-id-type="pmid">7823156</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimojo</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Hersh</surname><given-names>LB</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Role of zinc finger domains of the transcription factor neuron-restrictive silencer factor/repressor element-1 silencing transcription factor in DNA binding and nuclear localization</article-title><source>The Journal of Biological Chemistry</source><volume>276</volume><fpage>13121</fpage><lpage>13126</lpage><pub-id pub-id-type="doi">10.1074/jbc.M011193200</pub-id><pub-id pub-id-type="pmid">11145971</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimojo</surname><given-names>M</given-names></name><name><surname>Hersh</surname><given-names>LB</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>REST/NRSF-interacting LIM domain protein, a putative nuclear translocation receptor</article-title><source>Molecular and Cellular Biology</source><volume>23</volume><fpage>9025</fpage><lpage>9031</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.24.9025-9031.2003</pub-id><pub-id pub-id-type="pmid">14645515</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimojo</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Huntingtin regulates RE1-silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) nuclear trafficking indirectly through a complex with REST/NRSF-interacting LIM domain protein (RILP) and dynactin p150 Glued</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>34880</fpage><lpage>34886</lpage><pub-id pub-id-type="doi">10.1074/jbc.M804183200</pub-id><pub-id pub-id-type="pmid">18922795</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slomowitz</surname><given-names>E</given-names></name><name><surname>Styr</surname><given-names>B</given-names></name><name><surname>Vertkin</surname><given-names>I</given-names></name><name><surname>Milshtein-Parush</surname><given-names>H</given-names></name><name><surname>Nelken</surname><given-names>I</given-names></name><name><surname>Slutsky</surname><given-names>M</given-names></name><name><surname>Slutsky</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Interplay between population firing stability and single neuron dynamics in hippocampal networks</article-title><source>eLife</source><volume>4</volume><elocation-id>e04378</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.04378</pub-id><pub-id pub-id-type="pmid">25556699</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soldati</surname><given-names>C</given-names></name><name><surname>Bithell</surname><given-names>A</given-names></name><name><surname>Conforti</surname><given-names>P</given-names></name><name><surname>Cattaneo</surname><given-names>E</given-names></name><name><surname>Buckley</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington’s disease</article-title><source>Journal of Neurochemistry</source><volume>116</volume><fpage>415</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.07122.x</pub-id><pub-id pub-id-type="pmid">21105876</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>EM</given-names></name><name><surname>Chandler</surname><given-names>KE</given-names></name><name><surname>Haddley</surname><given-names>K</given-names></name><name><surname>Howard</surname><given-names>MR</given-names></name><name><surname>Hughes</surname><given-names>D</given-names></name><name><surname>Belyaev</surname><given-names>ND</given-names></name><name><surname>Coulson</surname><given-names>JM</given-names></name><name><surname>Stewart</surname><given-names>JP</given-names></name><name><surname>Buckley</surname><given-names>NJ</given-names></name><name><surname>Kipar</surname><given-names>A</given-names></name><name><surname>Walker</surname><given-names>MC</given-names></name><name><surname>Quinn</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Regulation and role of REST and REST4 variants in modulation of gene expression in in vivo and in vitro in epilepsy models</article-title><source>Neurobiology of Disease</source><volume>24</volume><fpage>41</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2006.04.020</pub-id><pub-id pub-id-type="pmid">16828291</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiegel</surname><given-names>I</given-names></name><name><surname>Mardinly</surname><given-names>AR</given-names></name><name><surname>Gabel</surname><given-names>HW</given-names></name><name><surname>Bazinet</surname><given-names>JE</given-names></name><name><surname>Couch</surname><given-names>CH</given-names></name><name><surname>Tzeng</surname><given-names>CP</given-names></name><name><surname>Harmin</surname><given-names>DA</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Npas4 regulates excitatory-inhibitory balance within neural circuits through cell-type-specific gene programs</article-title><source>Cell</source><volume>157</volume><fpage>1216</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.03.058</pub-id><pub-id pub-id-type="pmid">24855953</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Styr</surname><given-names>B</given-names></name><name><surname>Slutsky</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer’s disease</article-title><source>Nature Neuroscience</source><volume>21</volume><fpage>463</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0080-x</pub-id><pub-id pub-id-type="pmid">29403035</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Npas4: Linking Neuronal Activity to Memory</article-title><source>Trends in Neurosciences</source><volume>39</volume><fpage>264</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2016.02.003</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanwick</surname><given-names>CC</given-names></name><name><surname>Murthy</surname><given-names>NR</given-names></name><name><surname>Kapur</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Activity-dependent scaling of GABAergic synapse strength is regulated by brain-derived neurotrophic factor</article-title><source>Molecular and Cellular Neurosciences</source><volume>31</volume><fpage>481</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2005.11.002</pub-id><pub-id pub-id-type="pmid">16330218</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamamaki</surname><given-names>N</given-names></name><name><surname>Yanagawa</surname><given-names>Y</given-names></name><name><surname>Tomioka</surname><given-names>R</given-names></name><name><surname>Miyazaki</surname><given-names>JI</given-names></name><name><surname>Obata</surname><given-names>K</given-names></name><name><surname>Kaneko</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse</article-title><source>The Journal of Comparative Neurology</source><volume>467</volume><fpage>60</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1002/cne.10905</pub-id><pub-id pub-id-type="pmid">14574680</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turrigiano</surname><given-names>GG</given-names></name><name><surname>Leslie</surname><given-names>KR</given-names></name><name><surname>Desai</surname><given-names>NS</given-names></name><name><surname>Rutherford</surname><given-names>LC</given-names></name><name><surname>Nelson</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Activity-dependent scaling of quantal amplitude in neocortical neurons</article-title><source>Nature</source><volume>391</volume><fpage>892</fpage><lpage>896</lpage><pub-id pub-id-type="doi">10.1038/36103</pub-id><pub-id pub-id-type="pmid">9495341</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turrigiano</surname><given-names>GG</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The self-tuning neuron: synaptic scaling of excitatory synapses</article-title><source>Cell</source><volume>135</volume><fpage>422</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.10.008</pub-id><pub-id pub-id-type="pmid">18984155</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valente</surname><given-names>P</given-names></name><name><surname>Casagrande</surname><given-names>S</given-names></name><name><surname>Nieus</surname><given-names>T</given-names></name><name><surname>Verstegen</surname><given-names>AMJ</given-names></name><name><surname>Valtorta</surname><given-names>F</given-names></name><name><surname>Benfenati</surname><given-names>F</given-names></name><name><surname>Baldelli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Site-specific synapsin I phosphorylation participates in the expression of post-tetanic potentiation and its enhancement by BDNF</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>5868</fpage><lpage>5879</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5275-11.2012</pub-id><pub-id pub-id-type="pmid">22539848</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valente</surname><given-names>P</given-names></name><name><surname>Orlando</surname><given-names>M</given-names></name><name><surname>Raimondi</surname><given-names>A</given-names></name><name><surname>Benfenati</surname><given-names>F</given-names></name><name><surname>Baldelli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fine Tuning of Synaptic Plasticity and Filtering by GABA Released from Hippocampal Autaptic Granule Cells</article-title><source>Cerebral Cortex</source><volume>26</volume><fpage>1149</fpage><lpage>1167</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhu301</pub-id><pub-id pub-id-type="pmid">25576534</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valente</surname><given-names>P</given-names></name><name><surname>Romei</surname><given-names>A</given-names></name><name><surname>Fadda</surname><given-names>M</given-names></name><name><surname>Sterlini</surname><given-names>B</given-names></name><name><surname>Lonardoni</surname><given-names>D</given-names></name><name><surname>Forte</surname><given-names>N</given-names></name><name><surname>Fruscione</surname><given-names>F</given-names></name><name><surname>Castroflorio</surname><given-names>E</given-names></name><name><surname>Michetti</surname><given-names>C</given-names></name><name><surname>Giansante</surname><given-names>G</given-names></name><name><surname>Valtorta</surname><given-names>F</given-names></name><name><surname>Tsai</surname><given-names>JW</given-names></name><name><surname>Zara</surname><given-names>F</given-names></name><name><surname>Nieus</surname><given-names>T</given-names></name><name><surname>Corradi</surname><given-names>A</given-names></name><name><surname>Fassio</surname><given-names>A</given-names></name><name><surname>Baldelli</surname><given-names>P</given-names></name><name><surname>Benfenati</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Constitutive Inactivation of the PRRT2 Gene Alters Short-Term Synaptic Plasticity and Promotes Network Hyperexcitability in Hippocampal Neurons</article-title><source>Cerebral Cortex</source><volume>29</volume><fpage>2010</fpage><lpage>2033</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhy079</pub-id><pub-id pub-id-type="pmid">29912316</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandesompele</surname><given-names>J</given-names></name><name><surname>De Preter</surname><given-names>K</given-names></name><name><surname>Pattyn</surname><given-names>F</given-names></name><name><surname>Poppe</surname><given-names>B</given-names></name><name><surname>Van Roy</surname><given-names>N</given-names></name><name><surname>De Paepe</surname><given-names>A</given-names></name><name><surname>Speleman</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes</article-title><source>Genome Biology</source><volume>3</volume><elocation-id>RESEARCH0034</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2002-3-7-research0034</pub-id><pub-id pub-id-type="pmid">12184808</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>MK</given-names></name><name><surname>Nakanishi</surname><given-names>K</given-names></name><name><surname>Ohba</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Ikegaya</surname><given-names>Y</given-names></name><name><surname>Nishiyama</surname><given-names>N</given-names></name><name><surname>Matsuki</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Brain-derived neurotrophic factor promotes the maturation of GABAergic mechanisms in cultured hippocampal neurons</article-title><source>The Journal of Neuroscience</source><volume>22</volume><fpage>7580</fpage><lpage>7585</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-17-07580.2002</pub-id><pub-id pub-id-type="pmid">12196581</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zullo</surname><given-names>JM</given-names></name><name><surname>Drake</surname><given-names>D</given-names></name><name><surname>Aron</surname><given-names>L</given-names></name><name><surname>O’Hern</surname><given-names>P</given-names></name><name><surname>Dhamne</surname><given-names>SC</given-names></name><name><surname>Davidsohn</surname><given-names>N</given-names></name><name><surname>Mao</surname><given-names>C-A</given-names></name><name><surname>Klein</surname><given-names>WH</given-names></name><name><surname>Rotenberg</surname><given-names>A</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Church</surname><given-names>GM</given-names></name><name><surname>Colaiácovo</surname><given-names>MP</given-names></name><name><surname>Yankner</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Regulation of lifespan by neural excitation and REST</article-title><source>Nature</source><volume>574</volume><fpage>359</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1647-8</pub-id><pub-id pub-id-type="pmid">31619788</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69058.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Slutsky</surname><given-names>Inna</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Tel Aviv University</institution><country>Israel</country></aff></contrib></contrib-group></front-stub><body><p>This manuscript investigates the role of the repressor-element 1-silencing transcription/neuron-restrictive silencer factor (REST/NRSF) in homeostatic regulation of neuronal activity in response to chronic hyperactivity in cultured neural networks. This work demonstrates the role of REST in network firing properties and specifically the role of inhibition in this regulation. This paper is of potential interest to a broad audience of neuroscientists, interested in the mechanisms of homeostatic plasticity and in brain disorders associated with neural dyshomeostasis.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69058.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Slutsky</surname><given-names>Inna</given-names></name><role>Reviewing Editor</role><aff><institution>Tel Aviv University</institution><country>Israel</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Carvalho</surname><given-names>Ana Luisa</given-names></name><role>Reviewer</role><aff><institution>CNC-Center for Neuroscience and Cell Biology, University of Coimbra</institution><country>Portugal</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;REST/NRSF drives homeostatic plasticity of inhibitory synapses in a target-dependent fashion&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Lu Chen as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Ana Luisa Carvalho (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>In order to strengthen the conclusions of the manuscript, we recommend the authors to provide a better link between the network-wide effects of REST silencing and its synaptic effects altering excitation-inhibition balance and BDNF-dependent molecular mechanisms underlying these effects.</p><p>1. MEA experiments:</p><p>1a. Control cultures show now no stability, ~40% increase in mean firing rate was observed after 48 hr of recordings. If possible, it would be great to improve recording conditions to stabilize the control recordings (could be due to evaporation, pH changes in the recording chamber etc).</p><p>1b. Control cultures show over-compensation of mean firing rate in response to 4AP. These results are problematic since the chosen perturbation impairs mean firing rate compensation in control conditions, resulting in over-compensation. I suggest to validate this conclusion. It is possible that 4AP at the concentration used causes excitotoxity which is pathological. The authors may use different treatments to induce hyperactivity that have been previously shown in the literature to induce normal compensation of mean firing rate under control conditions (or lower concertation of 4AP). Otherwise, these results are difficult to interpret and ODN-mediated rescue of homeostatic mean firing rate compensation is relevant only for pathological, epilepsy-like conditions. It should be clearly stated.</p><p>1c. In contrast to mean firing rate, burst properties were normalized following 48hr 4AP treatment. However, ODN treatment impaired this compensation. These results suggest that REST differentially regulate mean firing rate and firing pattern. The authors should make these conclusions clearly and explain how their mechanistic data support these network-wide effects.</p><p>2. In the paper the authors use term 'homeostatic' without mentioning what network parameter is under homeostatic control. According to the data in the manuscript, only firing pattern is homeostatically preserved following 2 days of 4AP treatment. The authors did not make an attempt to link their cellular data (in the current and the previous papers) and recent network data. The discussion of this link should be added to the revised manuscript. How REST-mediated changes in excitatory and inhibitory synapses, in addition to changes in intrinsic excitability, can explain the network-wide over-compensation of mean firing rate and compensation of firing pattern following 4AP treatment.</p><p>3. The authors address possible mechanisms underlying the observed effect, and focus on BDNF and Npas4 as possible mediators. The rationale for testing a role for BDNF is that BDNF is known to strengthen inhibitory inputs, and the authors argue that it is released mainly by excitatory neurons (although conclusive evidence for this is missing). Since enhanced GABAergic transmission was only detected on inhibitory contacts to excitatory neurons, it is proposed that BDNF could be the retrograde messenger driving the specificity of the observed effect. This idea, while attractive, lacks confirmation. The issues below should be considered to strengthen the molecular part of the study:</p><p>a) Data presented in the manuscript do show that inhibition of BDNF binding to TrkB mimics the effect of REST inhibition on eIPSCs amplitude and on the PPR, as well as on the density of perisomatic inhibitory synapses onto excitatory neurons (Figures 6 and 7; but curiously not the decrease on dendritic inhibitory synapses, which is blocked when REST is inhibited). The authors additionally show that chronic treatment with 4AP to enhance activity leads to increased expression of Npas4 and BDNF, which are partially blocked by blockade of REST (Figure 8). However, an experiment showing that the effects of increased REST activity (elicited by hyperactivity) on inhibitory transmission depend on BDNF has not been performed. The evidence showing that the effects of REST on inhibitory transmission depend on BDNF needs to be provided.</p><p>b) The authors suggest that REST activation upon hyperactivity leads to Npas4 activation and consequent p1-BDNF expression. However, in Figure 8B it is shown that Npas4 is upregulated in the absence of active REST, but at a later time point (6h and onward). It is also persistently upregulated. These data do not match the protein analysis data (Figures 8I and J), in which ODN blocks the upregulation of Npas4 at 24h. The authors should explain these discrepancies.<italic>Reviewer #1:</italic></p><p>The manuscript by Cosimo Prestigio et al., studies the role of the repressor-element 1-silencing transcription/neuron-restrictive silencer factor (REST/NRSF) in homeostatic regulation of neuronal activity in response to chronic hyperactivity in cultured neural networks. While previous studies by the authors established the role of REST in homeostatic regulation of intrinsic neuronal excitability and excitatory synaptic transmission, how REST affects network firing properties and the role of inhibition in this regulation has remained elusive.</p><p>The authors demonstrated that translocation of REST to the nucleus in response to hyperactivity occurs in both, excitatory and inhibitory neurons, while activating distinct transcriptional program based on the postsynaptic target. In particular, fast REST silencing by decoy oligodeoxynucleotide (ODN) specifically occluded an increase in mIPSC frequency and eIPSC properties (release probability, RRP size and amplitude) of inhibitory synapses on excitatory neurons, but not inhibitory neurons. Moreover, ODN-mediated REST silencing abolished an increase in the density of peri-somatic inhibitory synapses on excitatory neurons in response to hyperactivity. The authors demonstrated that this regulation of inhibition was mediated by NPAS4-BDNF signaling. At the network level, REST silencing differentially regulated mean firing rate and firing patterns in response to hyperactivity.</p><p>The paper is clearly written, the experimental design is elegant, combining network and single-cell measurements, and the data quality is high. This work strongly suggests that transcriptional regulation plays an important role in homeostatic regulation of network-wide firing properties. In order to strengthen the conclusions of the manuscript, I recommend the authors to provide a better link between the network-wide effects of REST silencing and its synaptic effects altering excitation-inhibition balance.<italic>Reviewer #2:</italic></p><p>The manuscript by Prestigio and colleagues describes a very relevant study addressing the role of REST in homeostatic regulation of inhibitory synaptic transmission. The authors determine that in hippocampal neurons hyperactivity triggers the nuclear translocation of the transcription repressor REST, which is required for the homeostatic recovery from network hyperactivity. REST activity is also necessary for the increased GABAergic inhibition that contributes to this recovery, and which the authors show to be specific for inhibitory synapses in excitatory neurons. In a second part of the study the authors found that blocking BDNF signaling produces similar effects as blocking REST activity, and thus claim an implication of BDNF in the pathway triggered by chronic hyperactivity and leading to enhanced inhibitory activity, and which depends on REST activation.</p><p>Strengths:</p><p>This first part of the manuscript, regarding the implication of REST on homeostatic regulation of inhibitory transmission, is very convincing and well documented. The target-specific effect that was observed, with inhibitory transmission onto excitatory cells being specifically affected, is very relevant.</p><p>Weaknesses:</p><p>The implication of BDNF as a retrograde signal, originating from the postsynaptic excitatory neuron, in mediating REST effects on the homeostatic upscaling of inhibitory transmission needs to be further explored. Even though blockade of BDNF binding to TrkB replicates some of the effects of REST inhibition on preventing the effects of chronic hyperactivity on inhibitory synaptic transmission, it was not shown that the role of REST in this scenario depends on BDNF signaling.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69058.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>In order to strengthen the conclusions of the manuscript, we recommend the authors to provide a better link between the network-wide effects of REST silencing and its synaptic effects altering excitation-inhibition balance and BDNF-dependent molecular mechanisms underlying these effects.</p></disp-quote><p>We tried to address most of the criticisms in the revised version of the manuscript, although we realize that some questions might still have remained unanswered, due to the complexity of the epigenetic pathways underlying the hyperactivity-dependent homeostatic response. We think that the new version of the manuscript better clarifies of the REST-dependent homeostatic response. We also take the opportunity to thank the Editors and Reviewers for their constructive criticisms that we fully endorsed.</p><disp-quote content-type="editor-comment"><p>1. MEA experiments:</p><p>1a. Control cultures show now no stability, ~40% increase in mean firing rate was observed after 48 hr of recordings. If possible, it would be great to improve recording conditions to stabilize the control recordings (could be due to evaporation, pH changes in the recording chamber etc).</p></disp-quote><p>Indeed, MEA recordings in 4AP-untreated cultures show a 40% increase of MFR, mostly due to the increased burst duration during the 48 h of observation, and this effect complicates the interpretation of the results. However, under our culture conditions, we regularly observe a time-dependent increase in activity (see, e.g., Suppl. Figure 7d in (Pozzi et al., 2013)).</p><p>Under our conditions, the healthy neural networks behave as a dynamic entity that, over the course of the in vitro maturation, increases the number and strength of its synaptic connections, as well as the intrinsic cell excitability. As a consequence, we routinely observe an increase in MFR, BF and BD, a phenomenon that is particularly strong between the second and third week in vitro.</p><p>This time-dependent increase could have been enhanced by the adoption of the 48-multiwells Axion BioSystems MEAs (1.1 x 1.1 mm recording area, instead of the wider MCS MEAs used in Pozzi et al., 2013) and by the corresponding higher cell-density (2500 cell/mm<sup>2</sup>) that we used. This could have contributed to the noticeable time-dependent increase of spontaneous activity, consistent with previous reports showing that the activity increase is enhanced by cell density, particularly during the third week in vitro (Biffi et al., 2013; Ito et al., 2010).</p><p>However, we agree that the mean firing rate increase of ~40% under control conditions (former Figure 2B) makes data interpretation more difficult. In the first version of the manuscript, we excluded only those wells that contained &lt;4 active electrodes (&lt; 5 spikes/min). We have now re-analyzed the data also excluding control wells showing a time-dependent increase of the spontaneous activity higher than 60% and 4AP-treated wells that were unresponsive to 4AP. This new analysis did not affect the final results, but significantly limited the activity increase under control conditions, also reducing overcompensation.</p><disp-quote content-type="editor-comment"><p>1b. Control cultures show over-compensation of mean firing rate in response to 4AP. These results are problematic since the chosen perturbation impairs mean firing rate compensation in control conditions, resulting in over-compensation. I suggest to validate this conclusion. It is possible that 4AP at the concentration used causes excitotoxity which is pathological. The authors may use different treatments to induce hyperactivity that have been previously shown in the literature to induce normal compensation of mean firing rate under control conditions (or lower concertation of 4AP). Otherwise, these results are difficult to interpret and ODN-mediated rescue of homeostatic mean firing rate compensation is relevant only for pathological, epilepsy-like conditions. It should be clearly stated.</p></disp-quote><p>As mentioned above, overcompensation was substantially reduced by the new data analysis. While the concern on 4AP excitotoxicity is reasonable, we have investigated it in detail in our previous paper (see Figure 4F of Pozzi et al., EMBO J, 2013), showing that a treatment with 100 µM 4AP for 24, 48 and 96 h does not affect cell viability.</p><disp-quote content-type="editor-comment"><p>1c. In contrast to mean firing rate, burst properties were normalized following 48hr 4AP treatment. However, ODN treatment impaired this compensation. These results suggest that REST differentially regulate mean firing rate and firing pattern. The authors should make these conclusions clearly and explain how their mechanistic data support these network-wide effects.</p></disp-quote><p>The chronic chemical stimulation with 4AP (100 µM; maintained for the entire period of observation, 48hr) dramatically increased network activity (Figure 2B), but also the sPSCs and firing frequency of individual neurons (see Suppl. Figure 1 of (Pecoraro-Bisogni et al., 2018)). At this low concentration (100 µM), the 4AP effect is limited to a moderate increase of AP width (Mitterdorfer and Bean, 2002) that, by activating a larger presynaptic ca<sup>2+</sup> influx, enhances both EPSP and IPSP amplitudes. This could well explain why the acute effect of 4AP consists of an increase of MFR and BR, accompanied by a decrease of BD. In fact, larger EPSPs will induce more efficiently and frequently burst activity, but the IPSP rise will make feedback inhibition stronger, silencing burst activity more rapidly and generating shorter BD.</p><p>We agree that in the first version of the manuscript, the MEA results showed that REST differentially regulates MFR and firing pattern. However, our data did not show that the burst properties (BF and BD) are both normalized following 48hr 4AP treatment. In the previous version of Figure 2, only BF recovered the control condition while BD, similarly to MFR, was over-compensated. With the re-analysis of the data, the over-compensation of the MFR becomes not significant, although a moderate overcompensation of BD is preserved.</p><p>To further prove that the progressive increase of activity under control conditions and the possible over-compensation associated with the homeostatic effect is not due to experimental artifacts, see Figure 6E from Pozzi et al., 2013, where it is possible to appreciate the dramatic impairment in the build-up of the firing rate during in vitro development in cultures overexpressing REST. These data demonstrate that overexpression of exogenous REST, evoked a dramatic over-compensation of activity. Thus, it is possible that the hyperactivity-induced REST activation induces moderate over-compensation. Our current and previous data suggest that over-compensation could be a direct consequence of the multiple homeostatic processes triggered by hyperactivity that overcome the physiological activity increase due to network maturation. We better discuss these points in the paper.</p><disp-quote content-type="editor-comment"><p>2. In the paper the authors use term 'homeostatic' without mentioning what network parameter is under homeostatic control. According to the data in the manuscript, only firing pattern is homeostatically preserved following 2 days of 4AP treatment. The authors did not make an attempt to link their cellular data (in the current and the previous papers) and recent network data. The discussion of this link should be added to the revised manuscript. How REST-mediated changes in excitatory and inhibitory synapses, in addition to changes in intrinsic excitability, can explain the network-wide over-compensation of mean firing rate and compensation of firing pattern following 4AP treatment.</p></disp-quote><p>We realized we did not discuss how the homeostatic effects induced by hyperactivity on the inhibitory system may contribute to the previously described homeostatic effects in intrinsic excitability (Pozzi et al., 2013) and strength of excitatory transmission (Pecoraro-Bisogni et al., 2018). On a whole, 4AP-induced chronic hyperactivity induces the following compensatory responses triggered by REST, namely: (1) reduced expression of voltage-gated Na<sub>V</sub>1.2 channels, downregulating intrinsic excitability particularly at the level of excitatory neurons (Pozzi et al., 2013); (2) reduced strength of excitatory synapses to excitatory neurons, acting at the presynaptic level (Pecoraro-Bisogni et al., 2018); (3) increased strength and density of peri-somatic GABAergic synaptic contacts to excitatory neurons; (rts after 1hr and peaks at 4) decreased density of dendritic inhibitory synapses onto excitatory neurons (current paper).</p><p>Collectively, the first three effects highlight a dramatic alteration of the E/I balance that could explain the over-compensating homeostatic action of REST. The latter effect, instead, deserves some considerations. It has been reported that somatic IPSP is larger and has an almost mono-exponential decay while dendritic IPSP is smaller, slower, and has a pronounced second phase. (Miles et al., 1996). It is known that precisely timed somatic inhibition should limit both the number of action potentials and the time window during which firing can occur (Pouille, 2001), while dendritic inhibition mostly modulates the summation of excitatory synaptic potentials (Chiu et al., 2013).</p><p>It is possible to speculate that the enhancement of peri-somatic inhibitory inputs represents the main limitation to the repetitive discharge of APs by excitatory neurons, thus reducing MFR, BF and BD. In parallel, the decrease of dendritic inhibition, that normally controls the efficacy of afferent inputs by suppressing the generation of dendritic ca<sup>2+</sup> spikes and limiting EPSC-induced depolarization (Miles et al., 1996), can favor postsynaptic integration and plasticity at dendritic level. It was previously shown that stability, as well as the compensatory feedback responses, are greater at the population compared to the single-unit level (Slomowitz et al., 2015), indicating that sim­ilar network properties may arise from multiple configurations of individual components (Marder and Goaillard, 2006; Prinz et al., 2004). Consistent with this concept, our results suggest that firing macro-stability can emerge from highly diverse combinations of synaptic strength and intrinsic neuronal properties.</p><disp-quote content-type="editor-comment"><p>3. The authors address possible mechanisms underlying the observed effect, and focus on BDNF and Npas4 as possible mediators. The rationale for testing a role for BDNF is that BDNF is known to strengthen inhibitory inputs, and the authors argue that it is released mainly by excitatory neurons (although conclusive evidence for this is missing).</p></disp-quote><p>We based our interpretation that glutamatergic principal neurons represent the main source of the activity-dependent release of BDNF based on previous reports (Matsumoto <italic>et al.,</italic> 2008; Dieni <italic>et al.,</italic> 2012) and on the demonstration that BDNF mRNA is unambiguously detected in cell bodies of excitatory neurons (Hofer et al., 1990; Isackson et al., 1991), while it is absent from cortical inhibitory interneurons (Cohen-Cory <italic>et al.,</italic> 2010; Andreska <italic>et al.,</italic> 2014). However, the most convincing data supporting our interpretation derive from the work of Greenberg and colleagues who clearly showed that high K<sup>+</sup>-induced depolarization enhanced BDNF mRNA in pure cultured excitatory neurons, while BDNF mRNA was not increased in pure cultured inhibitory neurons (Spiegel et al., 2014). Since enhanced GABAergic transmission was only detected at inhibitory contacts with excitatory neurons, it is tempting to speculate that BDNF could be the retrograde messenger driving the specificity of the observed effects. However, we agree that this is a debated point, as demonstrated, e.g., by a recent study which revealed expression of BDNF in both glutamatergic principal cells and GABAergic interneurons (Barreda Tomás et al., 2020).</p><disp-quote content-type="editor-comment"><p>Since enhanced GABAergic transmission was only detected on inhibitory contacts to excitatory neurons, it is proposed that BDNF could be the retrograde messenger driving the specificity of the observed effect. This idea, while attractive, lacks confirmation. The issues below should be considered to strengthen the molecular part of the study:</p><p>a) Data presented in the manuscript do show that inhibition of BDNF binding to TrkB mimics the effect of REST inhibition on eIPSCs amplitude and on the PPR, as well as on the density of perisomatic inhibitory synapses onto excitatory neurons (Figures 6 and 7; but curiously not the decrease on dendritic inhibitory synapses, which is blocked when REST is inhibited).</p></disp-quote><p>The lack of effect of the inhibition of BDNF binding to TrkB on the decrease of dendritic inhibitory synapses indicates that hyperactivity triggers BDNF-dependent (enhancement of the strength and number of peri-somatic inhibitory synapses) and BDNF-independent (inhibition of the number of axo-dendritic synapses) REST-mediated responses. Although the two effects are opposite, electrophysiology only revealed the enhancement of inhibitory inputs, being mostly sensitive to synaptic currents of somatic origin. These effects are fully consistent with the data obtained by Greenberg and colleagues, who showed that high K<sup>+</sup>-induced hyperactivity simultaneously increased strength and number of somatic inhibitory synapses onto CA1 pyramidal neurons in a Npas4- and BNDF-dependent manner, while it decreased number and strength of dendritic inhibitory synapses in a Npas4-dependent but BDNF-independent way (Bloodgood et al., 2013). Moreover, in models of temporal lobe epilepsy, spontaneous GABAergic inhibition is increased in the soma and reduced in the dendrites of pyramidal neurons (Cossart et al., 2001). A further confirmation of the specific somatic, and not dendritic, effects of BDNF comes from the work of Erin Shuman and colleagues who found that BDNF mRNA was present in the somatic compartment of hippocampal slices or the somata of cultured rat hippocampal neurons, but it was rarely detected in the dendritic processes (Will et al., 2013).</p><disp-quote content-type="editor-comment"><p>The authors additionally show that chronic treatment with 4AP to enhance activity leads to increased expression of Npas4 and BDNF, which are partially blocked by blockade of REST (Figure 8). However, an experiment showing that the effects of increased REST activity (elicited by hyperactivity) on inhibitory transmission depend on BDNF has not been performed. The evidence showing that the effects of REST on inhibitory transmission depend on BDNF needs to be provided.</p></disp-quote><p>We thank the Reviewer for the suggestion. To this end, we studied the increase in peri-somatic synapses as a proxy of the homeostatic response to hyperactivity by addressing the question of whether the homeostatic effects of REST and BDNF occur in parallel (i.e., are independent mechanisms both activated by hyperactivity and converging on the same target) or they are serially connected with BDNF acting downstream of REST.</p><p>Thus, we have carried out new confocal imaging experiments where we compared the effects of the following treatments on the 4AP-induced increase of peri-somatic synapses:</p><p>1. REST inhibition</p><p>2. TrkB inhibition</p><p>3. TrkB inhibition + REST inhibition</p><p>4. REST inhibition + TrkB activation (with exogenous BDNF)</p><p>5. REST activation + TrkB activation</p><p>The results were statistically analyzed (2-way ANOVA) to demonstrate the presence of pure additive effects (in case of the “<italic>in parallel</italic>” model) or an occlusion (in case of the “<italic>in series</italic>” model). The new results that we obtained, support the hypothesis that the increase of peri-somatic synapses depends on an “<italic>in series”</italic> activation of REST and BDNF. In fact, combined inhibition of REST and BDNF exerts the same extent of inhibition of the homeostatic response (increase in peri-somatic synapses) of the respective single treatments. On the other hand, exogenous BDNF fully rescues the homeostatic response in the presence or absence of REST inhibition, indicating that BDNF lies downstream of REST activation.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69058-sa2-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>b) The authors suggest that REST activation upon hyperactivity leads to Npas4 activation and consequent p1-BDNF expression. However, in Figure 8B it is shown that Npas4 is upregulated in the absence of active REST, but at a later time point (6h and onward). It is also persistently upregulated. These data do not match the protein analysis data (Figures 8I and J), in which ODN blocks the upregulation of Npas4 at 24h. The authors should explain these discrepancies.</p></disp-quote><p>Our data suggest that REST plays a dual role on Npas4 mRNA levels: (1) it allows an early induction of Npas4 mRNA, that starts after 1hr and peaks at 6 h; (2) it also favors the late return of Npas4 mRNA to basal levels after 24 h. Indeed, when REST is blocked by ODN, the NPAS4 mRNA increase is delayed and does not return to basal values after 24 h. We agree with the Editor that the direct comparison of Npas4 mRNA and protein levels shows some discrepancies, but the apparent mismatch is conditioned by the temporal lag between transcription and translation. This explains why Npas4 mRNA increases after 1 h of hyperactivity and is followed by a similar change in Npas4 protein after 20 h. We noted a similar time-lag for other REST target genes (vGAT and GAD67), whose mRNAs increase after 12/24 h of hyperactivity, while the protein levels change after 48 h.</p><p><bold>References</bold></p><p>Andreska T, Aufmkolk S, Sauer M, Blum R. 2014. High abundance of BDNF within glutamatergic presynapses of cultured hippocampal neurons. <italic>Front Cell Neurosci</italic> 0. doi:10.3389/fncel.2014.00107</p><p>Asada H, Kawamura Y, Maruyama K, Kume H, Ding RG, Kanbara N, Kuzume H, Sanbo M, Yagi T, Obata K. 1997. Cleft palate and decreased brain γ-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. <italic>Proc Natl Acad Sci U S A</italic> 94:6496–6499. doi:10.1073/pnas.94.12.6496</p><p>Barreda Tomás FJ, Turko P, Heilmann H, Trimbuch T, Yanagawa Y, Vida I, Münster-Wandowski A. 2020. BDNF Expression in Cortical GABAergic Interneurons. <italic>Int J Mol Sci</italic> 21:E1567. doi:10.3390/ijms21051567</p><p>Biffi E, Regalia G, Menegon A, Ferrigno G, Pedrocchi A. 2013. The influence of neuronal density and maturation on network activity of hippocampal cell cultures: a methodological study. <italic>PLoS One</italic> 8:e83899. doi:10.1371/journal.pone.0083899</p><p>Bloodgood BL, Sharma N, Browne HA, Trepman AZ, Greenberg ME. 2013. The activity-dependent transcription factor NPAS4 regulates domain-specific inhibition. <italic>Nature</italic> 503:121–125. doi:10.1038/nature12743</p><p>Chiu CQ, Lur G, Morse TM, Carnevale NT, Ellis-Davies GCR, Higley MJ. 2013. Compartmentalization of GABAergic inhibition by dendritic spines. <italic>Science</italic> 340:759–762. doi:10.1126/science.1234274</p><p>Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S. 2010. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. <italic>Developmental Neurobiology</italic> 70:271–288. doi:10.1002/dneu.20774</p><p>Cossart R, Dinocourt C, Hirsch JC, Merchan-Perez A, De Felipe J, Ben-Ari Y, Esclapez M, Bernard C. 2001. Dendritic but not somatic GABAergic inhibition is decreased in experimental epilepsy. <italic>Nature Neuroscience</italic> 4:52–62. doi:10.1038/82900</p><p>Dieni S, Matsumoto T, Dekkers M, Rauskolb S, Ionescu MS, Deogracias R, Gundelfinger ED, Kojima M, Nestel S, Frotscher M, Barde Y-A. 2012. BDNF and its pro-peptide are stored in presynaptic dense core vesicles in brain neurons. <italic>J Cell Biol</italic> 196:775–788. doi:10.1083/jcb.201201038</p><p>Esclapez M, Houser CR. 1999. Up-regulation of GAD65 and GAD67 in remaining hippocampal GABA neurons in a model of temporal lobe epilepsy. <italic>J Comp Neurol</italic> 412:488–505.</p><p>Esclapez M, Tillakaratne NJ, Kaufman DL, Tobin AJ, Houser CR. 1994. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. <italic>J Neurosci</italic> 14:1834–1855.</p><p>Fukuda T, Aika Y, Heizmann CW, Kosaka T. 1998. GABAergic axon terminals at perisomatic and dendritic inhibitory sites show different immunoreactivities against two GAD isoforms, GAD67 and GAD65, in the mouse hippocampus: A digitized quantitative analysis. <italic>Journal of Comparative Neurology</italic> 395:177–194. doi:10.1002/(SICI)1096-9861(19980601)395:2&lt;177::AID-CNE3&gt;3.0.CO;2-#</p><p>Harney SC, Jones MV. 2002. Pre- and postsynaptic properties of somatic and dendritic inhibition in dentate gyrus. <italic>Neuropharmacology</italic> 43:584–594. doi:10.1016/s0028-3908(02)00169-7</p><p>Hartman KN, Pal SK, Burrone J, Murthy VN. 2006. Activity-dependent regulation of inhibitory synaptic transmission in hippocampal neurons. <italic>Nat Neurosci</italic> 9:642–649. doi:10.1038/nn1677</p><p>Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA. 1990. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. <italic>EMBO J</italic> 9:2459–2464.</p><p>Isackson PJ, Huntsman MM, Murray KD, Gall CM. 1991. BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF. <italic>Neuron</italic> 6:937–948. doi:10.1016/0896-6273(91)90234-q</p><p>Ito D, Tamate H, Nagayama M, Uchida T, Kudoh SN, Gohara K. 2010. Minimum neuron density for synchronized bursts in a rat cortical culture on multi-electrode arrays. <italic>Neuroscience</italic> 171:50–61. doi:10.1016/j.neuroscience.2010.08.038</p><p>Kash SF, Johnson RS, Tecott LH, Noebels JL, Mayfield RD, Hanahan D, Baekkeskov S. 1997. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. <italic>Proc Natl Acad Sci USA</italic> 94:14060–14065. doi:10.1073/pnas.94.25.14060</p><p>Lau CG, Murthy VN. 2012. Activity-dependent regulation of inhibition via GAD67. <italic>J Neurosci</italic> 32:8521–8531. doi:10.1523/JNEUROSCI.1245-12.2012</p><p>Marder E, Goaillard J-M. 2006. Variability, compensation and homeostasis in neuron and network function. <italic>Nat Rev Neurosci</italic> 7:563–574. doi:10.1038/nrn1949</p><p>Matsumoto T, Rauskolb S, Polack M, Klose J, Kolbeck R, Korte M, Barde Y-A. 2008. Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF. <italic>Nat Neurosci</italic> 11:131–133. doi:10.1038/nn2038</p><p>Miles R, Tóth K, Gulyás AI, Hájos N, Freund TF. 1996. Differences between somatic and dendritic inhibition in the hippocampus. <italic>Neuron</italic> 16:815–823. doi:10.1016/s0896-6273(00)80101-4</p><p>Mitterdorfer J, Bean BP. 2002. Potassium currents during the action potential of hippocampal CA3 neurons. <italic>J Neurosci</italic> 22:10106–10115.</p><p>Pecoraro-Bisogni F, Lignani G, Contestabile A, Castroflorio E, Pozzi D, Rocchi A, Prestigio C, Orlando M, Valente P, Massacesi M, Benfenati F, Baldelli P. 2018. REST-Dependent Presynaptic Homeostasis Induced by Chronic Neuronal Hyperactivity. <italic>Mol Neurobiol</italic> 55:4959–4972. doi:10.1007/s12035-017-0698-9</p><p>Pouille F. 2001. Enforcement of Temporal Fidelity in Pyramidal Cells by Somatic Feed-Forward Inhibition. <italic>Science</italic> 293:1159–1163. doi:10.1126/science.1060342</p><p>Pozzi D, Lignani G, Ferrea E, Contestabile A, Paonessa F, D’Alessandro R, Lippiello P, Boido D, Fassio A, Meldolesi J, Valtorta F, Benfenati F, Baldelli P. 2013. REST/NRSF-mediated intrinsic homeostasis protects neuronal networks from hyperexcitability. <italic>EMBO J</italic> 32:2994–3007. doi:10.1038/emboj.2013.231</p><p>Prinz AA, Bucher D, Marder E. 2004. Similar network activity from disparate circuit parameters. <italic>Nat Neurosci</italic> 7:1345–1352. doi:10.1038/nn1352</p><p>Ramírez M, Gutiérrez R. 2001. Activity-dependent expression of GAD67 in the granule cells of the rat hippocampus. <italic>Brain Res</italic> 917:139–146. doi:10.1016/s0006-8993(01)02794-9</p><p>Rutherford LC, DeWan A, Lauer HM, Turrigiano GG. 1997. Brain-derived neurotrophic factor mediates the activity-dependent regulation of inhibition in neocortical cultures. <italic>J Neurosci</italic> 17:4527–4535.</p><p>Sexton CA, Penzinger R, Mortensen M, Bright DP, Smart TG. 2021. Structural determinants and regulation of spontaneous activity in GABAA receptors. <italic>Nat Commun</italic> 12:5457. doi:10.1038/s41467-021-25633-0</p><p>Slomowitz E, Styr B, Vertkin I, Milshtein-Parush H, Nelken I, Slutsky M, Slutsky I. 2015. Interplay between population firing stability and single neuron dynamics in hippocampal networks. <italic>eLife</italic> 4. doi:10.7554/<italic>eLife</italic>.04378</p><p>Spiegel I, Mardinly AR, Gabel HW, Bazinet JE, Couch CH, Tzeng CP, Harmin DA, Greenberg ME. 2014. Npas4 regulates excitatory-inhibitory balance within neural circuits through cell-type-specific gene programs. <italic>Cell</italic> 157:1216–1229. doi:10.1016/j.cell.2014.03.058</p><p>Stork O, Ji FY, Kaneko K, Stork S, Yoshinobu Y, Moriya T, Shibata S, Obata K. 2000. Postnatal development of a GABA deficit and disturbance of neural functions in mice lacking GAD65. <italic>Brain Res</italic> 865:45–58. doi:10.1016/s0006-8993(00)02206-x</p><p>Swanwick CC, Murthy NR, Kapur J. 2006. Activity-dependent scaling of GABAergic synapse strength is regulated by brain-derived neurotrophic factor. <italic>Mol Cell Neurosci</italic> 31:481–492. doi:10.1016/j.mcn.2005.11.002</p><p>Tian N, Petersen C, Kash S, Baekkeskov S, Copenhagen D, Nicoll R. 1999. The role of the synthetic enzyme GAD65 in the control of neuronal γ-aminobutyric acid release. <italic>Proc Natl Acad Sci U S A</italic> 96:12911–12916. doi:10.1073/pnas.96.22.12911</p><p>Will TJ, Tushev G, Kochen L, Nassim-Assir B, Cajigas IJ, tom Dieck S, Schuman EM. 2013. Deep Sequencing and High-Resolution Imaging Reveal Compartment-Specific Localization of Bdnf mRNA in Hippocampal Neurons. <italic>Sci Signal</italic> 6:rs16.</p></body></sub-article></article>